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SUMMARY 
The tetraspanins are a superfamily of 4-pass membrane proteins with a wide 
distribution in multi-cellular organisms. Tetraspanins have been implicated in a 
number of basic cellular functions and recent findings showed that they are playing 
roles during pathological conditions such as cancer and viral infections e.g. HIV -1. 
Their functions appear linked to their ability to form interactions with other 
membrane proteins like integrins and it is suggested that they act as "molecular 
facilitators" . 
A recent report from Takeda and co-workers shed a light on the involvement of 
tetraspanins in mononuclear phagocyte fusion to form multinucleated giant cells 
(MGCs). The authors found that antibodies to CD9 and CD81 enhanced the fusion of 
Concanavalin A stimulated peripheral blood monocytes, and that 
monocytes/macrophages from CD9/CD81 double knockout mice showed an enhanced 
MGC formation (Takeda et ai, J. Cell. BioI. 161:945-956). This thesis describes 
further attempts to investigate the role of tetraspanins in MGC formation, primarily 
using recombinant proteins corresponding to their large extracellular (EC2) domains 
expressed as GST fusion proteins. Using a Concanavalin A induced monocyte fusion 
system, we confirmed that antibodies to CD9 enhanced MGC formation. However, in 
contrast to Takeda et al (2003), we found that various anti CD63 antibodies inhibited 
this function. Recombinant EC2CD9 and EC2CD63 inhibited MGC formation, 
whereas EC2CD81, EC2CD82, EC2CD 151 and GST had no effect. The recombinant 
proteins did not appear to affect cell numbers and did not inhibit aggregation or 
normal monocyte adhesion, which are the pre-requisites for fusion. Flow cytometry 
analysis using EC2 tetraspanins labelled with fluorescent dyes indicated that 
EC2CD63 and EC2CD9 are binding specifically to the Concanavalin A stimulated 
monocytes. 
In addition this thesis reports attempts to characterise a single chain Fv (scFv) 
antibody with putative specificity for CD63. This had been isolated using 
combinatorial library techniques from a patient with ocular melanoma by a previous 
worker. Studies indicate that although it binds to melanoma cells, the antibody is not 
specific to human CD63. 
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CHAPTER} 
INTRODUCTION 
Cell surface proteins are of crucial importance because they provide the cell with the 
means by which to sense, respond to and interact with the environment (Wright and 
Tomlinsons, 1994). A recently discovered protein family, which gained the attention 
of the research community, is the tetraspanin superfamily since they display numerous 
functions that indicate their physiological importance. 
1.1.The tetraspanin superfamily of membrane glycoproteins 
The tetraspanin superfamily is a group of genes that encode cell-surface proteins 
expressed in humans as well as primitive organisms (Tomlinson and Wright, 1996). 
The transmembrane proteins of the tetraspanin or transmembrane 4 (TM4SF) 
superfamily are assembled in multimeric complexes on the cell surface and the spatial 
orientation of tetraspanins within these complexes may affect signalling functions of 
the associated transmembrane proteins or receptors such as integrins. Tetraspanins 
first appeared in multicellular organisms and the family contains more than 30 
members in mammals, 37 in Drosophila and 20 in Caenorhabditis elegans (Stipp et 
ai, 2003). 33 tetraspanin genes have been identified in human (P.N.Monk, University 
of Sheffield, personal communication). 
The existence of so many different tetraspanin molecules, as well as their expression 
in organisms as evolutionarily diverse as humans and schistomes, suggests a key role 
in biological systems (Wright and Tomlinons, 1994). 
The diversity of expression of tetraspanin proteins is impressive and ranges from the 
developing nervous system, the vascular endothelium and most cells of the immune 
system. The involvement in function is equally diverse and includes adhesion, cell-
cell contact and motility, antigen presentation, cell fusion, viral susceptibility and the 
control of cancer metastasis (reviewed in Wright and Tomlinson, 1994; Hemler et ai, 
1996; Maecker et ai, 1997; Boucheix et ai, 2001; Hemler, 2003; Martin et ai, 2005). 
The understanding of the molecular functions of tetraspanins may be a useful tool for 
the discovery of drug molecules for various life threatening diseases such as cancer, 
human immunodeficiency disorders etc. 
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Over the past few years extensive research has been carried out on the leukocyte 
tetraspanins such as CD9, CD37, CD53, CD63, CD81, CD82 and CD151 and the 
present study is focussed on functional characterisation of CD9 and CD63. 
1.1.1. Molecular cloning and characterisation of tetraspanins 
The melanoma associated membrane bound glycoprotein ME491 (later known as 
CD63) was the first tetraspanin cloned in mouse L-cell (Ltk- cell) lines and 
characterised in 1988 (Hotta et ai, 1988). In 1990 the tetraspanins such as CD9 
(Boucheix et ai, 1991), CO-029 (Szala et ai, 1990), Sm23 (Wright et ai, 1990), CD37 
(Classon et ai, 1990), CD81 [TAPA-I] (Oren et ai, 1990) and CD53 (Angelisova et 
ai, 1990) were cloned. Genes with homology to tetraspanins have also been identified 
in the nematode, Caenorhabaditis elegans, as part of its genome project (Stipp et ai, 
2003). Recently a tetraspanin encoding gene (PLS 1) was discovered in the plant 
pathogenic fungus Magnaporthe grisea. The authors also found that the protein 
deduced from this gene defines a novel class of orthologous tetraspanin specific to 
fungi (Gourgues et ai, 2002). 
1.1.2. Structural features of tetraspanin proteins 
Tetraspanins are 204-(SAS) to 355( oculospanin) amino acid surface proteins. They 
are characterised by four transmembrane domains (TMI-TM4) delimiting two extra 
cytoplasmic regions of unequal sizes, a small extracellular loop (EC 1) containing 20-
27 amino acids and large extracellular loop (EC2) containing 75-130 amino acids. 
The extracellular domains EC 1 and EC2 are punctuated by a single intracellular loop 
flanked by a short intracellular amino terminus (typically 9-24 amino acids) and 
typically 4-40 amino acids in the carboxy terminus (Maecker et ai, 1997; 
Berditchevski, 2001; reviewed by Hemler, 2003) (Fig.I.I.l). Apart from the 
conserved signature sequences (see below), the EC2 regions show the greatest 
sequence diversity between family members, and between species orthologs. These 
regions also contain crucial functional sites, and most tetraspanin-specific antibodies 
bind to the EC2 regions (reviewed in Stipp et ai, 2003). The antibody epitope 
mapping and glycosylation pattern confirmed that the hydrophilic regions are indeed 
extracellular. In tetraspanin CD9, the small extracellular loop 1 (ECI) is thought to 
contain a glycosylation site (Boucheix et ai, 1991) but in CD37, CD53, CD63 and 
CD82, glycosylation sites are found in extracellular loop 2 (EC2) region (Wright et ai, 
2 
1994). Studies from our group indicate that the glycosylation site on CD9 may be on 
EC2 (G.Moseley, PhD thesis, University of Sheffield, 2002). 
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Fig.l.l .l. General structure of tetraspanin (A); structure of tetraspanin CD63 showing 
conserved amino acid residues (B). Fig.(A) adopted from Hemler,(2003); Fig.(B) 
courtesy of Dr.P.N.Monk, Dept. of Neurology, University of Sheffield. Where small 
and large extracellular loops are represented as EC 1 or SEL and EC2 or LEL 
respectively. 
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The hydrophobic domains are highly conserved within the family and show no 
significant sequence similarity to other molecules with four transmembrane domains, 
such as CD20 and FcrRl~, the ligand-gated ion channels (acetyl choline receptor) or 
the connexins (a family of gap-junction membrane proteins) (Wright and Tomlinson 
et at, 1994; Maecker et at, 1997). 
1.1.2.1. Tetraspanin defining residues 
Although several types of proteins contain four transmembrane domains, they are not 
considered as the members of the tetraspanin family unless they contain many of the 
conserved residues. A number of highly conserved residues and motifs distinguishes 
tetraspanins from other proteins with four membrane-spanning domains, which are 
called tetraspanin-defining residues (Wright and Tomlinson, 1994; Maecker et at, 
1997). 
The transmembrane domain of the tetraspanins contains a larger number of polar 
amino acid residues than are found in 'single pass' transmembrane domains, although 
this is not unusual for multi-transmembrane proteins. In particular, transmembrane 
domain 1 has a highly conserved Asn (N) residue, and transmembrane domains 3 and 
4 contain highly conserved Glu or GIn (E/Q) residues. These highly polar residues are 
of major interest, since their placement in the lipid bilayer would be predicted to be 
energetically unfavourable. However, such residues have been shown to mediate 
stable protein assembly through their interaction with polar residues on other 
transmembrane helices. The highly polar transmembrane residues may interact intra 
molecularly and playa part in the folding of the molecule; alternatively, they may 
form intermolecular bonds and be involved in the assembly of complexes with other 
transmembrane molecules (reviewed in Stipp et at, 2003). 
The distinctive tetraspanin defining motifs present in the major extracellular domain 
contain four highly conserved cysteine residues such as CCG, PXSC and ECG. 
Binding of antibodies to a number of tetraspanins such as CD53, CD81 and Sm23 is 
sensitive to reducing agents (Tomlinson et at, 1993; Levy et at, 1991; Oligino et at, 
1988). At least two of these cysteine residues are likely to participate in the 
disulphide bonding that is essential to the correct folding of this domain (Levy et aI, 
1991; Tomlinson et at, 1993). This has been confirmed for CD81, as described below. 
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Tetraspanins may contain up to 4 additional cysteines in the EC2 region that may be 
involved in disulphide bond formation (Seigneuret et al, 2001). 
The cytoplasmic domains show little sequence similarity between different members 
of the superfamily, suggesting that these regions might have distinct functions 
(reviewed in Berditchevski, 2001), although some residues are conserved in most of 
the classical TM4SF molecules. These include: a Lys (K) residue in the N-terminal 
region; a Glu (E) residue between transmembrane domains 2 and 3; and an Ile (I) in 
the C-terminal region (Wright and Tomlinsons, 1994). The cytoplasmic domains are 
highly conserved with homologues in other species. 
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Peripherin and Rom-l have long (79-81residues) carboxy-terminal cytoplasmic tails 
as compared to other family members (Maecker et ai, 1997). 
Distant members of the family have been reported that share the same transmembrane 
pattern and are related to each other and to the rest of the tetraspanins, based on amino 
acid homology, but lack the tetraspanins signature e.g. epithelial protein L6, which 
lacks the highly conserved N (TMl), E/Q (TM3), E/Q in TM4 and the CCG motif in 
EC2. These are no longer considered true tetraspanins (Wright et ai, 2000; reviewed 
in Stipp et ai, 2003). Figure.1.1.2 predicts the comparative relationship of the 
tetraspanins on the basis of amino acid homology. 
1.1.2.2. Crystal structure of human CD81 large extra cellular domain 
Kitadokoro and co workers have recently resolved the crystal structure of the large 
extracellular loop of human CD81 at 1.6 A resolution using His-tag hCD81-EC2, a 
purified form of a recombinant protein (Kitadokoro et ai, 2001) (Fig. 1.1.3). 
The hCD81-EC2 is organised in a homodimeric structure, hosting 176 residues and 
194 solvent molecules per asymmetric unit. Each subunit in the dimer is composed of 
five a helices, A, B, C, D and E (Fig.l.l.3). In addition to this a short helical 
segment covers residues Leul62-Ala 164. The a helices run anti parallel and are 
arranged in stalk and head sub domains. The helices A and E can be seen as the stalk 
of a mushroom-shaped molecule, whose head sub domain (~60 residues) is essentially 
composed of the last two turns of the A helix, the B, C and D helices and their 
intervening segments and the DE loop. The anti parallel pairing of the Nand C 
terminal a helices allow the two termini of the expressed hCD81-LEL to fall spatially 
close to each other. 
The sub unit fold of hCD81 is stabilised by a number of interactions. The stalk region 
is held together by hydrophobic contacts, along the A and E helices and by two salt 
bridges. The head subdomain is stabilised by two tetraspanin invariant disulphide 
bridges involving four cysteines. The disulfide bonds originate from two adjacent 
(156 and 157) cysteine residues and stretch approximately in opposite direction within 
the domain, connecting the C-terminal region of the B-helix (Cys 156) to the first turn 
of the E helix (Cys190) and the BC segment (Cys 157) to the CD loop (Cys175). 
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The crystal structure of hCD81 contains two extended low polarity regions. The first 
one is a large hydrophobic cluster and has an area of 986 A 2 and the second low 
polarity patch is located in a solvent-exposed region comprising the C and D helices. 
In the crystal, this region is virtually solvent inaccessible and the region is 
energetically unfavourable and therefore may be prone to mutation by natural 
selection (Kitadokoro et ai, 2001). 
U sing the CD81 EC2 structure as a template, it is suggested the other tetraspanin 
EC2s are also composed of two sub domains (Seigneuret et ai, 2001. The first sub 
domain is relatively conserved and corresponds to the two fITst helices (A and B) and 
the last helix (E) of the CD81 EC2 crystal structure. The second subdomain is much 
more variable between tetraspanins, with an overall structure determined by the 
conserved disulfide linking and a globally conserved chain topology including two 
specific residues, glycine and proline, which in each case are neighbour to a disulfide-
linked cysteine and promote specific bends of the main chain (Seigneuret et ai, 2001). 
The variable regions are thought to be involved in tetraspanin-specific protein-protein 
interactions whereas the constant region is speculated to be involved in dimerisation 
(reviewed in Stipp et ai, 2003). A schematic diagram of this predicted structure is 
shown in figure 1.1.1.A. 
Fig.1.1.3. Crystal structure of large extra cellular domain of CD81 
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1.1.3. Expression pattern of tetraspanins 
Some of the tetraspanins such as CD9, CD63, CD81, and CD82 show nearly 
ubiquitous tissue expression, whereas other tetraspanins such as CD53 and CD37 
show a highly restricted pattern of expression. Some members of the tetraspanins 
appear to be highly expressed in the immune system. More recently it has been found 
that the tetraspanins are also expressed by the nervous system. The expression pattern 
of various tetraspanins are summarized in the table. 1. 1 
Tetraspanin 
CD9 
CD37 
CD53 
CD63 
Other 
name (s) 
MRP-1 , 
DRAP 27 
MB-1 
gp40-50 
i OX-44 
ME491, 
NKIIC3, 
NGA, 
MLA1, 
PTLGP40, 
LIMP, 
Gp55, 
granulo-
physin, 
Lamp3 
Main cellular distribution Reference 
Platelets, early B cells, activated Rubinstein and de 
and differentiating B cells, Hass, 1999 
activated T cells, eosinophils and 
basophils, endothelial cells, brain Wright and 
and peripheral nerves, vascular Tomlinson, 1994 
smooth muscle, cardiac muscle 
and epithelial cells, acute myeloid 
and chronic lymphoid leukaemias, 
non lymphoid cells. 
Normal and neoplastic mature B Schwartz-Albiez et ai, 
cells, resting and activated T cells, 1998; Moldenhauer 
neutrophils, granulocytes, et ai, 1999 
monocytes and macrophages. 
Wright and 
Tomlinson, 1994 
Band T cells, NK ells, Monocytes, Conjeaud et aI, 1997 
macrophages, granulocytes, 
dendritic cells, osteoblasts, Wright and 
osteoclasts. Tomlinson, 1994 
Low levels of expression on 
keratinocytes and bladder 
epithelium. 
Lymphoid and non-lymphoid 
distribution including platelets, 
monocytes, neutrophils, 
macrophages, vascular endothelial 
cells, fibroblasts, glomeruli, sinus 
histocytes, smooth muscle, neural 
tissue, osteoclasts, dendritic cells 
and kupffer cells. 
Largely associated with the 
glandular tissues, lysosomes of 
melanoma cell and Weibel Palade 
bodies of endothelial cells 
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Okochi et aI, 1997 
Okochi et aI, 1999 
de Haas and 
Azorsa, 1999 
DeHaas et ai, 1997 
Metzelaar et aI, 1989 
Nishibori et aI, 1992 
Smith et aI, 1997 
Knol et ai, 1991 
Hara et aI, 1994 
CD81 
CD82 
CD151 
L6 
A15 
CO-029 
TAPA-I, 
M38 
C33,IA4, 
R2, 
4F9,KAIl 
PETA-3, 
SFA-1 
TALLA-1 1 MXS1 
_~+ CCG-B7 
Rom-1 
UPla, UPlb 
Lbm 
Wide range of tissue expression 
including Band T cells, low 
expression on monocytes and 
granulocytes, thymocytes, 
follicular dendritic cells, 
eosinophils, monocytes and 
epithelial cell. 
Band T cells, monocytes and 
granulocytes; platelets, NK cells. 
Various non haemopoietic cells 
Most of non lymphoid tissues, 
platelets, megakaryocytes, HTL V 
transformed T cells, epithelial 
cells, smooth and striated muscle 
and Schwann cells 
Lung, breast, colon, ovanan 
carCInomas, normal epithelial 
tissue 
Brain, skeletal muscle, spleen 
Colon carcinoma 
Eye 
Bladder epithelium 
Expressed on the axons, terminal 
arbors, and growth cones of 
motorneurons of Drosophila 
melanogaster 
Table.1.1. Tissue distribution of tetraspanins. 
1.1.4. Molecular Associations of tetraspanins 
Wright and 
Tomlinson, 1994 
Levy et aI, 1998 
Jones and 
Mason, 1997 
Lagudriere-Gesbert 
and Conjeaud, 1997 
Ashman et aI, 1997 
Marken et aI, 1992 
Takgi et aI, 1995 
Sazala et aI, 1990 
Bascom et aI, 1993 
Yu et aI, 1994 
Fradkin et aI, 2002 
1.1.4.1. Tetraspanin enriched microdomains and the tetraspanin web 
The ability of tetraspanins to interact with each other, and other transmembrane 
proteins, has led to the hypothesis that tetraspanins predominantly exist in 
supramolecular complexes or tetraspanin enriched micro domains (TEMs) (Kurita-
Taniguchi et aI, 2002). The extended network of tetraspanin interactions is often 
referred to as the "tetraspanin web" (reviewed in Boucheix and Rubinstein, 2001). 
Not only do tetraspanins associate with each other, but also associate with Ig 
superfamily proteins, proteoglycans, complement regulatory proteins, integrins, 
growth factors, growth factor receptors, and signalling enzymes. As tetraspanins have 
no intrinsic enzymatic activity or signalling motifs, it has been suggested that 
tetraspanins act primarily as adaptor proteins, facilitating the interaction of associated 
molecules in tetraspanin signalling networks. 
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Of specific interest are recent reports evaluating tetraspanin complexes in relation to 
lipid microdomains ('rafts'). In lipid rafts, protein-protein interactions are facilitated 
by association with membrane regIOns enriched for cholesterol and 
glycosphingolipids (Simons and Ikonen, 1997). Tetraspanin complexes are thought to 
be autonomous units, existing both within lipid rafts and as non-raft domains (Claas et 
at, 2001; Kropshofer et at, 2002). 
The assembly of the tetraspanin web/TEMS is based on multiple levels of 
interactions, which have been divided into three categories based on their 
susceptibility to different detergents (Boucheix and Rubinstein, 2001; Claas et at, 
2001; Martin et at, 2005). 
(a) The first level includes primary interactions between specific tetraspanins and 
other proteins. These interactions are direct and resist disruption by relatively 
hydrophobic detergents such as NP40 or Triton X-I00. These interactions 
generally appear to be mediated by the EC2 regions of tetraspanins and can be 
captured by chemical cross-linking. Examples of primary interactions include 
that of CD 151 with a3 ~ 1 integrin (Yauch et at, 2000), and CD9 and CD81 
with the immunoglobulin gene superfamily (IGSF) members EWI-2 and EWI-
F (Stipp et at, 2001; Charrin et at, 2001). Some homodimeric 
tetraspanin:tetraspanin interactions (e.g. CD81 :CD81) are also considered to 
be primary interactions (Hemler, 2003). 
(b) Second level interactions are indirect, more numerous, and much more 
sensitive to disruption by digitonin or Triton X-I00. Soluble second level 
complexes are maintained in detergents such as Brij-96, Brij-97. In this type 
of complex, tetraspanins associate with each other, and thereby link together 
multiple primary complexes. Secondary interactions appear to involve the 
transmembrane and/or intracellular regions (Charrin et at, 2002). Level 2 
associations are promoted or stabilized by tetraspanin palmitoylation (Yang et 
at, 2002). 
(c) A third level of tetraspanin complex assembly occurs in the context of 
complexes stable only in mild detergents such as Brij-99 or and CHAPS ((3-
[(3-Cholamidopropyl) dimethyl ammonio ]-1 propane sulfonate)]. Tertiary 
interactions are large complexes containing multiple tetraspanins and 
associated molecules, and are hypothesised to result from coalescence of 
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higher order complexes. It has been shown that tertiary interactions can occur 
independently of lipid rafts or large detergent-insoluble fractions (Claas et ai, 
2001). 
Palmitoylation may play a role in the incorporation of tetraspanins into TEMs. 
Charrin and co workers have found that all tetraspanins studied (CD9, CD37, CD53, 
CD63, CD81 and CD151) incorporated [3H] palmitate. By site-directed mutagenesis, 
the authors found that CD9 was palmitoylated at anyone of the four internal 
juxtamembrane cysteines. In addition to these the authors found that the 
palmitoylation of CD9 did not influence the partition in detergent-resistant 
membranes but contributed to the interaction with CD81 and CD53 (Charrin et ai, 
2002). 
PRIMARY INTERACTIONS SECONDARY INTERACTIONS 
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Fig. 1.1.4_ Interactions oftetraspanins. Image courtesy of Martin et ai, (2005). 
TEMS may form extended structures of primary tetraspanin complexes indirectly 
connected in large networks (Figure. 1. 1.4). It is likely that TEMs are dynamic 
structures that can change in their composition or subcellular localisation. It is known, 
for example, that the location of tetraspanin complexes can change in response to 
stimulation. Thus CD63 is reported to associate with aIIb~3 integrin-CD9 complexes 
on platelets after activation (Israels et ai, 2001). In B cells, the interaction of the 
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CD811CD21/CD19 coreceptor complex with lipid rafts has been shown to be 
modulated by palmitoylation of CD81 (Cherukuri et ai, 2004). 
In addition, soluble ligands have been identified for CD9. The pregnancy specific 
glycoproteins (PSGs) are a family of highly similar, placentally secreted proteins, 
originally isolated from the circulation of pregnant women. The human PSG induces 
IL-I0, IL-6 and TGF~l expression in human monocytes. This suggests that PSGs, 
through the induction of these Th2 cytokines, may have a role in protecting the foetus 
from attack by the maternal immune system (Snyder et ai, 200 I). Recently it was 
found that CD9 acts as a receptor for the PSGs. Anti CD9 mAb inhibited the binding 
of PSG 17 to CD9 on CD9 transfected cells and RAW 264.7 cells and PSG 17 binding 
to macrophages from CD9 deficient mice was significantly reduced (Waterhouse et 
ai, 2002). Very recently CD9 has also been shown to function as a receptor for the 
cytokine IL-16 as an alternative to CD4 receptor and mediates IL-16 related 
chemotaxis and activation of mast cells (Qi et ai, 2005). 
1.1.4.2. Association of tetraspanins with integrins 
The involvement of various tetraspanins in adhesion and cell motility (and possibly 
other functions) seems to be related to their ability to form interactions with integrins. 
The integrins are heterodimeric, two-ways signalling receptors, which are composed 
of non- identical a and ~ sub units, which recognize ligands through the extracellular 
domains and transmit intracellular signals through cytoplasmic tails (Liu et ai, 1996; 
Kishimoto et ai, 1999). Integrins are expressed on all nucleated cells, which regulate 
cell adhesion to extracellular matrix (ECM) proteins as well as intercellular cell-cell 
adhesive interactions. In humans there are at least 18 different integrin a chains and 8 
different ~ chains and they pair together noncovalently in specific patterns depending 
on the cell types in which they are expressed. The presence of particular a/~ pairs on 
the cell surface confers the ability to bind the specific ECM proteins or counter 
receptors on the other cells. The activity of integrins is controlled by a process of 
"inside-out" (short cytoplasmic tail sequences of integrins alter ligand binding) 
signalling and "outside-in" (ligand binding triggers long-range alterations in the 
cytoplasmic domain interactions) signalling (reviewed in van der Flier, 2001). 
Changes in integrin affinity for ligands are the result of changes in integrin 
conformation. Certain cations (e.g. Mg ++) and antibodies may activate integrins by 
12 
stabilizing or inducing the active conformation. In addition, binding between integrins 
and ligands is increased by integrin clustering (van der Flier et al, 2001). 
Beyond their role in regulating cell adhesion, it has become clear that integrins 
transduce signals inside the cell, which regulate the rearrangement of the actin 
cytoskeleton, cell movement, activation of specific cellular functions, gene 
transcription, cell proliferation and survival. These intracellular signals collaborate 
with signals transduced from growth factor receptors, cytokine receptors and other 
transmembrane receptors to regulate many anchorage-dependent cellular properties 
(reviewed in Berton et al, 1999). However, the short cytoplasmic regions of integrins 
have no intrinsic enzymatic activity. Instead, integrins interact with various 
cytoplasmic proteins including cytoskeletal proteins, potential signalling molecules 
and calcium binding proteins (reviewed in van der Flier, 2001). In addition they 
interact with transmembrane proteins including Ig superfamily members, growth-
factor receptors and tetraspanins (reviewed in van der Flier, 2001; Berditichevski, 
2001). 
The association of leukocyte tetraspanins (including CD9, CD53, CD63, CD81, CD82 
and CDI51) with ~1 integrins is well-documented (reviewed in Berditchevski, 2001). 
In addition, CD9, CD63 and CD151 are reported to associate with aII~3, CD151 
associates with a6~4 and CD63 associates with aM~2 on neutrophils and dendritic 
cells (Berditchevski, 2001; Mantegazza et al, 2004). Whilst some of these interactions 
are only preserved in relatively mild detergents (signifying secondary or tertiary 
interactions) the interactions between CD151 and a3~1, a6~1, a6~4 and a7~1 and 
between CD81 and a4~ 1 integrins are classed as a primary interactions. The 
interaction between CD 151 and a3 ~ 1 has been extensively studied and shown to 
involve the EC2 of CD 151 and the extracellular region of the a3 subunit (Yauch et ai, 
2000). 
Tetraspanins do not appear to alter integrin ligand binding, and do not modulate 
integrin-dependent static cell adhesion. Rather they are linked to processes such as 
cell morphology, spreading (reviewed in Berditchevski, 2001; Hemler, 2003) and 
adhesion strengthening (Lammerding et ai, 2003). In addition, there are many reports 
that tetraspanins are involved in homotyic and heterotypic adhesion (Berditcheyski, 
2001) and in cell migration. 
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1.1.4.3. Interaction between tetraspanins, integrins and signalling molecules 
Many studies suggest that integrin-associated tetraspanins are involved in adhesion-
dependent signalling. In the Raji B cell line, ectopically expressed CD9 associated 
with a4~1 and a6~1 integrin and potentiates fibronectin and laminin-I dependent 
tyrosine phosphorylation of 130 kDa and 69 kDa proteins (Shaw et ai, 1995). In 
addition, the expression of CD9 in fibrosarcoma cells specifically affects the de-
phosphorylation rate of focal adhesion kinase (F AK) (Berditchevski and Odintsova 
1999), and clustering of the a3~I-tetraspanin complexes in breast carcinoma cells 
stimulates the PI3-kinase-dependent signalling pathway (Sugiura and Berditchevski, 
1999). The contribution of tetraspanins to adhesion-dependent signalling might be 
linked with their ability to recruit certain signalling enzymes into the integrin 
complexes (Hemler, 1998). Various tetraspanins are associated with phosphoinositol 
4 -kinase (Ptdlns 4-K) (Berditchevski et ai, 1997; Yauch and Hemler, 2000; 
Berditchevski, 2001; Claas et ai, 2001; Israels and McMillan-Ward, 2005) and protein 
kinase C isoforms (Zhang et ai, 2001), and they may facilitate assembly of signalling 
complexes by tethering these enzymes to integrin heterodimers. At the plasma 
membrane, integrin-tetraspanin signalling complexes are partitioned into specific 
microdomains proximal to cholesterol-rich lipid rafts. 
It has been suggested that tetraspanins can affect organization of the actin 
cytoskeleton. This may occur, for example, via the interaction of CD9 and CD81 with 
protein kinase C isoforms (Zhang et ai, 2001; Berditchevski, 2001) or other signalling 
enzymes. A recent study shows that CD82, which act as a co-stimulator during T cell 
activation, may act as an adaptor protein, linking lipid rafts and the actin cytoskeleton 
in T cells during antigen presentation (Delaguillaumie et ai, 2004). Previous studies 
had shown that CD82 activation involved Rho GTPases (Delaguillaumie et ai, 2002). 
It has also been suggested that CD63 can modulate aIIb~3-dependent cytoskeletal 
reorganization in adherent platelets via its interaction with Ptdlns 4-K (Israels and 
McMillan-Ward, 2005). 
It has recently been shown that CD9 and CD81 can associate with a G-protein 
coupled receptor (GPCR), GPR56. The findings indicate that these tetraspanins act as 
scaffolding proteins, mediating interactions between GPCR and their intracellular 
heterotrimeric G-protein subunits (Little et ai, 2004). 
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1.1.5. Functions of tetraspanins 
As indicated previously, tetraspanins have been linked to many basic cell processes 
such as cell motility, cell differentiation, cell adhesion, cell signalling, cell fusion etc. 
(Wright and Tomlinson, 1994; Maecker et ai, 1997; Boucheix et ai, 2001; Hemler 
2003; Martin et ai, 2005). The functional properties of tetraspanins have been 
elucidated by different approaches. The main initial approach is the analysis of 
cellular effects of anti-tetraspanin antibodies, the second evaluates the effects of over 
expression by transfection and the third relates the phenotype of genetic defects 
caused either by gene knockout or by human genetic diseases (Boucheix et ai, 2001). 
Their functions are undoubtedly linked to their ability to form association with one 
another and with other membrane proteins (e.g. integrins) as discussed in section 
1.1.4. This has made it difficult to define the precise role of individual tetraspanins. 
Also studies using knockout animals have in most cases failed to show strong 
phenotypic defects, suggesting overlapping functions or functional redundancy 
amongst tetraspanins. 
In considering the functions of tetraspanins, the main emphasis will be on examples 
relevant to those studies in this thesis i.e. CD9 and CD63. 
1.1.5.1. Adhesion and motility 
Cell adhesion and motility are complex processes involving extracellular matrix 
proteins, adhesion receptors, cytoskeletal components and signalling molecules. The 
role of tetraspanins in modulating adhesion/motility has been linked to processes such 
as wound-healing and cancer metastasis (Boucheix et ai, 2001). The involvement of 
various tetraspanins in cell motility and adhesion seems to be related to their ability to 
form interactions with integrins (see section 1.1.4.2 and 1.1.4.3). A substantial 
fraction of tetraspanins co-localise with integrins in various intracellular vesicular 
compartments. It is proposed that tetraspanins can influence cell adhesion/migration 
by one of the following mechanism (1) modulation of integrin signalling (2) 
compartmentalisation of integrins on the cell surface or (3) direction of intracellular 
trafficking and recycling of integrins (reviewed in Berditchevski, 2001). 
Although the role of tetraspanins in cell adhesion appears to relate to their association 
with integrin molecules, in the case of CD9, there is also evidence of a direct 
interaction with fibronectin. Cook and co workers (Cook et ai, 1999) demonstrated a 
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role for CD9 in adhesion and spreading on the extracellular matrix fibronectin protein 
using a transfected Chinese Hamster Ovary (CHO) cell system. The transfection of 
CD9 in cells causes morphological changes and a reduction in adhesion and 
spreading on fibronectin. The effects were reversed by ligation with anti CD9 
antibody and with CD9 mutants lacking EC2 (Cook et ai, 2002). In addition, direct 
binding of fibronectin to recombinant or platelet-derived CD9 has been shown 
(Longhurst et ai, 2002). 
Koyama et ai (1990) showed that antibodies to a cell surface glycoprotein (later 
identified as CD63 (Koyama et ai, 1998)) induced adhesion, spreading and 
morphological changes in myeloid cell lines HL-60, THP-1 and U93 7. In searching 
for integrin-associated proteins, Berditchevski et ai (1995) identified an anti CD63 
antibody that co-immunoprecipitated a3~1 and a6~lintegrins from Brij 96 detergent 
lysates. CD63 co-localised with these integrins in cellular "footprints" suggesting a 
role in integrin adhesive functions. Binding of anti CD63 antibodies to neutrophils 
was reported to induce increased adhesion to human umbilical endothelial cells 
(HUVECs) and an association between CD63 and ~2-integrin (CDllb/CD18) in 
neutrophils was reported (Skubitz et ai, 1996). This association was only observed 
with CD63 that had been up-regulated to the cell surface after neutrophil activation 
(Skubitz et ai, 2000). Tyrosine kinase activity was associated with CD63 in these 
cells. CD63 was also shown to be upregulated on activation of platelets and to 
associate with the aIIb~3-CD9 complex on the plasma membrane (Israels et ai, 
2001). Antibodies to CD63 did not affect platelet adhesion, but inhibited platelet 
spreading (Israels and McMillan-Ward, 2005). 
There are many reports that CD9 plays a role in regulating motility of cells. CD9 can 
induce motorgenic signals in association with ~ 1 integrin and activation of protein 
tyrosine kinase. The association of CD9 with motility was demonstrated on the poorly 
motile B cell line Raji, which shows dramatically enhanced migration after ectopic 
expression of CD9. Enhanced levels of tyrosine-phosphorylation were observed in the 
transfected cells and migration was inhibited by the protein tyrosine kinase inhibitor 
herbimycin (Shaw et ai, 1995). 
CD9 appears to playa role in migration during wound-healing/angiogenesis. In an in 
vitro mechanical wound model, mimicking the angiogenic process, anti CD9 
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antibodies showed a dose dependent inhibition of endothelial cell migration during 
lesion repair, whereas anti ~lantibodies affected both migration and proliferation. 
CD9 was shown to co-localise with ~1 and ~3 integrins on the endothelial cell plasma 
membrane (Klein-Soyer et at, 2000). CD9 and CD81 also inhibited keratinocyte 
motility in a wound healing migration assay, and accumulated with a3 and ~1 
integrins at intercellular junctions and in cellular footprints (Penas et at, 2000). 
Antibodies to CD9, CD63, CD81 and CD151 were shown to inhibit migration of 
hepatic stellate cells (HSC) that are involved in the progression of liver fibrosis, 
although cell adhesion was not affected (Mazzocca et at, 2002). Associations with ~ I 
integrin were shown, although only that between CD9 and CD 151 and ~ 1 integrin 
were preserved in strong detergent (NP-40). 
CD9 has also been implicated in the inhibition of cancer metastasis and is reported to 
inhibit motility of cancer cells in vitro (Boucheix et at, 2001). A co-operative effect 
between CD9 and the ganglioside GM3 was reported for the inhibition of motility in 
various human cancer lines (Ono et at, 2000). Kawakami and co workers found that 
the interaction of a3 and as integrins with CD9 is promoted by GM3 (Kawakami et 
at, 2002). 
CD63 has also been reported to associate with tetraspanins such as CD9 and CD81 
and ~1 integrin on the surface of melanoma cell lines MV3 and MEL-FC as 
determined by co-immunoprecipitation using mild detergent (Radford et at, 1996). It 
was reported that transfection of human CD63 into a CD63 negative human 
melanoma cell line KM3 caused up regulated expression of ~ 1 integrin. The motility 
of CD63 transfected KM3 cells was markedly suppressed but increased adhesion on 
~ 1 substrates was observed (Radford et at, 1997). However, the recent demonstration 
by our group that the KM3 cell line used in these studies is a rat cell line questions the 
validity of this work (Moseley et at, 2003). However, studies by Jang et at, (2003) 
also indicated that reduced CD63 expression during the malignant progression of 
human melanoma may promote metastasis. For the study the authors transfected 
CD63 eDNA into Mel Juso melanoma cells, which have endogenous CD63 
expression. It was observed that decreased CD63 expression enhanced the 
invasiveness of the human melanoma cells. 
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Recently, antibodies to CD9, CD63, CD81 and CD82 were shown to enhance the 
chemokine-induced migration of dendritic cells (Mantegazza et ai, 2004). It was 
shown that antibodies to CD63 and CD82 diminished the surface expression of CD29 
(~1 integrin), CD 11 b (integrin aM), CD 18 (~2 integrin) and as integrin. CD63 was 
shown to associate with CD 11 b and CD 18 by co-immunoprecipitation in mild 
detergent (Mantegazza et ai, 2004). 
1.1.5.2. Role of tetraspanins in membrane trafficking 
A number of the human leukocyte tetraspanins (CDI51, CD63, A15 (CD231), CO-
029, CD37, CD82 and Tspan-3) contain tyrosine-based sorting motifs at their C-
terminus that might playa role in trafficking (Beridtchevski, 2001;Stipp et ai, 2003). 
Tyrosine-based motifs (Y-X-X-~, where ~ is a hydrophobic residue) in the 
cytoplasmic domains of membrane proteins are recognized by clathrin adaptor 
complexes and play important roles in endocytosis and lysosomal targeting (Robinson 
and Bonifacino, 2001). These tetraspanins can be expressed in intracellular vesicles in 
addition to on the cell surface. The association of tetraspanins with a diverse array of 
other proteins could be used for the control of endocytosis and intracellular protein 
trafficking. 
The tetraspanin CD63 resides in late endosomes, lysomes, secretary vesicles, and at 
the plasma membrane is rapidly internalised. CD63 contains a GYEVM motif at its C-
terminus. The GY motif, which is unique amongst human tetraspanins, is a putative 
lysosomal targeting motif also found in many type 1 lysosomal glycoproteins e.g. 
Lamp-l (Honing and Hunziker, 1995). Site-directed mutagenesis has shown that this 
region is crucial in determining the intracellular localisation and rapid plasma 
membrane internalization of CD63 (Rous et ai, 2002; G. Mal, PhD thesis (2005), 
University of Sheffield). 
1.1.5.3. Association of CD63 with membrane trafficking molecules 
Duffield et ai, 2003 reported that CD63 is present in tubulovesicular elements, the 
intracellular compartments that contain the H, K-ATPase (a heterodimeric ion pump) 
in unstimulated gastric parietal cells. The ~-subunit of H, K-ATPase and CD63 
complex colocalized in parietal cells. Expression of CD63 with ~-subunit of H, K-
A TPase induces the redistribution of the ~-subunit from the cell surface to CD63+ 
intracellular compartments by enhanced endocytosis of H, K-ATPase ~-subunit 
complexed with CD63. They found that the enhanced internalisation of ~-subunit may 
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be due to the capacity of CD63 to interact with adaptor protein complexes 2 and 3, 
since the ~-subunit did not internalise when co-expressed with CD63 containing a 
mutation at the C-terminal internalisation motif. From the study the authors concluded 
that the tetraspanin CD63 may play a role in the recyling of plasma membrane 
components to their appropriate intracellular compartment. 
CD63 was also recently found to promote targeting and lysosomal proteolysis of 
membrane-type 1 matrix metalloproteinase (MTI-MMP) (Takino et aI, 2003). Matrix 
Metallo Proteinases (MMP) are a family of Zn2+ dependent enzymes anchored to 
plasma membrane, that are essential for extracellular matrix (ECM) turnover in 
normal and pathological conditions. MTI-MMP is believed to be a crucial for the 
invasion of malignant tumors. The authors found that the ectopic expression of CD63 
accelerated degradation of MTI-MMP. In addition, MTI-MMP and CD63 were 
shown to form a complex through haemopexin-like domain ofMTl-MMP and the N-
terminal region of CD63. The enhanced internalisation was not observed with a CD63 
mutant lacking the lysosomal targeting motif. 
As discussed above, CD63 may also promote internalisation of integrins (Mantegazza 
et aI, 2004). Thus, CD63 does appear to play a role in protein trafficking. 
Mantegazza et aI, (2004) also suggested that CD63 may play a role in the 
internalisation of complex antigens, since internalisation of CD63 was observed 
during phagocytosis of yeast particles. An association between CD63 and the ~­
glycan receptor dectin-l (which is involved in recognising particles such as yeast) was 
demonstrated by co-immunoprecipitation. 
1.1.5.4. Tetraspanins in the immune response 
There have been several recent reviews on the role of tetraspanins in the immune 
response (Tarrant et aI, 2003; Wright et aI, 2004; Levy and Shoham, 2005) and only 
certain aspects will be detailed here. Specific interactions of tetraspanins with a wide 
range of leukocyte receptors have been reported, including interactions with CD2, 
CD3, CD4, CD8, CDS, CDI9, CD21, IgM, Fc receptors and MHC class I and class II 
(Tarrant et aI, 2003; Wright et aI, 2004; Levy and Shoham, 2005). As described 
previously, tetraspanins also associate with integrins and signalling enzymes 
expressed on leukocytes. Cross-linking tetraspanins at the cell surface can result in 
tyrosine phosphorylation, calcium fluxes and inositol phosphate turnover (Tarrant et 
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aI, 2003). As mentioned previously, signalling is likely to be indirect via the presence 
of signalling molecules in TEMs. 
1.1.5.4.1. Association of tetraspanins with MHC 
The MHC molecules play an important role in the presentation of antigens to T-
lymphocytes. Rubinstein et aI, (1996), demonstrated that CD9, CD63, CD81 and 
CD82 associated with each other and with integrins and HLA-DR (MHCII) antigens 
on the cell surface. The authors demonstrated the interaction of tetraspanins with 
other proteins by over expression followed by immunoprecipitation studies. From the 
result it was observed that the different complexes (tetraspanltetraspanltetraspan, 
tetraspanitetraspanlHLA-DR and tetraspanlintegrin) are connected and that these 
complexes are organised in a cell type dependent manner. The authors suggested a 
possible function for the tetraspanins would be to play the role of surface organisers. 
Lagaudriere-Gesbert et aI, 1997, found that CD82 associated with HLA class I heavy 
chain using lysates prepared in mild detergent (CHAPS) and sequential 
immunoprecipitations and Western blot analysis. These association takes place at the 
cell surface and could interfere with the capacity of the MHC-I complex to protect 
targets from NK- mediated cytotoxicity. 
MHC class II antigens have also been shown to be associated with CD9, CDS3 and 
CD81 on the surface of dendritic cells (DCs) and CD9 and CD63 in cytoplasmic 
compartments (Engering and Pieters, 2001). Kropshofer et aI, (2002) found that the 
MHC class-II molecules such as HLA-DR and HLA-DP are localised to membrane 
microdomains with tetraspanin proteins CD9, CD81 and CD82, the peptide editor 
HLA-DM and the co stimulator CD86. The deficiency oftetraspanin microdomains in 
antigen presenting cells results in a reduced capacity to activate CD4+ T cells. 
Engering et al (2003) reported that CD63, which associates with intracellulary 
localised MHC class-II molecules in immature dendritic cells, was modified post-
translationally by poly N-acetyl lactosamine addition during maturation. This 
modification of CD63 was accompanied by a change in morphology of MHC class-II 
compartments from typical multivesicular organelles to structures containing densely 
packed lipid moieties. The authors postulated that post-translational modification of 
CD63 may be involved in the functional and morphological changes of MHC class II 
compartments that occur during dendritic cell maturation. 
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Recently the researchers focussed their attention towards the make-up of cytoplasmic 
MHC class II processing compartments (MIIC), a modified lysosomal compartments 
in which exogenous antigen is processed to peptides and loaded onto MHC class II 
molecules (Peters et aI, 1991). Tetraspanins (CD37, CD53, CD63, CD81 and CD82) 
are located on a subset of MIIC internal vesicles, named exosomes, which are 
released extracellularly following fusion of the MIIC with the plasma membrane 
(Thery et aI, 2002). The functions of tetraspanins in MIIC or exosomes is currently 
unknown but the exosomes are thought to present antigen, exchange membrane 
proteins with other cells or simply to dispose of redundant proteins (Thery et aI, 
2002). These vesicles might simply reflect an intermediate intracellular stage in the 
biosynthesis and assembly of tetraspanin-MHC complexes. Alternatively, 
tetraspanins could function in the endocytosis and/or trafficking of MHC class II 
molecules or indeed other molecules that they associate with, as discussed in 1.1.5.2. 
1.1.5.4.2. Role of tetraspanis in allergy 
Activation ofbasophils or mast cells enhances fusion of cytoplasmic granules with the 
plasma membrane and results in the release of inflammatory mediators, such as 
histamine. Expression of CD63 on the cell surface is strongly induced after activation 
of platelets, neutrophils and basophils, following mobilisation of the intracellular 
pool, for example on activation of human basophils with anti IgE (Knol et aI, 1991). 
This has led to CD63 being used as a marker of platelet (Gutesohn et aI, 1996) and 
basophil (Monneret et aI, 2002) activation. 
Mast cells and basophils express tetraspanins CD9 and CD63 in a constitutive manner 
(Valent and Bettelheim, 1992). Mast cells or basophils activated by IgE dependent 
stimuli or other agonists show significant changes in the expression of CD9 and 
CD63. Knol and co workers found that the activation of basophilic granulocytes with 
anti-IgE or with chemotactic peptide (formyl-methionyl-Ieucyl-phenyl alanine), 
increased the expression of CD63 up to 100 fold on the surface (Knol et aI, 1991). 
Furuno et aI, (1996) reported that surface expression of the rat homologue of CD63 
(AD 1) occurred simultaneously with the release of histamine corresponding to the 
degranulation in rat basophilic leukaemia (RBL2H3) cells. High levels of CD63 
expression were observed in bone marrow mast cells from the adults with indolent 
systemic mast cell disease as compared to normal mast cells from healthy individuals 
(Escribano et aI, 1998). 
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CD63 translocation has also been observed in activated eosinophils (Mahudi-Azer et 
ai,2002). In resting eosinophils, CD63 immunoreactivity was localized to the plasma 
and crystalloid granule membrane. In interferon-y (IFN-y)- or C5aJcytochalasin B 
stimulated cells, intracellular CD63 appears to shift to the cell periphery and plasma 
membrane, while stimulation with a cocktail of interleukin-3 (lL-3)/IL-5/granulocyte-
macrophage colony-stimulating factor induced the appearance of discrete intracellular 
clusters of CD63 immunoreactivity (Mahudi-Azer et ai, 2002). 
There have been reports of an association between CD63 and the high affinity IgE 
receptor (FcERI) on mast cells/basophils. An antibody directed against the rat 
homologue of CD63, AD 1, was found to inhibit IgE mediated release from RBL2H3 
cells. This suggested that CD63 and FCERI were closely associated on the cell surface 
and that CD63 might be involved in the control of FCERI function (Kitani et ai, 1991). 
By contrast, mouse IgG 1 anti human CD63 antibodies were shown to stimulate cell 
secretion from RBL2H3 cells transfected with human CD63 (Smith et ai, 1995). 
Similar findings were observed for IgG 1 anti CD9 antibodies on RBL2H3 cells 
transfected with CD9 (Higginbottom et ai, 2000). Stimulation of RBL2H3 cells by the 
anti-tetraspanin antibodies was shown to be dependent on the interaction of the Fc 
region of the IgG 1 antibodies with FCERI. An association between human CD9 and rat 
FCERI was suggested by their co-immunopreciptiation in mild detergent lysates of 
hCD9-transfected RBL2H3 cells (Higginbottom et ai, 2000). Most recently, 
antibodies that inhibited FCERI-mediated degranulation of rat RBL2H3 cells were 
shown to recognise CD63 (Kraft et ai, 2005). Inhibition of degranulation was only 
observed for mast cells adherent to fibronectin and vitronectin ECM proteins. 
Furthermore the anti-CD63 antibodies inhibited adhesion of mast cells to these ECM , 
proteins. Inhibition of FERI mediated degranulation therefore correlates with the 
effect of the antibodies on adhesion and is likely to relate to the known association of 
CD63 with ~ 1 integrins. The same group also showed that an antibody directed to 
CD81 also inhibited mast cell degranulation (Fleming et ai, 1997). 
1.1.5.5. The role of tetraspanins in viral infection 
There are many reports on the role of tetraspanins viral infectivity and life cycle 
(reviewed in Martin et ai, 2005). 
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1.1.5.5.1. Hepatitis C virus and CD81 
The tetraspanin CD81 is playing a role in the aetiopathogenesis of hepatitis 'C'virus 
(HCV), which infects 170 million people worldwide. The infection caused by HCV 
leads to hepatocellular cirrhosis and carcinoma and also immune disease related to 
lymphoid B cells (cryoglobulinaemia, lymphoproliferative disorders, and 
autoantibody production). 
Flint and co workers have characterised the interaction of HCV envelope glycoprotein 
E2 and human CD81. The E2 glycoprotein of HCV binds specifically to tetraspanin 
CD81 (hCD81) transfected RBL2H3 and KM3 rat cell lines. Recombinant forms of 
hCD81 encoding both EC 1 and EC2 or EC2 alone were expressed as -Nor -C 
terminal fusion proteins were used to compete with cell surface expressed CD81 for 
binding ofE2. From the result it was observed that GST-EC2 inhibited E2 binding to 
hCD81 expressed at the surface of rat or human cell equivalently. Furthermore they 
found that there was no binding of HCV-E2 in COS cells derived from African green 
monkey. The African green monkey CD81 differs from human CD81 by just 4 
residues, all in the carboxyl terminal region of the large extracellular loop (EC2) 
implicating one or more of these residues as important for HCV E2 binding (Pileri et 
aI, 1998; Flint et aI, 1999). Higginbottom et aI, 2000 defined the critical amino acid 
residues within the EC2 by mutating each of four positions in human CD81 to the 
corresponding African green monkeys (AGM) residues and expressing them as 
soluble GST-EC2 proteins in bacteria or as complete membrane protein III 
mammalian cells. Amino acid 186 of hCD81 was found to be critical for the 
interaction with HCV E2 and for binding of certain anti CD81 mAbs. Kitadokora et 
aI, (2001) have demonstrated the residues reported to be involved in the interaction 
between hCD81 and HCV E2 glycoprotein reside in the smaller, solvent exposed 
apolar cluster comprising hcD81-LEL-C and D helices (see section 1.1.2.2). 
Van Compemolle et aI, (2003) have evaluated the possibility of using molecules 
designed to mimic CD81 helix D that may be able to competitively bind to HCV-E2 
to prevent infection. The authors synthesised compounds that were structurally related 
by a common imidazole 4, 5-dicarboxamide (145DC) scaffold and presenting CD81 
helix D amino acid side chains which acts as competitive inhibitors of HCV -E2 
binding to human CD8l. One compound almost completely blocked the HCV-E2 
binding to CD81 in a dose dependent manner. 
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1.1.5.5.2. Canine distemper virus and COg 
CD9 is associated with the infection of cells with Canine Distemper Virus (CDV), a 
lymphotropic and neurotropic negative stranded RNA virus of morbilli virus genus. 
An anti-CD9 antibody inhibits the infection of cells with CDV (Loffler et aI, 1997) 
although the virus is not directly associated with CD9, suggesting that CD9 is not the 
attachment receptor. Human CD9 transfected into NIH 3T3 or MDBK cells rendered 
these cells permissive for viral infection and raised virus production by a factor of 10 
to 100. Anti CD9 antibodies reduced the number of infectious centres and the plaque 
size, possibly by steric hindrance of virus attachment or inhibition of fusion. These 
data indicate that CD9 is the component of a receptor complex for CDV, but it is also 
possible that CD9 acts via intracellular signalling, enhancing the expression or 
activity of a receptor molecule. CD9 may be necessary for the uptake of CDV by 
target cells, the formation of syncytia, and the production of progeny virus 
1.1.5.5.3. HIV and C063 
Macrophages and CD4+ T lymphocytes are the potential target cells for human 
immunodeficiency virus type-l (HIV-l) infection. Recently von Lindem et aI, (2003) 
identified CD63 as a new co-factor involved in the CCRS but not CXCR4-mediated 
HIV -1 infection in macrophages. The role of CD63 in HIV -1 infection was 
demonstrated on macrophages, which were pre treated with anti CD63 mAb. Dose-
dependent inhibition of new viral DNA formation for two separate RS strains was 
observed, indicating that the block occurs early in the virus life cycle, prior to reverse 
transcription. Anti CD63 antibodies did not affect levels of CD4, CCRS or p-
cytokines. Von Lindem and co workers also assessed the possible role of CD63 in 
HIV-l Env gp120-gp41 mediated cell-to-cell fusion. A quail fibrosarcoma line QT6, 
which expresses low levels of endogenous CD63, was used for the CD63 transfection 
experiments. Transfection of CD63 had no effect on HIV -1 Env mediated cell: cell 
fusion of these cells. Anti-CD63 antibodies also had no effect in a system where 
primary macrophages were induced to fuse with HIV-1 Env transfected 283T cells. 
The authors suggested that the anti CD63 antibodies might be affecting CD4-CCRS 
complex formation (Von Lindem et aI, 2003). 
Most recently our research group in collaboration with Dr C. Chengmeyer (Aaron 
Diamond AIDS Research Center, New York) have found that recombinant GST-EC2 
domain of human tetraspanins CD9, CD63, CD81 and CD lSI potently inhibited 
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CCR5 (R5) and virions pesudotyped with CXCR4 (X4) tropic HIV-l infection of 
macrophages at lower (nanomolar) concentrations. In this study we observed that the 
GST-EC2 tetraspanins did not decrease CD4 or co-receptor expression (Ho et ai, 
manuscript submitted). 
CD63 has been shown to accumulate preferentially in the viral envelope of HIV 
released from macrophages (Pelchen-Matthews et ai, 2003). Since CD63 is associated 
with late endosomes, this suggested that most virus is released from late endosomes in 
these cells. It is not known if virus envelope-associated CD63 plays any role in virus 
transmission, although it may contribute to the ability of anti CD63 antibodies to 
inhibit HIV infection (von Lindem et ai, 2003). 
1.1.5.5.4. FIV and COg 
Feline immunodeficiency virus (FIV) infection appears to involve CD9. In cells 
expressing feline CD9, an anti CD9 antibody was found delay reverse transcriptase 
activity post-infection (deParseval et ai, 2001). The antibody also reduced viral 
budding in infected cells and inhibited FIV spread in culture, suggesting an effect on 
viral assembly or release. FIV can infect CD9 -ve cells, but ectopic expression of CD9 
enhances infectivity (Willett et ai, 1994). 
1.1.5.5.5. HTLV and C082 
In addition to these, as discussed in section 1.1.5.6 CD82 has been implicated in 
syncytium formation by human T-cell leukemia virus type 1 (HTL V -1) (Imai et ai, 
1992). 
1.1.5.6.Tetraspanin and cell fusion 
Tetraspanins CD9, CD81 and CD82 have also been implicated in cell fusion 
processes, including sperm-egg fusion, myoblast fusion and virus syncitium 
formation. 
1.1.5.6.1. Sperm-Egg fusion 
The integrin a6~ 1 has previously been proposed to act as a sperm receptor for fertilin 
on the egg cell surface and antibodies to this integrin inhibit fertilization (Almeida et 
ai, 1995). Since CD9 is known to associate with integrins (including a6~ 1) its role in 
sperm:egg fusion was investigated (Chen et ai, 1999). CD9 was found to be 
abundantly expressed and localised in the microvilli of eggs and densely concentrated 
on the sperm attachment site. The association of CD9 in the mouse sperm-egg fusion 
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process was demonstrated in vitro usmg anti CD9 mAb, which showed dose 
dependent inhibition of sperm-egg binding and fusion. The antibody disrupted 
binding of beads coated with native fertilin or a recombinant fertilin ~ disintegrin 
domain (ADAM 2). 
The role of CD9 on sperm: egg fusion was conclusively demonstrated using CD9 
knockout (CD9 -/ -) mice (Miyado et ai, 2000; Le Naour et ai, 2000; Kaji et ai, 2000). 
CD9 deleted mice grew and developed normally without any obvious abnormalities. 
However, Miyado et ai (2000) observed that the litter size of CD9 knockout female 
mice was less than 2% of that of the wild type. Sperm penetration through the zona 
pellucida and binding to the egg plasma membrane were normal, but oocytes from 
CD9 knockout mice showed severely inhibited sperm-egg fusion (Miyado et ai, 2000; 
Kaji et ai, 2000; Le Naour et ai, 2000). Sperm injected directly into the cytoplasm of 
CD9 null oocytes yielded normal development, indicating that the role of CD9 is 
limited to initial sperm-oocyte fusion (Miyado et ai, 2000). Kaji et ai (2000) reported 
that intracellular calcium (Ca2+) oscillations, which signal fertilization, was absent in 
almost all mutant (CD9 -/ -) eggs. 
As described above, ealier studies indicated that a6~ 1 integrin was a receptor for 
sperm (Almeida et ai, 1995), and since CD9 associates with integrins it was suggested 
that egg CD9 acts in association with the integrin during fusion (Chen et ai, 1999). 
More recent studies indicate that a6~ 1 is not essential for sperm-egg binding and 
fusion (Miller et ai, 2000). Eggs from mice lacking the a6 subunit showed no 
impairment of fertilization rate, fertilization index or sperm:egg binding relative to 
controls. Furthermore, inhibition of sperm fusion with a6 (-) eggs by anti CD9 
antibody indicates that CD9 acts alone or in association with other proteins in gamete 
binding and fusion to eggs. The association of CD9 and CD81 with EWI-2, might be 
involved for the sperm-egg fusion (Stipp et ai, 2001). 
Normal fusion occurs after human or murine CD9 mRNA injection into the CD9 
knock-out mice oocytes (Zhu et ai, 2002; Kaji et ai, 2002). The over expression of 
human CD9 and mouse CD81 on CD9 -/ - eggs restored the fertilisation rate up to ~90 
and ~50 % respectively, against the wild type eggs. This result suggests that CD81 
has the potential to compensate for CD9 function in sperm-egg fusion (Kaji et aI, 
2002). Zhu and co workers reported that CD9 interacts through its EC2 domain with 
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an un identified egg surface protein, and recombinant CD9 EC2 inhibited sperm:egg 
fusion. In murine CD9, three residues SFQ (173-175) in variable subdomain of the 
EC2 are required for CD9s function in gamete fusion and mutating the SFQ residues 
to 173-175 SFQ to AAA abolished CD9 activity (Zhu et al, 2002). 
Higginbottom et al (2003) further investigated sperm:egg fusion using recombinant 
tetrasapanin EC2 proteins. They showed that human CD9EC2 is as potent an inhibitor 
as mouse CD9 EC2 in mouse sperm-oocyte fusion assays and that CD9 EC2 can also 
inhibit sperm-oocyte binding. Using mutated human CD9 EC2s, the authors also 
demonstrated that the two disulphide bridges that define membership of the 
tetraspanin family are critical for structure and function of human CD9 EC2. Also 
mutation of residues in the EC2 variable subdomain encompassing those identified as 
essential in murine CD9 activity (Zhu et al, 2002) also affected the fusion inhibitory 
activity of human CD9 EC2. 
1.1.5.6.2. Myoblast fusion 
There is evidence that CD9 and CD81 are involved in muscle cell fusion. Tachibana 
and Hemler demonstrated that CD9 and CD81 are abundantly expressed on murine 
myoblast C2C12 cells and expression ofCD9 is upregulated during the early phase of 
myogenic differentiation. The authors have also found that anti CD9 and CD81 
antibodies delayed the fusion of C2C12 myoblast cells and RD rhabdomyosarcoma 
cells. Over- expression of CD9 promoted cell fusion in four independently transfected 
myoblast derived RD cell line (Tachibana and Hemler 1999). CD9 and CD81 
therefore appear to accelerate muscle cell fusion and are involved in myotube 
maintenance (Tachibana and Hemler, 1999). CD9 on C212 cells associates with 
various PI integrins, with a3pl on a3-transfected RD cells (Tachibana and Hemler, 
1999). Involvement of this tetraspanin in fusion may thus be indirect, relating to its 
control of integrin functions. 
1.1.5.6.3. Role in viral syncytium formation 
Earlier studies showed that antibodies to CD82 inhibited human T cell leukaemia 
virus type 1 (HTL V-I) but not HIV -1 induced syncitia formation (Fukudome et al, 
1992; Imai et al, 1992). Co-immunoprecipitation experiments showed that HTL V-I 
env glycoproteins associate with highly glycosylated forms of CD82 (Pique et ai, 
2000). The co expression of CD82 protein with HTL V-I envelope glycoproteins 
resulted in marked inhibition of syncytium formation, whereas CD82 proteins had no 
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effect on syncytium formation induced by human immunodeficiency virus type 1 
(HIV -1) envelop proteins. This effect was demonstrated using co transfection 
experiments in COS-1 cells (Pique et at, 2000). 
1.1.S.6.4.Role in cellular membrane fusion 
As described in section 1.1.5.2 CD63 IS associated with the membranes of 
intracellular vesicles and is upregulated on activation of several cell types. Studies 
using GFP-tagged CD63 show that on RBL2H3 cell activation, granules containing 
CD63 fuse with the plasma membrane within 2-3 min. (Amano et at, 2001). Also as 
described above, CD63 has been implicated in phagocytosis (Mantegazza et at, 2004). 
This has led some workers to speculate that CD63 may be involved in cellular 
membrane fusion (Mahudi-Azer et at, 2002), although there is no direct evidence for 
this. 
1.1.S.6.S.Tetraspanins in mononuclear phagocyte fusion 
Recently a potential role for tetraspanins in the fusion of monocytes/macrophages to 
form multinucleated giant cells (MGCs) has been described. Takeda et at (2003) 
investigated the role of tetraspanins CD9 and CD81 in the Concanavalin A-induced 
fusion of mononuclear phagocytes (see section 1.2.4.3). They found that the 
expression of CD9 and CD81 and their complex formation with ~ 1 and ~2 integrins 
were up-regulated when blood monocytes were cultured under normal conditions but 
under fusogenic conditions in the presence of the lectin, the up regulation of CD9 and 
CD81 was inhibited and their complex formation with integrins was down regulated. 
In addition to this, the authors demonstrated that the anti CD9 and CD81 antibodies 
unexpectedly promoted the fusion of monocytes and alveolar macrophages. The 
effects did not appear to be due to effects of the antibodies on monocytes adhesion, 
aggregation or cytokine production. An anti CD63 antibody was reported to have no 
effect on fusion, although CD63 expression was upregulated under fusogenic 
conditions. Monocyte fusion was inhibited by a recombinant protein corresponding to 
the EC2 region of CD9. Alveolar macrophages and bone marrow cells of CD9 and 
CD81 null mice showed enhanced formation of multinucleated cells when stimulated 
in vitro or in vivo compared with those of wild type mice. In addition, CD9/CD81 
double knockout mice showed spontaneous formation of multi-nucleated giant cells in 
the lung and enhanced osteoclastogenesis in the bone. From the results the authors 
suggest that the normal role of CD9 and CD81 is to co ordinately prevent the fusion 
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of mononuclear phagocytes (Takeda et aI, 2003). As described above, this appears to 
be in contrast to their role in sperm:egg fusion. 
CD9 has also been implicated in the formation of osteoclasts (Tanio et aI, 1999). An 
anti CD9 antibody inhibited the formation of osteoclasts from haematopoietic stem 
cells on established stromal cell layers. This was due to effects of the antibody on 
CD9 expressed by the stromal cells, possibly blocking production of a factor required 
for osteoclastogenesis. 
1.2. Multinucleated giant cells (MGCs) 
Multinucleated Giant Cells (MGCs) are a characteristic histo-pathological feature of 
granulomatous inflammations (reviewed in Anderson, 2000; Fais et aI, 1997) and 
their presence in tuberculosis granuloma was first described by Langhans (Langhans, 
1868). Such MGCs, thought to be formed by fusion of cells of the 
monocytes/macrophage lineage, (Postlethwaite et aI, 1982; Weinberg et aI, 1984) 
were thereafter observed in a variety of infectious (mainly bacterial) and non-
infectious granulomatous conditions (e.g. in response to foreign bodies such as 
implants, some cancers, and other disorders of unknown etiology such as Crohn' s 
disease, sarcoidosis and primary biliary cirrhosis (reviewed in James, 2000; Okamoto 
et aI, 2003; Weingberg et aI, 1984)). Mostly the granulomatous inflammations are 
chronic, predominantly mononuclear host reactions to persisting, poorly degradable 
tissue irritants (Takashima et aI, 1993). The release of lymphokines is likely to occur 
and the inflammatory conditions are known to lead to activation of macrophages (Abe 
et aI, 1983). 
In addition, the bone-resorbing osteoclasts, which are derived from monocytes pre-
cursors, may be considered giant cells (Anderson, 2000; Vignery, 2000). Some 
viruses, notably HIV-1, also induce the in vitro formation of syncitia (HIV-S) that 
share some of the characteristics of MGCs (Anderson, 2000; Fais et aI, 1997). Since 
this thesis is concerned with MGCs derived from the mononuclear phagocyte lineage, 
a brief review of the properties of these cells will be given. 
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Fig.l.2.1. Multinucleate giant cells of monocytes (scale =20).Jm) 
1.2.1. Mononuclear phagocytes 
The immune system of vertebrates consists of organs and tissues composed of many 
different types of cells plus a variety of actively trafficking cells (Roitt et aI, 1993). 
Among these cells the mononuclear phagocyte system (MPS) is a specialised tissue 
distributed throughout the body and composed of diverse differentiated cell types 
such as liver Kupffer cells, lung alveolar macrophages, serosal (peritoneal) 
macrophages, brain microglia, dendritic cells (DC), and osteoclasts, as well as 
granuloma-forming macrophages at sites of inflammation (Geissmann et aI, 2003). 
Fig.l.2.2. Monocyte represented by blue arrow 
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The mononuclear phagocytes develop in the bone marrow from dividing monoblasts 
and are released into the blood stream as non dividing cells, and enter tissues 
(Geissmann et ai, 2003). They may continue to proliferate, mature, and become 
functionally activated in various tissues. Almost every organ of the body contains 
mononuclear phagocytes that possess unique characteristics for that location, while 
still sharing common features with analogous cells in other organs (reviewed in 
Wiktor-Jedrzejczak et ai, 1996). 
Morphologically, monocytes are characterised as mononuclear cells with bean! 
horseshoe-shaped nuclei (Fig.l.2.2) and often contain faint azurophilic granules. The 
size of the monocyte is 10-181lm diameter, relatively larger than lymphocytes. Ultra 
structurally, the monocyte possesses ruffled membranes, a well-developed golgi 
complex and many intracytoplasmic lysosomes. These lysosomes contain peroxidase 
and several acid hydro lases, which are important in intracellular killing of 
microorganisms (Roitt et ai, 1993). In addition the monocytes are characterised on 
the basis of expression of CD 11 b, CD 11 c, and CD 14 in humans and lack of B, T, NK, 
and DC markers (Geissmann et ai, 2003). Furthermore monocytes may be classified 
into subpopulations compnsmg CD 14++/CD 16- and CDI4++/CDI6+ cells. 
CD 14++/CD 16- cells are the major population and CDI4++/CDI6+ cells are regarded as 
pro inflammatory monocytes (Okamoto et ai, 2003). CDI4++/CDI6+ cells account for 
10% of all blood monocytes and they are characterised by a low level expression of 
the CD14 molecule and a high level expression of the CD16 (FcyRIII) molecule 
(Ziegler-Heitbrock et ai, 1993). The very important functions of mononuclear 
phagocytes are to remove particulate antigens by phagocytosis and to present antigen 
to lymphocytes. The mannosyl-fucosyl receptor (MFR) is a very important receptor 
for phagocytic activity of human monocytes/macrophages, which binds to sugars on 
the surface of microorganisms (Roitt et ai, 1993). Monocytes/macrophages are highly 
expressing CD 14 (Barclay et ai, 1997), a receptor for lipopolysaccharide binding 
protein (LBP) normally present in serum and which coats gram-negative bacteria. In 
addition monocytes and macrophages constitutively express two distinct Fc receptors 
for IgG such as FcyRI (CD64) and FcyRII (CD32); a third FcyRIII (CD16) is 
predominantly expressed by macrophages (Barclay et ai, 1997). These receptors have 
different functions, which include triggering extracellular killing, or opsonization and 
phagocytosis. In addition to these a range of other receptors are important in uptake 
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of microorganisms including the complement receptor, CRI (C3b receptor, CD35) 
(Roitt et ai, 1993). Molecules of monocytes/macrophages involved mainly in 
adhesion, include the ~2 integrins (Roitt et ai, 1993); complement receptor CR3 (C3bi 
receptor, Mac-I) are present especially on activated macrophages, together with the 
'leucocyte function antigen' LFA-l and p150,95 (Roitt et ai, 1993). The integrins aL 
(CDlla), aM (CDllb) and aX (CDllc) form pairs with CD18 (~2 integrin) to form 
LFA-l, CR3 and pI59,95, respectively (Barclay et ai, 1997; Sanchez-Madrid et ai, 
1983). Both CDllb and CDllc are found in intra cytoplasmic vesicles (of 
macrophages) and are rapidly expressed following activation (Roitt et ai, 1993). Class 
II MHC antigens are present on some of the monocytes/macrophages and are 
important in presentation of antigens to T cells (Roitt et ai, 1993). None of these 
markers so far discussed are lineage specific, although FcyRI is a particularly useful 
marker (Roitt et ai, 1993). 
In addition to all of these molecules, monocytes and macrophages also have receptors 
for cytokines such as IL4, IFNy and migration inhibition factor (Roitt et ai, 1993). 
The functions of monocytes and macrophages can therefore be enhanced by T-cell 
derived cytokines through these receptors. Such activated monocytes/macrophages 
also generate cytokines including IFNs, IL-l and TNF-a (Roitt et ai, 1993). 
Complement components and prostaglandins are also produced (Roitt et ai, 1993). 
Like neutrophils, monocytes contain peroxidase, which inactivates the peroxide ions 
that they generate while killing ingested microorganisms (Roitt et ai, 1993). 
Monocytes/macrophages can fuse with themselves to form MGCs in tissues during 
chronic inflammatory reactions or osteoclasts in bone (Vignery, 2005). In addition 
there is now evidence that macrophages may act as hemopoietic stem cells by fusing 
with non-proliferating somatic cells and tumor cells (Vignery, 2005; Ogle et ai, 
2005). 
1.2.2. Types of multinucleated giant cell 
On the basis of the degree of antigen-specific lymphocyte involvement in the 
developing lesion, granulomas are classified into immune-type and foreign body type, 
and MGCs are a feature of both (Fais et ai, 1997). MGCs are generally classified into 
Langhans' giant cells or foreign body giant cells (FBGCs), based on their 
morphology. The Langhans' giant cells are characterised by a relatively small number 
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of nuclei, generally less than 20, arranged in a circular peripheral arrangement within 
the giant cell, whereas FBGCs generally consist of much larger number of nuclei, 
greater than 20, which are arranged in an irregular fashion throughout the giant cell 
(Anderson, 2000; Okamoto et ai, 2003). Langhans' giant cells are commonly seen in 
immune granulomas with epithelioid-like macrophages and are associated with 
indigestible particles of organisms surrounded by a collar of mononuclear leukocytes 
that are principally lymphocytes. The lymphocytic collar surrounding the immune 
granuloma is indicative of T cell-mediated immunity to the inciting agent, and 
products of activated T lymphocytes are thought to initiate the fusion of monocytes 
and macrophages to form Langhans' cells (Anderson, 2000). FBGCs are most 
commonly found in foreign body granulomas, where the indigestible or poorly 
digestible material is surrounded or encapsulated within a thin (one or two cells in 
thickness) layer of macrophages and FBGCs. The lymphocyte collar seen in immune 
granulomas is not present in foreign body granulomas. 
Fig.I.2.3. Langhans' Giant Cells (red arrows) and Foreign Body Giant Cells 
(green arrow) in tissue specimen. 
The surface antigens of monocyte-macrophage lineage cells and adhesion molecules 
showed the same expression profiles between LGC and FBGC i.e. CD 1 a-, CD 11 a low+, 
CDII b +, CDllc +, CDI4+, CDI6-, CD36-, CD54+, CD68+, CD86-, MAC38T and 3A5 
cytoplasmic +. These immunohistochemical results suggest that both types of MGCs rna 
be functionally as well as phenotypically similar cells with different distributions of 
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nuclei (Okamoto et ai, 2003). However the in vitro MGC formation models show that 
LGCs and FBGCs are induced by different stimuli (Postlethwaite et ai, 1982; Abe et 
ai, 1983; Abe et ai, 1986; McNally et ai, 2003). 
1.2.2.1. Langhans' giant cells 
As described earlier, the Langhans' giant cells are seen in immune granulomas in the 
presence of indigestible particles of organisms such as the M tuberculosis. They are 
also found in granulomatous disorders of unknown causes such as sarcoidosis and 
Crohns' disease (Anderson et ai, 2000). As mentioned above, the association of 
lymphocytes with immune granulomas indicates a T cell mediated immune response 
to the infectious agent. Similarly the lesions of Crohn' s disease consist of a diffuse 
infiltrate of lymphocytes and monocytes, together with epithelioid cells, MGCs and 
granulomas, which indicates that lymphocytes are very important for MGC formation 
here (Fais et ai, 1997); spontaneous secretion of IFN-y was observed in sarcoidosis 
and Crohn's disease (Fais et ai, 1997). As described in section 1.2.4.1, various 
cytokines have been used to induce the formation of MGCs in vitro, to try to elucidate 
their role in vivo. Although some of the evidence is controversial, IFN-y appears to be 
one of the pivotal factors promoting the formation of Langhans' cells. Antibodies to 
IFN-y have been shown to inhibit the formation of giant cells in vitro (Most et ai, 
1990; Fais et ai, 1994) and in vivo (Chensue et ai, 1992). In addition the membrane 
bound molecules of mycobacterium in combination with cytokine containing 
supernatants directly induces the fusion of human monocytes in vitro to form MGCs. 
This suggests a direct effect of mycobacterium on the fusion process in vivo (Gasser 
and Most, 1999). 
Some studies in vitro indicate that monocytes are more able easily to form MGCs than 
macrophages. It is suggested that since monocytes are better at killing intracellular 
bacteria than macrophages, monocytes newly arrived at the site of infection may fuse 
with infected monocytes/macrophages to the benefit of the immune response (Most et 
ai, 1997). It is reported that MGCs in sarcoidal lesions express monocyte (CDlla, 
CDI4, 3A5) but not macrophage markers (CDI6, MAC387) (Okamoto et aI, 2003). 
This group also reported that MGCs are formed from the CDI4++/CDI6-, but not the 
CDI4+/CD16+ subpopulation ofmonocytes in vitro. 
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However, the precise functions of the Langhans' cells are unknown and there are 
several ideas for the functional role of MGC in granulomas, including a disposal 
function for effete macrophages and specific functions in the phagocytosis of 
pathogens involved in granuloma formation (Most et ai, 1997). Byrd demonstrated 
that IFN-y/IL-3 treatment reduced the growth of Mycobacterium tuberculosis in an in 
vitro infection assay (Byrd, 1998). This growth restriction was associated with the 
development of Langhans' giant cells from monocyte monolayers. Byrd observed 
dense growth of Mtuberculosis in the centre of the Langhans' cells and suggested that 
physical sequestration of the bacterium by giant cells might limit cell to cell spread. It 
has also been suggested that giant cells form because several phagocytes are 
necessary to ingest large aggregates of bacteria (Gasser and Most, 1999). 
1.2.2.2. Foreign body giant cells 
The most common foreign body granuloma is the suture granuloma, in which the 
macrophages and FBGCs are present at the surface of the sutures (Anderson, 2000). 
In vivo the FBGCs may remain at the implanted-tissue interface for the lifetime of the 
device, which in some cases may extend beyond 20 years (Anderson, 2000). FBGCs 
may be responsible for surface cracks, and degradation of biomaterial (Zhao et ai, 
1991; Nathan et ai, 1987). 
The research group of McNally and Anderson have extensively studied the biology of 
FBGCs in vitro (McNally and Anderson, 2003). The cell-derived factors responsible 
for the FBGCs formation were demonstrated by using recombinant human 
lymphokines with freshly isolated human monocytes. The authors reported that 
human interleukin-4 induced the formation of FBGCs from human monocyte derived 
macrophages, an effect that was optimised with either granulocyte-macrophage 
colony-stimulating factor (GM-CSF) or interleukin-3 (Anderson, 2000). Interleukin-4 
induced very large FBGCs with randomly arranged nuclei (~280) and extensive 
cytoplasmic spreading (Anderson et ai, 2000). The morphology of FBGCs developed 
from human monocytes in vitro with IL-4 is indistinguishable from those that from on 
implanted biomaterials (McNally et ai, 1995), which may be > Imm in diameter and 
occupy up to 25% of implant surface area (Zhao et aI, 1992). IL-4 is produced by T-
helper type2 (Th2) lymphocytes. Interestingly, IL-13, another Th2 cytokine, also 
induces FBGC formation in vitro (DeFife et ai, 1997). IL-4 and IL-13 appear to act 
independently of one another (DeFife et ai, 1997). 
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McNally and Anderson have also extensively investigated the role of substrate surface 
chemistry on monocytes adhesion and FBGC formation on biomaterials. In this 
process the adhesion of monocyte on implanted material is critical to biocompatible 
outcome because it initiates macrophage development and FBGC formation. The 
authors hypothesized that monocyte adhesion to biomaterial occurs via specific 
adhesion mechanisms i.e. interactions of cell surface receptors (e.g.integrins) with 
adsorbed proteins and that material-dependent protein adsorption determines the 
nature of adhesion molecules engaged. They have found that FBGC formation is 
significantly affected by the surface chemistry of the substrate to which the 
monocytes adhere, presumably reflecting differences in the composition and/or 
conformation of the proteins that are adsorbed (McNally et ai, 1994; Anderson, 
2000). 
1.2.2.3. Osteoclasts 
Bone is a complex, dynamic structure governed by the coupled actions of osteoclasts 
and osteoblasts (Bonewald et ai, 2002). Most adult skeletal diseases (osteoporosis, 
periodontal disease, rheumatoid arthritis, multiple myeloma and metastatic cancers) 
are due to excess osteoclastic activity, leading to an imbalance in bone remodelling 
which favours resorption (Boyle et ai, 2003). Osteoclasts are bone-degrading 
polykaryons, derived from monocyte-macrophage precursors at or near the bone 
surface (reviewed in Blair and Athanasou, 2004; Boyle, 2003). They are playing a 
regulatory role in balancing calcium homeostasis with skeletal modelling and repair 
(Blair et ai, 2005). Recent studies have elucidated the factors involved in the 
differentiation of these cells and the biochemistry of bone resorption. A full 
description of these processes is outside the scope of this thesis. Briefly, however, 
osteoclasts are generated by the interaction between macrophage colony stimulating 
factor 'RANK' generated by monocytes/macrophages and TNF-family ligand 
'RANKL' from mesenchymal cells in bone. The RANK and RANKL are considered 
as major determinants of osteoclast formation (Blair and Athanasou, 2005). In 
contrast, TNF -a, IL-6 and IL-ll have also been shown to promote osteoclast 
formation by RANKL-independent processes (reviewed in Blair and Athanasou, 
2004; Blair et ai, 2005). In addition the hormones, such as PTH/PTHrP, 
glucocorticoids and 1,25(OH)2D3, and humoral factors including TNF-a, IL-l, TGFs 
and prostaglandins also influence osteoclast formation (Blair and Athanasou, 2005). 
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Osteoclasts generally contain 10-20 nuclei per cell (Anderson, 2000). Whilst they are 
formed from precursors belonging to the monocytes/macrophage lineage, they appear 
distinct in terms of function and phenotype from Langhans' cells and FBGCs 
(Roodman, 1996; Anderson, 2000). Also, neither IFN-y nor IL-4 have been identified 
as significant in their development. 
1.2.2.4. HIV-mediated syncitium formation 
Human immunodeficiency virus-l infection of T lymphocytes and freshly isolated 
monocytes leads to the formation of giant cells also known as HIV -1 syncytia (HIV I-
S) and MGCs respectively. The formation of HIV -1 infected CD4+ T lymphocytes 
syncytia is highly dependent on interaction between intercellular adhesion molecule 
(ICAM-l) and LFA-l (CDlla/CDI8) (Fais et at, 1997; Anderson, 2000). In addition 
to CD4+, the interaction between CD98 and CD147 is very essential in regulation of 
virus-induced cell fusion of monocytes; the cell fusion mediated by HIV-l occurs 
between viral glycoprotein-gpl60 and CD4+ monocyte or lymphocytes. Mori and co-
workers demonstrated the monocyte fusion in vitro using U937-2 cells (CD4+ U937 
cells) transfected with HIV -gp 160 gene (Mori et at, 2004). Similarly the syncytia 
were generated in vitro by the infection of AIDS retrovirus with CD4 positive T cell 
lines 1M (Jurkat) and VB (Lifson et at, 1986). The antibodies to CD4 specifically 
inhibited the fusion (Lifson et at, 1986). Steffy and co-workers showed that the HIV-2 
fusion peptide gp41 is capable of inducing syncytium formation in vitro (Steffy et at, 
1992). The morphology of giant cells produced by HIV -1 infection of normal human 
primary monocytes is similar to that observed with IFN-y induced MGCs (Anderson, 
2000). In contrast to these monocyte-derived macrophages did not produce 
multinucleated giant cells (Anderson, 2000). 
1.2.3. Multinucleated giant cells in disease 
1.2.3.1. Infections 
The multinucleated giant cells containing granulomas are associated with infections 
caused by bacteria especially mycobacteria; parasites (e.g. schistosomiasis, 
leishmania); fungi (Aspergillus, Histoplasma, Coccidioides) (James, 2000) and viral 
infections such as HIV -1 and HIV -2 (Steffy et at, 1992; Alkhatib et at, 1996; Choe et 
at, 1998). 
The HIV-l induced CD4+ T cell derived syncytia (HIV-S) have never been obseryed 
in vivo since they are cellular structures with high numbers of nuclei that inevitably 
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die shortly after infection. This is suggested as an explanation for the fact that HIV-S 
have not been identified in tissues of AIDS patients whereas the monocyte derived 
MGCs were observed in vivo in brain and lymph nodes of AIDS patients (Fais et ai, 
1997; Anderson, 2000); this may result from the homotypic fusion of HIV -1 infected 
blood monocytes recruited and activated in these tissues (Fais et ai, 1997). 
Multinucleated giant cells produced by HIV -1 infection of monocytes/macrophages 
are bi-and trinucleated cells that remain viable for a considerable period of time (Fais 
et ai, 1997). 
1.2.3.2. Immune disorders 
The multinucleated giant cells are common features of immune disorders such as 
Crohn's disease, sarcoidosis and primary biliary cirrhosis. It is speculated that these 
disorders may have an undiagnosed infection as a root cause (James, 2000; Okamoto 
et ai, 2003). For example, sarcoidosis is a systemic granulomatous disease 
characterised by non-caseating granulomas (Okamoto et ai, 2003). It is generally 
recognized that sarcoidosis is a disorder of T lymphocyte-mediated inflammatory 
response to the unknown antigenic stimuli (reviewed in Newman et ai, 1997). In 
particular, mycobacterium and propionic bacteria have received much attention as the 
possible etiologic agents of sarcoidosis (Ishige et ai, 1999; Eishi et ai, 2002). 
Granulomas are also associated with some type III hypersensitivity reactions 
involving the lung e.g. farmers' lung. Granulomas also develop in response to some 
chemicals such as silica, (leading to silicosis), beryllium, zirconium and talc on 
inhalation (James et ai, 2000). As described above, FBGC containing granulomas 
develop in response to surgical implants/devices and may shorten the life span of the 
implant. 
1.2.3.3. Cancer 
There is often a granulomatous component in malignant diseases. Sarcoid granulomas 
may be found in various tumors and in their draining lymph nodes, particularly those 
draining carcinoma of the lung, stomach, and uterus (James et ai, 2000). 
Interestingly, the recent evidence suggests that tumor cells may fuse with themselves, 
as well as with monocyte/macrophages to create diversity, enhanced metastasis, 
chromosomal aberration and epigenetic regulation (Vignery, 2005). 
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1.2.4. Formation of MGCs in vitro 
MGCs originate from fusion of monocytes or macrophages, but little is known about 
the mechanisms of the fusion process itself. Furthermore, it is not clear how monocyte 
fusion is induced in vivo and whether different mechanisms are involved in different 
pathological states. 
1.2.4.1. Effect of stimulants used 
There have been many attempts to generate MGCs in vitro, in an effort to understand 
how this process occurs and is controlled in vivo and in different pathological states. 
However, these have used different types of stimuli, different sources of 
monocytes/macrophages and different culture conditions. The list of factors that have 
been used to generate MGCs from human monocytes are given in table.1.2.1. 
Stimulants 
SN of mono~ytes 
Tetanus toxoid, PPD, NaI04 
Con A 
PMA 
IFN-y 
IL-3 
IL-4 
Con A + IFN-y 
PHA 
IL-4 + M-CSF 
Nippostrongylus brasiliensis 
SN of Con A stimulated mononuclear cells 
Heat-killed candida albicans 
IL-4 + GM-CSF 
IL-13 
IL-4 + M-CSF 
39 
Authors 
Black et aI, 1976 
Postlethwaite et aI, 1982 
Kreipe et aI, 1988, 
Takashima et aI, 1993 
Falzoni et aI, 1995 
Hassan et aI, 1989 
Merrill et aI, 1997 
Hassan et aI, 1989 
Most et aI, 1990 
Enelow et aI, 1992 
Fais et aI, 1994 
Falzoni et aI, 1995 
Byrd, 1998 
Enelow et aI, 1992 
Byrd, 1998 
Takashima et aI, 1993 
Kazazi et aI, 1994 
McNally et aI, 1995 
DeFife et aI, 1997 
Jenney et aI, 1998 
McNally et aI, 2002 
Falzoni et aI, 1995 
Postlethwaite et aI, 1982 
Liu et aI, 1996 
Akagawa et aI, 1996 
Seitzer et aI, 1997 
Most et aI, 1997 
Heinemann et aI, 1997 
Dugast et aI, 1997 
DeFife et aI, 1997 
Ikeda, et aI, 1998 
Ikeda et af 1998 
SN ofHIV-transfected T cells + BCG Gasser et aI, 1999 
SN of Con A stimulated mononuclear cells ± MDP Mizuno et aI, 2001 
Vitamin E + a-tocopherol McNally et aI, 2003 
Vitamin D3 Abe et aI, 1983 
Table.l.2.1. Stimuli used for in vitro generation of MGCs from 
monocyte/macrophage. Where: SN=Supernatants; PHA=Phytohemagglutinin-A; Con 
A=Concanavalin A; PMA=Phorbol myristate acetate; MDP=Muramyl dipeptide. 
In addition MGCs have been generated from various sources of animal macrophages 
and also from myeloid cell lines, as discussed below. Peripheral blood monocytes are 
generally considered as non-replicating cells and autoradiograpahy confirmed that 
fusion occurred between non-replicating monocytes, rather than by nuclear division 
(endomitosis) without cytoplasmic division (Postlethwaite et aI, 1982; Weinberg et aI, 
1984). 
Early studies showed that a factor derived from antigen or mitogen-stimulated T cells 
promoted the fusion of human monocytes to form MGCs in vitro (Postlethwaite et aI, 
1982). Subsequently, there have been various attempts to identify cytokines that may 
be involved in inducing fusion and many studies have indicated the importance of 
IFN-y in MGC formation. Thus recombinant IFN-y has been shown to induce fusion 
of human monocytes to form Langhans' type cells (Weinberg et aI, 1984; Okamoto et 
aI, 2003) and antibodies to IFN-y inhibit fusion induced by cytokine-containing 
supernatants (Weinberg et aI, 1984; Most et aI, 1990; Fais et aI, 1994). It has been 
reported that IL-3 enhances IFN-y-induced fusion, whereas IL-4 had an inhibitory 
effect (Ene1ow et aI, 1992); IL-4 has also been shown to inhibit Con A-induced 
monocyte fusion (Takashima et aI, 1993). Interestingly, McNally and Anderson 
reported that Langhans' giant cells (LGC) were formed under the influence of IFN-y 
whereas IL-4 induced the formation of FBGCs under otherwise identical culture 
conditions (McNally and Anderson, 1995). From these and other studies it is clear 
that the characteristics of MGCs are dependent on the stimulant used. DeFife and co-
workers reported that the lymphokine interleukin IL-4 and the related lymphokine IL-
13 are the only human macrophage fusion factors known to induce very large FBGCs 
(DeFife et aI, 1997). Although IL-4 and IL-13 are strong inducers of 
monocyte/macrophage fusion, the maximum fusion was achieved by the combination 
of the two interleukins. The antibody studies showed that the fusion inducing effect of 
IL-13 is acting independently of IL-4 to promote foreign body giant cell formation but 
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IL-4 and IL-13 may trigger a common mechanism for macrophage fusion (DeFife et 
aI, 1997). The addition of IL-3 or GM-CSF optimised the effect of IL-4 on the 
formation of FBGC (Okamoto et aI, 2003; McNally and Anderson, 1995). In contrast 
to these, Takashima and co-workers found an inhibitory effect with IL-4 on Con A 
induced MGCs formation (Takashima et aI, 1993). In general, TH1-type cytokines 
appear to promote Langhans' giant cell formation, whereas TH2-type cytokines 
appear to induce FBGCs (Anderson, 2000). 
There are some reports that bacterial components influence the monocyte/macrophage 
fusion. Eishi, (1994) reported that muramyl dipeptide (MDP) from bacterial cell wall 
evokes epitheliod cell granulomas. Recently, Mizuno et aI, (2001) found that the 
MDP significantly increased the Con A conditioned medium-induced fusion of 
CD14++/CD16- peripheral blood monocytes. By contrast, Takashima and co-workers 
reported that bacterial lipopolysaccharide (LPS) inhibited Con A induced monocyte 
fusion (Takashima et aI, 1993). 
In their research on FBGC formation, McNally and Anderson showed that Vitamin E 
alone induced FBGC formation from monocytes to some extent and enhanced IL-4 
induced fusion in their system (McNally and Anderson, 2003). They also showed that 
a component of vitamin E a-tocopherol was much more potent than vitamin E itself. 
a-tocopherol is reported to activate diacylglycerol kinase and an inhibitor of this 
enzyme (R59022) completely abrogated FBGC formation. The authors therefore 
suggest a role for diacylglycerol kinase in FBGC formation. 
Other workers have investigated the effects of la, 25-dihydroxy vitamin D3, a known 
stimulator of osteoclast differentiation (Roodman, 1996) in MGC formation. Abe and 
co-workers have examined the effects of 1 a, 25-dihydroxy vitamin D3 in the fusion of 
mouse alveolar macrophage. Conditioned medium from spleen cells co-cultured with 
la, 25-dihydroxy vitamin D3, stimulated fusion of alveolar macrophages and the 
vitamin alone also induced some cell fusion (Abe et aI, 1983). Some effect of 1 a, 25-
dihydroxy vitamin D3 on MGC formation by human monocytes has also been 
reported (Enelow et aI, 1992). 
1.2.4.2. Effects of differentiation/activation 
Attempts to look at the differentiation stage of cells that gives rise to MGCs have 
been made. In humans, it appears that MGCs are formed more easily from monocytes ~ <:) 
<~~~y 
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than macrophages (Most et ai, 1997). Whilst freshly isolated monocytes gave high 
fusion rates when cultured with cytokine-containing supernatants, this decreased 
when the cells were induced to differentiate into macrophages by culturing them with 
human serum. Almost no MGC formation could be seen by day 8 of culture, and 
human serum had a negative effect on fusion. However, macrophages were still able 
to fuse with freshly isolated monocytes. Since the antimicrobial activity of monocytes 
declines during maturation in macrophages, the authors speculated that fusion with 
monocytes could benefit macrophages that take up certain bacteria or parasites in 
infectious granulomas. Fais and Pallone (1995) reported that virtually no MGC were 
formed from intestinal macrophages, in contrast to autologus peripheral monocytes. 
Interestingly, intestinal macrophages from Crohn's disease patients formed MGCs 
spontaneously; it suggests that MGCs in Crohn's disease might be recruited 
monocytes. However, the conditions required for the formation ofMGCs in vitro may 
vary depending on the stimuli, and on the source and animal species of the 
mononuclear phagocytes used as starting material. Thus, Anderson and McNally have 
generated FBGC from human monocytes allowed to differentiate for 3 days, followed 
by the addition of IL-4 or IL-13 to induce fusion (McNally and Anderson, 2002). 
Also, Vignery and co-workers has generated MGCs using highly purified (over 99%) 
rat alveolar macrophages, which fuse spontaneously in culture to form MGCs 
containing large numbers of nuclei that express osteoclast markers. The relationship 
between these MGCs and classical bone-associated osteoclasts is unclear (Vignery, 
2000). The fusion of rat alveolar macrophage initiates within few hrs after plating and 
is complete within 3 days in the absence of proliferation and differentiation factors 
such as M-CSF and RANKL, respectively, to induce their multinucleation. The 
researchers point out that this system differs from many others that use mixed 
populations of cells and may require growth factors M -CSF and RANKL to generate 
macrophages that are capable of fusing (Vignery, 2000). 
The rate and extent of fusion thus also varies depending on the differentiation status 
of the starting population of cells and the stimulus used. Abe et ai reported the 
differences in the time course of mouse macrophage fusion, depending on different 
treatments. The fusion rate induced by Con A-conditioned medium almost attained a 
plateau (~85% of cells fused) on day 2 and it increased further on day 3. However. 
fusion induced by IL-4 occurred as early as day 1 of culture but the maximal fusion 
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rate was only 30 to 40%. The 1 u, 25-dihydroxy vitamin D3 induced the fusion of 
macrophages after 24 hrs, which then increased linearly until the maximal fusion rate 
(similar to that obtained with Con A-CM) was observed on day 3 (Abe et ai, 1991). In 
humans, variations between donors in the efficiency. of MGC formation from 
monocytes have been observed in response to the same stimuli (Most, 1997; Spot et 
ai, 1995). In general, Langhans' type MGCs (induced by IFN-y) start to appear by 
24hrs in culture and fusion is maximal by 72-92hrs (Weingberg et ai, 1984). FBGCs 
formed on day 2 from the bone marrow cells cultured with IL-4 and reached 
maximum fusion by day 5 (McInnes and Rennick, 1988); the interleukin 13 induced 
FBGCs formed within 3 days from the macrophage/monocytes (DeFife et ai, 1997). 
Myeloid cell lines have also been used to study fusion. For example, Weinberg and 
co-workers generated the polykaryons from the human promyelocytic leukaemia cell 
line HL-60 using IFN-y. From these observation the authors are pointing out that 
small numbers of contaminating lymphocytes in blood monocytes will not affect the 
formation of polykaryons (Weinberg et ai, 1984). Some investigators raised doubts 
about the relevance of MGCs generated from transformed cell lines (Anderson, 2000). 
1.2.4.3. Concanavalin A induced formation of MGCs 
In this thesis, a model system in which lectin Concanavalin A induces fusion of 
adherent human monocytes was used. Therefore it is pertinent to review what is 
known of this system. 
Concanavalin A (Con A) is a member of a group of proteins called lectins, which is 
isolated from jack beans. Con A binds to a variety of eukaryotic cells through specific 
interactions with sugar residue or saccharide-containing cellular receptors and it has 
been widely used as a molecular probe in studies of cell membrane dynamics and cell 
division (Reeke et ai, 1975). Con A is a well-known activator and mitogen for T 
lymphocytes (Ruscetti and Chervenick, 1975). 
Initial studies used conditioned medium from Con A treated spleen cell cultures to 
generate MGCs from mouse alveolar macrophages (Abe et ai, 1983). Subsequent 
studies indicated GM-CSF was a major fusion inducing factor in the Con A 
conditioned medium (Abe et ai, 1992) but the relevance of these findings to Con A 
induced human monocytes fusion is unknown. 
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Most et al (1990) reported that conditioned medium from Con A stimulated peripheral 
blood mononuclear cells readily caused generation of MGCs from monocytes. This 
effect was completely abrogated by monoclonal antibody to IFN-y. IFN-y alone was 
less effective than the conditioned medium, but other cytokines (IL2, IL4 and TNF-a) 
considered to activate monocytes, neither induced the MGC nor enhanced the effect 
of IFN-y. The authors reported that the formation of MGC could be almost entirely 
inhibited by mAb to a or ~ chain of LF A-I and to a lesser extent by relatively high 
concentration of a mAb against ICAM-l, one of the ligands of LFA-l. In addition, 
mAb to LFA-l very efficiently inhibited clustering of monocytes, which is a pre-
requisite for the formation ofMGC. This effect was not observed with mAb to IFN-y. 
Takashima et al (1993) reported that MGCs could be produced by incubation of 
highly purified human blood monocytes with Con A alone and that the effect was 
dose and time dependent. Efficient fusion was observed with 10J.lg.mr l Con A and 
MGC were observed by 24hrs, reaching a plateau by 72hrs. The MGC were 
predominantly of the Langhans' type on their morphological character basis. The 
authors reported that T cell-derived cytokines (IFN-y, IL-2, IL-4, GM-CSF, TNF-a) 
did not induce MGC when added to the monocyte culture alone and an antibody to 
IFN-y did not suppress Con A induced fusion. However, IFN-y enhanced Con A 
induced MGC formation in a dose-dependent manner. By contrast, IL-4 suppressed 
MGC formation in a dose and time dependent manner and IL-4 antagonised the 
enhancing effect of IFN-y. The suppressive effect on the formation of MGC was 
completely abrogated after treatment with anti IL-4 antibody. The involvement of 
monokines (IL-Ia, IL-~, IL-6 and TNF-a) in Con A induced monocyte fusion was 
investigated by treatment with corresponding anti monokine antibodies. The anti 
TNF -a antibody suppressed Con A induced monocyte fusion in a dose dependent 
manner and a high dose of anti IL-6 antibody also had a partially suppressive effect. 
The authors argued that T cell-derived cytokines are not necessarily required to 
induce fusion and that monokines such as TNF -a, and the activation status of the 
monocytes may be important. The apparent discrepancy between these results and 
those reported by Most and co-workers (1990) may be due to differences in 
experimental conditions. The recent report by Takeda and co-workers, and results 
described in this thesis confirm that incubation of human monocytes with Con A 
alone can induce MGC formation (Takeda et at, 2003), but do not rule out effects of 
cytokines produced by contaminating lymphocytes. 
1.2.5. Mechanism of mononuclear phagocyte fusion 
As outlined above, there have been some difficulties in determining which signals 
(cytokines etc.) are required to stimulate MGC formation. This is in part due to the 
fact that different research groups have used different culture systems and different 
sources of monocytes/macrophages. Nevertheless, it is becoming apparent that the 
different types of mononuclear phagocyte-derived giant cells (Langhans' cells, FBGC 
and osteoclast) are formed in response to different signals. Prior to fusion itself, the 
cells must achieve a critical density, either by proliferating in situ, as may be the case 
for osteoclasts (Vignery, 2000) or accumulating from the bloodstream by chemotaxis. 
There must also be cell:cell contact and recognition (Vignery, 2000). 
Recently, progress has been made in identifying cell surface molecules that may be 
involved in the monocyte/macrophage fusion process itself. However, the molecular 
basis of fusion is still be elucidated and it is unclear, as yet, whether a common 
mechanism will be shared by the different types of MGC. Prior to describing 
molecules that have been identified as of importance in mononuclear phagocyte 
fusion, it is useful to discuss what is known of other cell fusion mechanisms. 
1.2.5.1. Membrane fusion: virus:cell and intracellular vesicle fusion 
The fusion of viruses with cells, in particular influenza virus and human 
immunodeficiency virus (HIV), provided strong evidence that fusion is mediated both 
by viral proteins (ligand) and host cell surface molecules that function as viral 
receptors (reviewed in Vignery, 2005). The receptor-ligand interaction mediates the 
binding of viral membrane glycoproteins to a receptor on the target cells (Vignery, 
2005; Ogle et at, 2005) e.g. the HIV viral membrane glycoproteins gp120 binds to its 
receptor CD4 + in T lymphocytes and macrophages; similarly the hemagglutinin 
protein of influenza binds to its receptor sialic acid on epithelial cells (Vignery, 2005). 
The fusion proteins are integral membrane glycoproteins that exist as oligomers on 
the surface of each virion. Most viral fusion proteins contains a stretch of hydrophobic 
amino acids, known as a fusion peptide, which penetrates host cells, destabilising the 
lipid bilayer of the host cell. The fusion protein then undergoes a conformational 
change, forming a hairpin-like a-helical bundle, which acts like a spring to propel the 
viral membrane close enough to the cell membrane to trigger fusion (Fig.l.2.4) 
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(Vignery, 2005). Apart from these it has been reported that the chemokine family of 
G-protein coupled receptors, most notably CXCR4 and CCR5, are involved in l-llV 
infection (Vignery, 2000). There are now at least IO chemokine receptors identified as 
HIV co receptors (Vignery, 2000). 
Fig.I.2.4. Hypothetical model of the synaptic fusion complex as it joins two 
membranes. In contrast to viral hairpins fusion protein (Red arrow), cellular SNARE 
pins (Green arrow) are formed from separate polypeptides that reside in different 
membranes before fusion. Cellular SNAREpins and viral hairpins suggest that they all 
employ a fundamentally similar mechanism to coalesce lipid bilayers (Image: 
Vignery, 2000). 
Another type of fusion occurs between distinct membranes within a cell during 
intracellular trafficking between the endoplasmic reticulum and golgi apparatus; the 
fusion of an intracellular vesicle with its target membrane is mediated by a set of 
conserved proteins that are collectively called as SNAREs (soluble NSF attachment 
protein [SNAP] receptors) (Vignery, 2005). Many vesicle (v) - and target (t)-
SNAREs have been characterized in yeast, plants, and animals, and shown to form a 
bundle of a-helices (SNAREpins) that bring opposing membranes close enough to 
fuse. The fusion process between intracellular membranes occurs ill a manner 
analogous to that between viruses and cells (Vignery, 2000). 
1.2.5.2 Cell: Cell fusion 
A number of putative fusion proteins involved in cell:cell adhesion have recently been 
identified e.g. immunoglobulin superfamily proteins (reviewed in Chen and Olson, 
2005). These proteins do not contain an obvious fusion peptide or a-helical spring 
suggesting that cell:cell fusion may use different mechanisms from other types of 
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membrane fusion. Also, it is postulated that different types may have cell-type 
specific fusion mechanisms (Vignery, 2000). 
Among the different types of cell fusions, fertilisation is perhaps the most well known 
form of cell-cell fusion. The membrane fusion between sperm and egg occurs after a 
series of pre-fusion events, including penetration of outer layer of the oocytes by 
sperm, secretion of enzymes by the lysosome-like acrosome in the sperm head, and 
penetration of the egg's inner layer, the zonapellucida, by the sperm. In addition 
proteins such as ADAM (A Disintegrin and Metallo protease) family transmembrane 
proteins on the sperm, such as fertilin a , fertilin ~, and cyritestin, tetraspanin CD9 and 
integrins on egg surface have been postulated to mediate membrane fusion (Chen and 
Olson, 2005; Takahashi et ai, 2001; Kaji et ai, 2002, see section 1.1.5.6.1). 
Fig.1.2.5 . Sperm-egg fusion. Image adapted from Wassarman et ai, (2001 ). 
Similarly the fusion of mononucleated myoblasts to form multinucleated muscle 
fibers is an essential step in skeletal muscle differentiation. The embryo of 
Drosophilia contains two populations of myoblasts such as founder cells (seeds for 
future muscle fibers) and fusion competent cells, which undergo fusion by the activity 
of two classess of proteins such as Immunoglobulin (Ig) domain-containing 
transmembrane proteins Dumbfounded (Dut), Roughest (Rst), Sticks and stones (Sns) 
and Hibris (Hbs). These cell surface receptors are thought to mediate recognition and 
adhesion of the two types of muscle cells through direct interactions (Chen and Olson 
2005). 
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In addition the syncytium formation by fusion occurs during the development of 
placenta (Ogle et at, 2005), where for the mammalian placenta, trophoblasts fuse to 
form a syncytial layer of cells (syncytiotrophoblast) that functions as a barrier 
between maternal and fetal blood vessels. The proteins that are involved in this type 
of fusion are not known except syncytin (Chen and Olson, 2005). Syncytin is a 
single-pass transmembrane protein that can induce ecotopic cell-cell fusion in 
transfected cells and it is nearly identical to the envelope protein of the human 
endogenous retrovirus HERV-W. Syncytin functions as a class I fusion protein like 
hemagglutinin (HA). However, this mechanism of trophoblast fusion is unlikely to be 
universal, because syncytin is only present in primates and not in other mammals in 
which placental trophoblasts also undergo cell fusion to form the layer of 
syncytiotrophoblasts (Chen and Olson, 2005). 
Cell fusion events are also involved in the regeneration of liver tissue and it was 
demonstrated that the bone marrow cells from mice fused with hepatocytes of mice 
(Ogle et at, 2005). 
1.2.5.3. Cell surface molecules implicated in MGC formation 
A number of putative fusion proteins have recently been identified in the plasma 
membrane of various types of fusing cells from different species, many of which 
belong to the immunoglobulin superfamily of proteins, which are discussed below 
(Vignery, 2003; Vignery, 2005). 
LFA-l and ICAM-l 
Various groups have shown that antibodies to LFA-1 and ICAM-1 inhibit fusion 
(Most et at, 1990; Gasser and Most, 1999; Kurachi et at, 1993). Other integrins 
especially a V~3 have also implicated in osteoclast formation (Boissy et at, 1998). 
However, involvement of integrins and their ligands in fusion may be indirect since 
they are known to be involved in adhesion, spreading and aggregation, which are pre 
requisite for fusion. Thus Boissy and co-workers found that a cell permeable peptide 
that blocks a V~3 function inhibited spreading and fusion in an osteoclast like model 
system in vitro. In their studies on in vitro formation of FBGC McNally and Anderson 
reported that the initial monocyte adhesion is strongly mediated by ~2 integrins, 
whereas during the induction of macrophage fusion by IL-4, an additional dependence 
on pI integrins is acquired. This indicates that both ~ 1 and ~2 integrin play 
cooperative roles in cell adhesion during the formation of multinucleated giant cells, 
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but does not necessarily mean that they are involved in the fusion process (McNally 
and Anderson, 1994; McNally and Anderson, 2002). 
Cadherins 
E-Cadherin is ·a member of the homophilic calcium-dependent adhesion molecules 
family involved in cell:cell interactions. An antibody to E-Cadherin inhibited mouse 
osteoclast formation in vitro, but did not affect proliferation or adhesion (Mbalaviele 
et ai, 1995). 
CD98 and integrin a.3 (FRP-l and FRP-2) 
Recently additional molecules, which regulates cell fusion have been identified and 
are designated as fusion regulatory protein-l (FRP-l) and fusion regulatory protein-2 
(FRP-2). FRP-l and FRP-2 were identical to CD98 heavy chain and integrin u3, 
respectively (reviewed in Tsurudome and Ito, 2000). The FRP-l system is involved 
in virus-mediated cell fusion and multinucleated giant cell formation of blood 
monocytes. Monoclonal antibody against human FRP-l heavy chain induces 
polykaryocytes that have properties of osteoclasts (reviewed in Tsurudome and Ito, 
2000). Similarly mAbs to FRP-l and FRP-2 proteins induced MGC formation in vitro 
from monocytes (Tabata et ai, 1994; Higuchi et ai, 1998), and enhanced fusion of 
CD4+ U937 cell line transfected with HIV gp160 gene or HeLa cells infected with 
Newcastle disease virus (Ohgimoto et ai, 1995; Higuchi et ai, 1998). CD98 is a type 
II integral membrane protein that associates covalently with several alternative light 
chains on the cell surface. It has been implicated in a range of functions including 
differentiation, oncogenic transformation, apoptosis and amino acid transport. It 
associates with integrins and has roles in regulating integrin signalling (Cho et aI, 
2003; Feral et ai, 2005). It has been suggested that CD98 is a component of an egg 
surface "tetraspanin web" that includes CD9, CD81, integrins and integrin-associated 
proteins that is necessary for fusion (Takahashi et ai, 2001). 
ADAM9 
The ADAMs (A Disintegrin And Metalloprotease) is a family of transmembrane 
proteins with putative roles in fertilisation and myoblast fusion. An anti ADAM9 
antibody was found to block anti CD98 or RANKL mediated fusion of human 
monocytes, whereas it enhanced anti CD98 mediated adhesion. An inhibitor of 
ADAM9 metalloprotease activity also suppressed MGC formation. Interestingly 
ADAM9 contains a potential fusion peptide (Namba et aI, 2001). 
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Mannose receptor 
The mannose receptor IS an endocytic/phagocytic receptor expressed by 
monocytes/macrophages. Inhibitors of mannose receptor activity (alpha-man-nan and 
synthetic neoglycoprotein conjugates) inhibited IL-4 induced FBGC formation 
(McNally et ai, 1996). Inhibitors (swainsonine and castano spermine) of glycoprotein 
processing that interferes with the arrival of newly synthesized mannose receptors at 
the cell surface also attenuated macrophage fusion and the formation of giant cells. 
Mannose receptors were specifically up regulated by IL-4 in the culture system and 
were present and concentrated at macrophage fusion interfaces. These data suggest 
that the macrophage mannose receptor may be an essential participant in the 
mechanism of IL-4 induced macrophage fusion. IL-13, which also induces fusion, 
upregulates mannose receptor (DeFife et ai, 1997). A role for this receptor has also 
been implied in a cell line (RA W264.7) model for osteoclast development (Morishima 
et ai, 2003). 
P2Z/P2X7 purinergic receptor 
Purinergic (pore-forming) receptors are emerging as one of the most interesting new 
families of plasma membrane receptors, which are also known as pore-forming 
receptor that binds ATP (Chiozzi et ai, 1997; Falzoni et ai, 1995). Falzoni and co-
workers showed that human MGC formation induced by Con A was blockable with 
the P2X7 blocker, oxidised ATP (Falzoni et ai, 2000). Macrophage cell lines 
expressing high levels of P2X7 fuse spontaneously in culture, whereas those with low 
levels do not (Chiozzi et ai, 1997). mAbs to these receptor block fusion (Falzoni et ai, 
2000), but fusion is enhanced by enzymes that destroy extracellular ATP. P2X7 
receptor appears to be preferentially localised to sites of cell-to-cell contact in fusing 
macrophages (Falzoni et ai, 2000). 
Macrophage fusion receptor (MFR) 
Components of the putative machinery that mediates the fusion of macrophages were 
identified initially by Vignery's research group using monoclonal antibodies that 
recognized cell surface determinants and altered fusion in tissue culture. The first 
protein identified in this way was macrophage fusion receptor (MFR) (Vignery, 
2000). MFR is a type 1 transmembrane protein belonging to Ig gene superfamily with 
3Ig (2C 1,1 V, Fig.1.2.6) loops, structurally closly resembling CD4. MFR (a.k.a 
CD 172a, P84, SHPS-l, SIRPu and BIT) is expressed only by myeloid cells and 
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neurons (Vignery, 2000). MFR is strongly but transiently expressed in macrophages 
at the onset of fusion. mAbs to MFR and the recombinant extracellular domain of 
MFR block cell fusion; mAbs do not block aggregation, but a recombinant protein 
corresponding to extracellular domain did (Vignery, 2005). MFR contains 4 putative 
tyrosine phosphorylation sites belonging to immunoreceptor tyrosine based inhibitory 
motif (ITIM). An alternatively spliced form lacking two of the Ig domains is also 
produced transiently at the onset of fusion (Vignery, 2000). MFR binds to CD47 
(Vignery, 2005). 
CD47 
CD47 is a ubiquitously expressed IgSF member with 5 transmembrane domains 
(Vignery, 2005). It shares the homology (28%) with vaccina virus protein A38L 
(which promotes calcium entry into cells, possibly by forming a pore). It also acts as 
a receptor for thrombospondin. 
Attachment -------11 .. __ F u sion ........ 1------ Attac rnent 
CD47 MFA/SIRP CD44 
Key: 
V-set Ig domain of MFA/SlAP 
• C1-set 19 domain of MFA/SlAP 
• V-set Ig domain of CD47 
Fig.1.2.6. Hypothetical mechanism for homotypic fusion of macrophages: recognition 
of 'self. Macrophage-macrophage adhesion is achieved by binding of the 
macrophage fusion receptor MFR to CD47, which allows cells to recognise each other 
as 'self. The stepwise association of the long form of MFR and then the short form of 
MFR (MFR -s, lacking the C 1 set Ig domains) with CD47 reduces the distance 
between the plasma membranes. This might be facilitated by the shedding of the 
extracellular domain of MFR. The distance between macrophage plasma membranes 
could be reduced to 5-10nm ifMFR-s and CD47 bend upon binding. Meanwhile, the 
extracellular domain of CD44 might also be shed, further facilitating plasma 
membranes from apposing cells to get closer and fuse. Image courtesy of Vignery,A 
(2005). 
CD47 contains one extracellular Ig variable domain (IgV), followed by five predicted 
transmembrane segments terminating in a cytoplasmic tail. As described above the 
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MFR is expressed in two types, namely a long form and a short form, both with an 
extracellular N-terminal IgV domain. During the fusion CD47 and MFR appear to 
interact via the IgV domains (Vignery, 2005). Vignery speculates that the long form 
of MFR (with 2 IgC domains) first secures the attachment of cells, since their 
expression is more during fusion, and then switches to short form of MFR to bring the 
plasma membrane of cells closer to one another (Fig.1.2.6). However, CD47 KO mice 
develop normally (Vignery, 2000; Vignery, 2005). 
CD44 
CD44 is an integral membrane glycoprotein, a receptor for hyaluronan and membrane 
type 1 matrix metalloproteinase (MT1-MMP) (Vignery, 2005; Kajita et ai, 2001). It is 
known to be involved in cell-cell and cell-substrate interactions and playing roles in 
cell migration, lymphopoiesis and lymphocyte homing (Vignery, 2000). This has also 
been implicated in monocyte/macrophage fusion. It is strongly and transiently 
induced at the onset of fusion (Vignery, 2005) and extracellular ligands of CD44 
block the fusion and multinucleation. Recombinant extracellular domain in the form 
of GST fusion proteins blocks fusion by interacting with a putative cell-surface 
binding site (Vignery, 2000). Vignery and co-workers suggested that over expression 
of CD44 is required to override extracellular ligands and provide unoccupied CD44, 
which can then interact with a putative macrophage receptor. The extracellular 
domain of CD44 is cleaved from the cell membrane by MT1-MMP matrix 
metalloproteinase and sheds from the cell membrane in tumour cells promoting 
migration (presumably by allowing detachment from ECM (Kajita et ai, 2001)). 
Vignery and co-workers suggest that this may also happen in fusing monocytes 
possibly allowing closer apposition of cells. 
DC-STAMP 
DC-ST AMP was originally described as a molecule with 7 putative transmembrane 
domains expressed preferentially by (monocyte-derived) dendritic cells (Hartger et ai, 
2000). The molecule was later shown to be involved in osteoclast formation: its 
expression is rapidly induced on osteoclast progenitors by e.g. RANKL, and siRNA 
or antibody to DC-STAMP inhibited osteoclasts formation, whereas over expression 
enhanced RANKL-induced osteoclastogenesis (Kukita et ai, 2004). More recently, 
studies in DC-STAMP knockout mice indicated a critical role for this molecule in 
both osteoclast and foreign body giant cell formation. Loss of osteoclast formation in 
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the knockout mice was restored by retroviral introduction of DC-STAMP (Yagi et at, 
2005). 
1.2.5.4. Multinucleated Giant Cell formation may involve phagocytosis 
One of the important functions of macrophage is internalisation of apoptotic cells, 
pathogens and foreign bodies and their subsequent routing towards lysosomes for 
degradation. It has been proposed that MGC formation occurs via a process similar to 
phagocytosis or "cellocytosis" (Vignery, 2005). However, macrophages must use an 
alternative pathway for cellocytosis leading to fusion, because cellocytosed cells 
survive and become integrated into the new cell (Vignery, 2005). Apoptosis by 
macrophages is a multistep molecular event associated with sequential modification 
of plasma membranes, in addition to the high level expression of phospho serine on 
the cell surface that is crucial for effective recognition and phagocytosis of target 
cells. The difference between cellocytosis of live cells and phagocytosis of apoptic 
cells might therefore involve specific cell-surface determinants, expressed by the 
internalised cell, such as CD47 (Vignery, 2005) (Fig. 1.2.7). Most recently McNally 
and co-workers (2005) assessed the involvement of the endoplasmic reticulum and the 
mannose receptor for FBGC formation. In this study the authors found evidence for a 
phagocytic mechanism of macrophage fusion, including requirements for 
microtubules, V -type ATPase, and iPLA2. They also found that endoplasmic 
reticulum (ER) markers are present at fusion interfaces and on macrophage surfaces 
during FBGC formation, suggesting that the mechanism of macrophage fusion 
leading to multinucleated giant cell formation is supported by ER-mediated 
phagocytosis. Co-localisation of ER markers with Con A reactivity at fusion 
interfaces further raises the possibility that the ER presents ligands to mannose 
receptor (MR) during FBGC formation (McNally and Anderson, 2005). The 
involvement of mannose receptor (MR) in the macrophage-macrophage fusion the 
FBGC formation concurs with their earlier study (McNally and Anderson, 1996). 
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(e) (d) 
Fig.1.2.7. Macrophage 'Cellocytosis': (a) Extensive interdigitations of the plasma 
membrane between fusing macrophages; (b) Higher-magnification of the area 
enclosed by a red dotted line in (a); (c) Internalised, membrane-bound, but not fused, 
rat alveolar macrophages in tissue culture; (d) Multinucleate alveolar macrophages 
that contain a large number of nuclei; (e) Cellocytosis: a hypothetical model 
represents multinucleate cell expands. Image courtesy ofVignery, A (2005). 
1.3. AIMS 
The main aim of this project was to further investigate the role tetraspanins are 
playing in MGC formation, following the report of Takeda and co-workers (Takeda 
et ai, 2003). Initially, a monocyte fusion assay was to be set up using Con A 
stimulation of normal human peripheral blood monocytes. The effects of different 
anti tetraspanin antibodies would be tested in this, to see if the [mdings reported by 
Takeda and colleagues could be reproduced and extended. The effects of a panel of 
tetraspanin GST-EC2 fusion proteins on Con A stimulated monocyte fusion was to be 
investigated. If the study elicited any interesting information, attempts would be 
made to elucidate the mechanism of action of the tetraspanins e.g. looking at their 
effects on adhesion, cell proliferation and aggregation. The binding of the tetraspanin 
EC2s to monocytes would also be assessed and attempts made to identify any 
interacting molecules. 
Another initial aim of the project was to further characterise a human single chain Fv 
(scFv) antibody that was thought to bind CD63. This antibody had been isolated by 
Dr. Ann Marshall, previously a post-doctoral worker in the group. The antibody had 
been selected from a phage-display combinatorial library generated from patients with 
ocular melanoma. The background to this work is given in chapter 6. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1. MATERIALS 
2.1.1. General chemicals and reagents 
Unless otherwise stated general chemicals and reagents were purchased from Sigma, 
BDH, Fisher Chemicals or Bio Rad and were of analytical grade or equivalent. 
2.1.2. Water 
Milli-Q water was prepared usmg millipore apparatus (PURITE NEPTUNE, 
Scientific Laboratory supplies Limited). 
2.1.3. Sterilisation 
Bacterial culture media, molecular biology buffers and glassware were sterilised by 
autoclaving at 121°C for 20min. at 15lb/sq.in. The media for tissue culture and BSS 
were filter sterilised using a 0.2~m micro culture capsule. 
2.1.4. Media and Buffers 
The media used for mammalian and bacterial cell culture and their method of 
preparation are summarised in section 2.1.4.1 and 2.1.4.2 respectively. Methods of 
preparation of commonly used buffers are given in section 2.1.4.3. Antibiotics used 
for the selection of mammalian and bacterial cells are given in section 2.1.4.3.10. 
2.1.4.1. Media for mammalian cell culture 
The media used for the mammalian cell culture for the present research project are 
summarised in the table 2.1. 
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Media 
DMEM 
(Dulbecco 's 
Minimal 
Essential 
Medium) 
I RPMI 1640 
(Bicarbonate 
Buffered) 
HEPES 
buffered 
RPMI1640 
Preparation 
1 canister of powdered DMEM (Gibco, cat. no. 31600-075) was 
dissolved in 2L of MQ water with 1 x 1 06units of benzyl penicillin 
(Sigma, cat. no. P3032) and 0.5x106 units of streptomycin sulphate 
(Sigma, cat. no. S 0890). 50ml of 100x non-essential amino acids 
I (Gibco, cat.no.1l140-035), 1.46g of tissue culture grade solid 
glutamine (Gibco, cat.no.21051-024), 18.5g of tissue culture grade 
sodium bicarbonate (Sigma, cat. no. S5761) were added and 
sufficient MQ water was added to make 4.8L. The pH of the 
medium was adjusted between 7.2-7.4 before the final volume was 
adjusted to 5L. The medium was filter sterilised. 
-
I 1 canister of powdered RPMI 1640 (Gibco, cat. no. 3010755) was 
I dissolved in 2L of MQ water with 1x106 units of benzyl penicillin 
I (Sigma, cat. no. P3032) and 0.5x106 units of streptomycin sulphate 
(Sigma, cat. no. S0890). 10g of tissue culture grade sodium 
bicarbonate (Sigma, cat. no. S5761) were added. Sufficient MQ 
water was added to make 4.8L. The pH of the medium was adjusted 
to 7.2-7.4 before the final volume was adjusted to 5L. The medium 
was filter sterilised. 
1 canister of powdered RPMI 1640 with 25mM HEPES (Gibco, cat. 
no. 13018023) was dissolved in 2L ofMQ water with 1x106units of 
I benzyl penicillin (Sigma, cat. no. P3032), 0.5x106units of 
streptomycin sulphate (Sigma, cat. no. S0890) and 4.25g of tissue 
culture grade sodium bicarbonate (Sigma, cat. no. S5761). 
Sufficient MQ water was added to make 4.8L. The pH of the 
medium was adjusted to 7.2-7.4 before the final volume was 
adjusted to 5L. The medium was filter sterilised. 
- -
Table.2.1 . Media used for mammalian cell culture. 
FCS: Mycoplasma free FCS (Labtech. International, cat.no.410 1500, batch no.1 231 
or Biowest Ltd, cat.no.S040 1 OS 181 0/50, batch no. S040 1 OS 181 0) was used fo r cell 
culture. For heat inactivation thawed FCS was placed in a water bath at 56°C for 
30min . Different batches of FCS were tested for their ability to support growth of 
cells before use. 
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2.1.4.2. Media for bacterial culture 
The media used for the bacterial cell culture are summarised in table 2.2. 
Media 
2TY 
2TYE 
liB medium 
LB medium 
Preparation 
109 yeast extract (OXOID, cat. no. L21) , 16g tryptone (OXOID, 
cat.no. LP0042), 5gm sodium chloride (BDH, cat. no. 1 02415K) 
were dissolved in 980ml of MQ water using a magnetic stirrer. pH 
of the medium was adjusted to 7.0 with 10M sodium hydroxide 
solution and the final volume was adjusted to 1L with MQ water. 
The medium was sterilised by autoclaving. 
109 yeast extract (OXOID, cat. no. L21), 16g tryptone (OXOID, 
cat.no.LP0042), 5gm sodium chloride (BDH, cat.no.1 02415K) were 
dissolved in 980ml of MQ water using a magnetic stirrer and the pH 
of the medium was adjusted to 7.0 with 10M sodium hydroxide. 
The final volume was adjusted to 1L with MQ water. l5g bacto-
agar (OXOID, cat.no. LPOO 11) was added. The medium was 
sterilised by autoclaving. 
--
109 of tryptone (OXOID, cat. no. LP0042), 5g Nacl (BDH, cat. no. 
I 102415K) and 5g yeast extract (OXOID, cat.no. L21) were 
dissolved in 980ml of MQ water using a magnetic stirrer and the pH 
of the medium was adjusted to 7.0 with 10M sodium hydroxide 
solutions. The final volume was adjusted to lL. The medium was 
sterilised by autoclaving. 
15g of bacto-agar added to 1L of LB medium. The medium was 
sterilised by autoclaving. The pH of the medium 7.0. 
Table.2. 2. Bacterial cell culture media used for the present study. 
2.1.4.3. Buffers and reagents 
2.1.4.3.1. General laboratory buffer solutions/reagents 
The general laboratory buffers used for the present research project are summarised in 
table 2. 3. 
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I 
Buffer 
BSS (Balanced Salt Solution) 
PBS (Phosphate Buffered 
Saline) O.lSM (10x.L- 1) 
PH7.2 
I 
Preparation 
43.36g sodium chloride (NaCI) , 1.83g potassium 
chloride (KCI), 8.19g D-sorbitol, 3.0g dipotassium 
hydrogen phosphate (K2HP04.3H20), 0.7g potassium 
dihydrogen phosphate (KH2P04) and 12.09g HEPES. 
The ingredients were weighed accurately and dissolved 
in 4.8L ofMQ water. The pH was adjusted between 7.2-
7.4 with 1M sodium hydroxide solutions. The final 
volume was adjusted to SL with MQ water. The solution 
was filter sterilised. Stored at 4°C in sterile bottles. 
80g sodium chloride (Nacl), 2g potassium chloride 
(KCI), 11.Sg di sodium hydrogen phosphate (Na2HP04) 
and 2g potassium hydrogen phosphate (KH2P04) were 
weighed and dissolved in 1L of distilled water. Usually 
1: 10 dilution in distilled water was used. 
BBN 
FACS) 
(Wash Buffer for 0.1 % sodium azide and 0.2% BSA (tissue culture 
standard) dissolved in BSS. Stored at 4°C. 
, TAE (SOx,L- 1) 
2%Paraformaldeyde 
solution 
20% PEG8000/ 
2.5M Nacl 
242g Tris base, S7.1ml glacial acetic acid, 100ml of 
O.SM EDTA and water to lL. 
2g of paraformaldehyde was dissolved in 100ml of 
1xPBS in a glass bottle by heating in a water bath for 1 
hr. at S6°C. The solution was allowed to cool at RT and 
then stored at 4°C. 
-
100g PEG8000 was dissolved in 400ml of 2.SM sodium 
chloride solution by stirring with a magnetic stirrer. The 
volume was adjusted to SOOml with 2.SM NaCl. The 
solution was sterilised by autoclaving. Cooled to RT and 
then stored at 4°C. 
Table.2. 3. General laboratory buffers and reagents. 
2.1.4.3.2. Reagent for freezing of mammalian cells 
Freezing mixture is a combination of 90%FCS and 10% dimethyl sulphoxide 
(DMSO) prepared in advance and stored at 4°C in dark. 
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2.1.4.3.3. Reagents and solution for testing the viability of mammalian cells 
The reagent and solution used for the testing the viability of mammalian cells were 
prepared as follows: 
(a) Erythrosine dye stock solution: OAg erythrosine B salt, 0.81g sodium chloride, 
0.06g potassium di-hydrogen orthophosphate 0.05g methyl-p-hydroxybenzoate. The 
ingredients were placed in 95ml of MQ water in a 250ml beaker, dissolved by heating 
to boiling in a heated stirrer. The pH was adjusted between 7.2-7.3 with 1M NaOH 
(about 8 drops). The final volume was adjusted to 100ml with MQ water. This 
solution is stable indefinitely at RT. 
(b) Trypan blue solution: 1:4 ratio of try pan blue (Sigma,cat.no.T8154) in 
mediumllxPBS. 
(c) Wright stain modified: A neat solution of Wright stain (Sigma,cat.no.WS-16) 
was used. 
2.1.4.3.4. Reagents and solutions for ELISA 
The reagents and solutions used for ELISA are summarised in table 2A. 
Reagents Preparation 
Blocking buffer / dilution 5% milk powder and 0.01 % tween 20 in lxPBS. Mixed 
buffers by stirring using a magnetic stirrer. 
1 % BSA, 2% dried milk powder in lxPBS. Mixed by 
I stirring using a magnetic stirrer. 
0.2% gelatin in lxPBS. Gelatin was dissolved by gentle 
heating in a microwave oven. 
1 % milk powder and 0.01 % tween 20 in PBS. Mixed by 
stirring using a magnetic stirrer. 
0.1 % BSA and 1 % dried milk powder in Ix PBS. Mixed 
by stirring using a magnetic stirrer. 
Phosphate-Cit~ate buffer 25.7ml of 0.2M dibasic sodium phosphate (Na2HP04), 
(0.05M) 24.3ml of 1M citric acid were mixed together and the 
TMB substrate solution 
volume was adjusted to 50ml with MQ water. The pH of 
the solution was adjusted to 5 either using 0.2M dibasic 
sodium phosphate or O.IM citric acid. 
A tablet (Img) of 3,3' , 5,5' tetramethyl benzidine free 
base (Sigma, cat. no. T5525) was dissolved in a mixture 
of 1 ml of DMSO + 9ml of 0.05M phosphate citrate 
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~ 
buffer pH S.O with 4111 of 30% H20 2. A solution was 
achieved by vortex mixing. Prepared just before use. 
------------ -- -
glutaraldehyde Iml of 2S% glutaraldehyde solution mixed with 99~1 of 0.2S% 
solution 
1xPBS. Stored at 4°C. 
20mM carbonate 1.S9g Na2C03 and 2.93g NaHC03 were dissolved in 
Ibicarbonate buffer 
(ELISA coating buffer) 800ml of MQ water using a magnetic stirrer. The pH 
was adjusted to 9.6 using 1M HCl or 1M NaOH. The 
final volume was adjusted to 1L with MQ water. Stored 
at 4°C in clean glass bottles. 
Table.2A. Reagents and solutions used for ELISA. 
2.1.4.3.5. Reagents and solutions/or FITC labelling o/proteins 
Conjugation buffer (O.SM carbonate-bicarbonate buffer) pH 9.S: S.8ml of S.3 % 
Na2C03 solution was added to 4.2ml of 4.2% NaHC03 solution. The pH of the 
solution was adjusted to 9.S. 
2.1.4.3.6. Reagents and solutions/or SDS-PAGE gels 
(a) Precast gel used for SDS-PAGE: 12% Tris-HCI Ready Gel (Biorad)-l Owell, 
30111 comb. 
(b) Protein standards for SDS-PAGE: Sigma marker ™ high molecular weight 
range (6.S-20S kDa). 
2.1.4.3.7. Reagent used/or monocyte work 
The monocytes were separated from the blood using Ficoll-Hypaque plus (Amersham 
Pharrnacia Biotech, cat.no.17 -1440-02). The monocytes were stimulated with 
Concanavalin A (Sigma, cat.no.CS27S). 
2.1.4.3.8. Reagents and solutions for SRB assay 
The reagents and solution used for the sulforhodamine B assay are summarised in 
table 2.S. 
Reagents 
OA%W/V 
Solution 
Preparation 
SRB 40mg of Sulforhodamine B salt (Sigma, cat. no. S9012) in 
10ml of 1 % acetic acid solution. 
SO% Trichloroacetic SOg Trichloroacetic acid was dissolved in 80ml of MQ 
acid solution water. The final volume was adjusted to 100ml with MQ 
water. 
Un buffered Tris base 1.21g of tris base (Sigma, cat. no . T-1S03) was disso l ed 
(lOmM) pH 10.S in 9Sml of MQ water and the pH was adju ted to 10 .S 
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using a concentrated solution of tri base. 
Poly L-lysine 50~g . mrl solution was prepared in carbonate bicarbonate 
buffer. 
Table.2.5. Reagents and solutions used for SRB assay. 
2.1.4.3.9. Reagents and solution for nuclear staining 
(a) Propidium iodide solution: A stock solution of propidium iodide 
(Sigma,cat.no.P4170) @1mg.mr l was prepared in 1xPBS and used at 1~g. mrl. 
(b) Bisbenzimide (Hoechst dye): A stock solution ofbisbenzamide (Sigma,cat.no. 
B2261) @1mg.mr l was prepared in MQ water and used at 1~g .mrl. 
2.1.4.3.10. Antibiotics used for mammalian cell culture and bacterial cell culture 
The antibiotics used for the selection of mammalian and bacterial cells are 
summarised in table 2.6. 
Antibiotic Stock Concentration Working 
(mg.mr1) Concentration 
I (lJg.mr1) 
I Carbenicillin 100 (in 50% ethanol) 50/1 00 
C1!1<:?r~~phenic~1 25 (in 1 OO~ eth~nolL _ 25 
Kanamycin 50 (in water) 50 
Tetracycline I 10 (in water) 10 
Qeneticin (G418) 29 (in cul~re ~ec!iumJ 0.4 
I Penicillin &_ strepto!!lycin 10,009 Units~mrl 100Upits.mrl 
Table.2.6. Antibiotics used for tissue culture and bacterial culture. 
2.1.4.3.11. Reagents used for scFv phage propagation 
Storage I 
(OC) 
-20 
-20 
4 
-20 
4 
-20 
(a) The expression of scFv phage was induced by isopropyl-~-D-Thiogalacto 
pyranoside (lPTG) (Sigma, cat. no. 16758). 
(b) The helper phage used for the scFv probation IS VCSM13 helper phage 
(Stratagene, cat. no. 200251). 
2.1.4.3.12. Immunofluorescent mounting medium 
The mounting medium used for the fluorescent slide preparation are: Immuno-Fluore 
mounting medium (lCN biomedical company, Ohio, US, cat. no. 62270); Citifluor 
mounting medium (Citifluor Ltd, London, cat. no. AFI+AF100); Mounting medium 
(The Binding Site Ltd, cat. no. CON195 .2). 
2.1.5. Primary antibodies and Isotype control 
The primary antibodies used for the immunofluorescent studies, monocyte fusion 
assay and ELISA are summarised in table 2.7 . 
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Antibody Target Species Label Conc. Source Cat. No Isotype 
antigen specificity used 
{~g.mr1 } 
Mouse anti CD9 Human FITC 10 Serotec MCA 469 F Mouse 
human CD9 IgGI 
Mouse anti CD9 Human None 20 Dr.F.Lanza, A 
human CD9 Strasbourg, France 
(Alma-I) 
-
-
Mouse anti CD9 Human None 20 ProfP .Andrews NA Mouse 
human CD9 Dept.of BMS, IgGI 
602.29 Univ.of Sheffield 
Mouse anti I CDllb Human FITC 10 Serotec MCA 551F Mouse 
human IgGI 
CDIIb 
-t-
Mouse anti CD14 Human FITC 10 Serotec MCA2185F Mouse 
I human CDI4 I IgGI 
Mouse anti CD18 Human FITC 10 Immunotec 1568 Mouse 
human CDI8 , IgGI 
I Rat anti I CD18 Human FITC 10 Serotec MCA503F Mouse 
human CDI8 IgGI 
Mouse anti CD29 Human FITC 10 Serotec MCAl949F Mouse 
~ human CD29 IgGI 
Mouse - anti I CD37 Human FITC 10 Serotec MCA483F Mouse 
human CD37 IgGl 
-
Mouse anti CD52 Human FITC 5 Serotec MCA 2188F Mouse 
f ~uman CD5~ ~ IgG I 
- + -
Mouse anti I CD63 Human None 15 In house None Mouse 
human CD63 I IgG l 
(H5C6) 
I Mouse . I CD63 Human FITC 14 In house NA Mouse antI I 
human CD63 
IgG I 
(H5C6) 
Mouse anti I CD63 Human FITC 50 In house NA Mouse 
I CD63 (LP9) IgGl 
Mouse anti CD63 Human None 65 In house NA Mouse 
CD63 (LP9) IgGl 
Mouse anti CD63 Human None Neat In house NA Mouse 
CD63 I SIN or 
IgG2b 
(BEMI) 40 mg. mrl 
--
Mouse anti ' CD63 Human None 20 Dr.K.Skubitz, NA 
CD63 (16.I) Dept.of Medicine, Univ. of 
Minnesota, U.S 
Mouse anti CD63 Human None 20 Dr.K.Skubitz, NA 
CD63 (16.5) Dept.of Medicine, Univ . of 
Minnesota, U.S. 
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Mouse anti CD68 Human None 10 Serotech MCA759T 
human CD68 
Mouse anti CD68 Human FITC 10 Serotech MCA34 1F 
rat CD68 
. I -. 
Mouse antI CD81 Human FITC 10 Serotech MCA1847F 
human CD81 I 
Mouse anti CD82 Human None 10 Serotech MCA 13 11 
human CD82 
I 
Mouse anti CD151 Human None 10 ' Prof.S.Levy,Stand NA 
human ford Univ. 
CD151 Medical Centre, 
t-- -
_Standford, U.S. 
Goat Anti GST None None 5 Amersham 27-4577-01 
GST Pharmacia biotech 
-
-
Table.2.7. Primary antibodies used for the fluorescent studies, monocyte fusion assay 
and ELISA, where NA =Not applicable; SIN=Supemate. 
The isotype control used for the immunofluorescent studies are summarised in table 
2.8 . 
Isotype control I Target antigen 
JC-l Phosphonamidate 
I hapten 
MOPC-21 
I (Mouse IgG 1-
FITC) 
N/A 
Species Type 
specificity 
N/A IgGl 
N/A IgGl 
Label Conc. Source 
used 
(lJg.mr1) 
None 10 In house 
(Muranova 
et ai, 2004) 
FITC 10 Sigma 
Table.2.8. Isotype control used for the immunofluorescence assays , where NA=Not 
applicable. 
2.1.6. Secondary antibodies/lmmunodetection reagents 
Secondary antibodies/ immuno detection reagents used for immunofluorescent studies, 
monocyte binding assays are summarised in table 2.9. 
Antibody/reagents Species Label Conc. Source Cat. No 
specificity used 
(1:!9·mr1 } 
Mouse anti GST GST Biotin 10 Serotec MCA 13 52B 
Mouse anti M 13 Phage- HRP 1 :5000 Amersham 27-9421 -0 1 
M13 dilution Pharmacia biotech 
-. - -
Mouse anti M 13 , fd, Phage- FITC 1 Progen 6 1497 
F 1 filam~nto~s phag~s M13 
--
-
Mouse anti M13 Phage Biotin Serotec MCA1858B 
bacteriophage M I3 
Mouse anti goat- sheep Goat IgG 1 HRP 5 Sigma A9452 
IgG and JgG2 
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Mouse 
IgGl 
Mouse 
IgG l 
Mouse 
IgG l 
Mouse 
IgGl b 
Mouse 
IgGI 
Mouse 
IgGI 
Cat. No 
N/A 
F6397 
Isotype 
Mouse 
IgG l 
Mouse 
!gG2a 
Mouse 
IgG2a 
Mouse 
JgG2a 
IA 
Anti mouse IgG Mouse FITC 10 Sigma F6397 
~ 
IgG 
Anti mouse IgG Mouse HRP 1:5000 Sigma A9 174 
IgG 
Anti mouse Mouse FITC 4 Sigma F10lO 
polyvalent immuno (IgG,IgA, 
gl o9':lJil!s __ or IgM). 
~-
Anti Goat IgG Rabbit- FITC 5 Sigma F7367 
-
G~at IgG 
T ---~li GoatIg~ Goat IgG HRP 5 Sigma A5420 
Extravidin -r FITC 2.25 Sigma E2761 
Extravidin HRP 0.5 Sigma E2886 
-
-- -
Table.2.9. Secondary antibodies/ immuno detection reagents 
2.1.7. Bacterial strains and vectors 
XL-l Blue E. coli competent cells (recAl endAl gyrA96 thi-l hsdR17 supE44 relAl 
lac [F'pro AB lacIQZ M15 Tnl0 (TenD were from Stratagene and were used for 
work involving human scFv clones. 
Clones containing scFv genes in the phage display vector pAK 100 (Krebber et aI, 
1997) such as 4E and 5F were obtained from Dr. Ann Marshal (University of 
Sheffield). Clones containing pAK 100 vector alone (No insert) were used as controls. 
This vector was a kind gift from Professor Andreas Pluckthun, University of Zurich. 
GST-EC2 fusion proteins cloned into the pGEX-KG GST fusion protein vector 
(Higginbottom et aI, 2003) were expressed from BL21 RP Codon plus® -RIL E.coli 
(Stratagene ). 
The selection of bacterial strains were carried out using antibiotic stocks as given in 
section 2.1.4.3.10. 
2.1.8. Cell lines 
Various non-human and human cell lines were propagated and stocks established. The 
cell lines and their culture conditions are summarised in tables.2.10&2.11. 
Mammalian cell lines expressmg human tetraspanins had been transfected with 
pEE6hCMV.neo vector (Celltech Ltd.) containing the human tetraspanin genes 
(Smith et aI, 1995). 
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fA 
NfA 
fA 
NfA 
N/A 
NfA 
NfA 
2.1.8.1. Non-human cell lines 
Cell line Type Source Culture medium 
RBL2H3- Rat Basophilic Dr.L.J.Partridge, Dept. of DMEM+ 1 0% FCS+G4 18 
hCD63 Leukaemic cell line Mol.Biol. & Biotech., 
transfected with Univ. of Sheffield, u.K. 
human CD63 
RBL2H3 Rat Basophilic Dr.B.Helm, Dept. of DMEM+IO% FCS 
Leukaemic cell I Mol.Biol. & Biotech., 
line-Untransfected Univ. of Sheffield, U.K. 
KT-5 Mouse cell line Dr. P.N. Monk, Dept. of DMEM+I0% FCS 
Neurol. Medical school , 
Univ. of Sheffield. u.K. 
CD9r Mouse macrophage Dr.G. Dveksler Dept. of DMEM+ 10% FCS 
and CD9 Pathol. Uniformed 
WT services Univ. of Health Sciences, Bethesda, MD, 
U.S. 
Table.2.10. Non-human cell lines used for the study and their culture conditions. 
2.1.8.2. Human cell lines/cells 
Cell line 
Mewo 
Mel-17 
U937 
THP-l 
HL60 
Type Source Culture medium 
i Melanoma cell line I Dr.1.Marshal, 
I 
ICRF, DMEM+lO% FCS 
London, UK. 
Melanoma cell line Dr.J . Marshal, ICRF, DMEM+I0% FCS 
: London, UK. 
Human monoblast Dr.J. Gallagher, Dept. of Hepes-buffered RPMI 
leukaemic cell line human Met. Clin. 1640+10% 
Biochem. Univ. of FCS+I00U.mr i of 
Sheffield, UK. penicillin and 100U.mr i 
of streptomycin 
Human Monocytic ECACC. RPMI 1640+ 10% FCS 
leukaemic cell line +100U.mr i of penicillin 
and 100U.mr i of 
streptomycin 
Pro-myelocytic Dr.P.N .Monk, Dept. of RPMI 1640 +10% FCS 
(Megakaryocytic Neurol. Medical school , + 100U.mr i of penicillin 
cell line) Univ. of Sheffield, U.K. and 100U.mr i of 
streptomycin 
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Culture 
Condition 
37°C In 
humid 
8%C02 
37°C In 
humid 
8%C02 
37°C In 
humid 
8%C02 
37°C In 
humid 
5%C02 
Culture 
Condition 
a 
a 
a 
a 
37°C in a 
humid 
8%C02 
37°C in a 
humid 
8%C02 
37°C In a 
humid 
5%C0 2 
37°C In a 
humid 
5%C02 
37°C In a 
humid 
5%C02 
KS 62 Promyelocytic cell Dr.P.N .Monk, Dept. of RPMI -1 640 + 10% FCS 37°C in a 
line Neurol. Medical school, +1 OOU.mr'of penicillin humid 
Univ. of Sheffield. U.K and 100U.mr' of 5%C02 
streptomycin 
DX3 Melanoma cell line Dr.] . Marshal, ICRF DMEM+10olo FCS , I ( 37°C in a 
humid 
8%C02 
London, UK. 
VUP Melanoma cell line Dr.J. Marshal, ICRF, DMEM+ 10% FCS 37°C in a 
humid 
8%C02 
London, UK. 
LoVo Colorectal ECACC. 
I carcinoma cell line 
DMEM+ 1 0% FCS 37°C in a 
humid 
5%C0 2 
IGROV1 I Ovarian carcinoma 
cell line 
Dr.J.Bemard, INSERM. RPMI+ 1 0% FCS 37°C in a 
humid ---~---- 5%C~02 
Table 2.11. Human cell lines used for the study and their culture conditions, where 
ECACC = European Collection of Animal Cell Culture. 
2.1.9. Instrumentation 
Equipment 
Agarose gel documentation 
Agarose gel electrophoresis 
Thermal cyclers 
Ultraviolet trans illuminator 
------
Autoclaves 
Supplier 
Polaroid DS34 instant camera, linked to 
photodoc camera hood _ 
Hybaid HB 1214 horizontal gel tank 
Jencons HU10 horizontal gel tank 
Consort E844 power supply 
Invitrogen X Cell Surelock TM 
electrophoretic cell 
MJ Research PTC 100, 
Techne Genius (Techne Limited) 
Camlab UVP 
Express Portable 
Rodwell MP24 
- --- -- ---- -
Balances 
I Centrifuge 
Microf!:lge 
Cold cabinet (4°C) 
Liquid nitrogen refrigerators and dewars 
Drying cabinet (S SOC) 
ELISA plate readers 
Water bath 
Freezers 
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Mettler PM46Q, AE100, AJlQO 
Beckman JA-2S 
MSE Mistral 3000 
Sigma 3K1S 
Si gma _ __ 
Sadia 
Taylor-Wharton, Jencons and 
Statebourne 
Belling 
Anthos HT2 linked to EPSON LX-8S0 
printer 
Tempette Junior TE-8J 
Scandinova (-20°C), 
Sanyo Ultra Low (-70°C) 
I 
Heat block 
CO2 incubators (tissue culture) 
Incubators 
Laminar flow cabinet 
Microwave oven 
pH mete! 
Pipettes (manual) 
Pipette (automatic) 
Spectrophotometer 
- - --
SDS-P AGE gel electrophoresis 
Rocking table 
Inverted light microscope 
Immunofluorescent microscope 
Cytospin 2 
Turntable 
V ortex mixer 
Flow cytometer 
Jenway 1200 
Herraeus, Forma Scientific water 
Jacketed incubator, 
§LS Galaxy R 
Gallenkamp (static), 
Ne_w Brunswick Scientific (Shaking) 
Medical Air Technology, Class II 
microbiological safety cabLnet 
Hitachi MR 6400 
~orning pH meter 220 
Gilson Pipetman P2, P10, P100, P200, 
P1000, P5000, Gilson 8 x 200111 multi 
channel 
IB S, -.Len cons 
Perkin Elmer Lambda3 dual beam 
UV IVisible light spectrophotometer, 
Cecil Instruments CE272, 
WP A Light wave 
'"1--~- - -
Biorad Protean 2 Vertical gel tank 
Luckham R100 
Nikon 
-
Deltavision restoration microscope, 
Nikon Eclipse E400 microscope with 
DXM 1200 digital camera and Lucia 
image processing software for pc, 
Carl-Zeiss confocal microscope 
Shandon southern products 
-,- -
Labinco 
Rotamixer deluxe 
CyAn ADP- Dako cytomation 
Beckmann-Coulter 
Densitometer Alpha Innotech_ corporation 
Table 2.12. General laboratory equipments and suppliers. 
2.1.10. General laboratory consumables and plastic ware 
Consumable Supplier 
0.2-0Allm filters PALL laboratories 
0.2Ilm, OAllm ~crodisc Sartorius 
0.5ml thin wall PCR tubes Alpha laboratories 
0.6mlll.5ml tubes Eppendorf 
Centrifuge tubes Beckman, 30ml, 250ml, SOOml 
Cling film Cater Pak 
Cocktail sticks Plastico 
Spectrophotometer cuvettes 
6 well tissue culture plate 
96 well microtitre ELISA plate 
96 well microtitre (Tissue culture) plate 
24 well tissue culture plate 
96 well plate sealers 
Sarstedt 
~orning 
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Nunc, Maxisorp 
Corning Incorporated 
Corning Incorporated 
Corning Incorporated 
Falcon tubes Becton Dickinson & Co. 
Gloves _Glovco,~tex-Lpowder free 
10ml, 25ml graduated pipettes Becton Dickinson & Co. 
100mm bacterial culture plates Bibby Sterilin 
100mm tissue culture dishes Iwaki 
25cm tissue culture flask Nunc 
175cm tissue culture flask Nunc 
_ Pipette tips __ ___ _ ____ Gilson Diamon non-sterile) 
Dialysing tube (12-14!(Da) GeBAflex-tube Maxi (D050) 
Tissue paper Kimberly Clark, Kimwipe 
Lens cleaning tissues Whatman International 
I Univer~al tubes ancl BUous Sterilin 
Shandon cytocentrifuge filters Shandon 
I Lab-Tek® II chamber slides , Nalge Nunc International, US 
22x64mm cover slip BDH 
22x22~m cover-slip - -- - ---~-BDH -
Ground edge microscope slide BDH 
Micro~~ope slides_ _ _ _ _~DH _ _ __ 
_ H~r ladder I markers _ ___ _ Bioline __ 
ID tapes Star lab 
5ml disposable column Qiagen 
10xl0x 45 cuvettes Sarstedt, G~rmany 
Quartz cu~ettes Merck 
Pipette tips 1000111 Molecular bioproducts 
Pipette tips 200111, 0.1-10111 Star lab 
Parafilm BDH 
- --
F ACS tubes Elkay lab products, U.K 
Cryo vials Nunc 
Pasteur pipett~ 1 )Omm &230mm Mexcel _ 
0.211m micro culture capsule Gelman Laboratory 
Table 2.13. General laboratory consumables and plastic ware. 
2.1.11. Software used 
2.1.11.1. Flow cytometry 
Flow cytometry data from the present research project was analysed using WINMDI 
2.8 software (Joseph Trotter: http ://facs.scripps.edu/software.html). The term mean 
fluorescence intensity (MFI) was used throughout the work as a measure of the 
intensity of staining of a population of cells. 
2.1.11.2. Statistical analysis 
Data of this research project was analysed using GraphPad Prism 4 software. 
2.1.11.3. Deltavision restoration microscopy 
The immunofluorescent images obtained using the Deltavision mlcroscope were 
processed using Softrex- Deltavision software. 
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2.1.11.4. Extinction coefficient of protein 
The protein concentration of rhodamine BITC/ AlexaFluor 647® labelled GST proteins 
was estimated using Protparam Tool software [from the Swiss Protein Database, 
http://www.expasy.cg]. which is based on the calculation of protein extinction 
coefficients from amino acid sequence data (Gilland Hippel (1989)]. 
2.2. METHODS 
2.2.1. Tissue culture methods 
Cell lines were cultured in standard tissue culture plastic plates or flasks in a 
humidified CO2 incubator under conditions described in tables 2.10 and 2.11. Medium 
preparation is described in table 2.1. 
2.2.1.1. Sub culturing of adherent cells 
Once cells were confluent they were split in to 1: 3 to 1: lOusing trypsinlEDT A 
solution. To subculture the medium was removed, cells were washed with 
approximately 10ml of sterile BSS per 10cm petri dish and incubated with 5ml of 
0.25% trypsiniEDTA solution (Sigma, cat. no. T4174) diluted 1110 in BSS) at 37°C. 
After 5-10min. the cells in petri dish were dislodged by agitation using a sterile 
Pasteur pipette. Trypsin was neutralised by mixing with an equal volume of suitable 
medium containing 10% FCS (Tables.2.1 0&2.11). The cells were pelletted by 
centrifugation at 400g for 5min., re suspended in fresh medium and transferred at 
15ml plate-I. 
2.2.1.2. Sub culturing of non-adherent cells 
Non-adherent cells were sub cultured as necessary by diluting cells 1:3 to 1: 10 with 
fresh medium. Non-adherent cells were routinely cultured in screw capped culture 
flasks. 
2.2.1.3. Cell counting 
A standard cell counting method using an improved Neubauer haemocytometer was 
used for cell counting. 
2.2.1.4. Cryo preservation of cell lines 
Cells were frozen in aliquots of 4-1 Ox 1 06. Cells with good viability (>90%) and in 
log phase were harvested by trypsinisation (adherent cells) or centrifugation 
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(suspension cells). After centrifugation, cells were resuspended in I ml cold FCS / 
10% DMSO and transferred to chilled cryotubes (Nunc, cat. no. 368632). Vials were 
incubated in a biological freezing tray (Jencons) in the liquid nitrogen vapour phase to 
allow cooling at IOC/2hrs. before lowering into liquid nitrogen for storage. The 
position and date of freezing were recorded in to an electronic logbook. 
2.2.1.5. Resuscitation of cryo preserved cells 
A vial from the liquid nitrogen was removed and agitated in a water bath at 37°C until 
nearly thawed. The contents were transferred quickly into a pre cooled universal tube 
on ice and washed by adding 10mi cold medium (no FCS) slowly. After centrifuging 
at 200g the cells were resuspended in appropriate medium containing 10% FCS. 
2.2.1.6. Dye exclusion test for viability 
The viability of the cells was assessed by exclusion of erythrosine dye or trypan blue 
solution (section 2.1.4.3.3). Stock erythrosine dye solution or trypan blue were mixed 
1: 10 or 1:4 with cell suspension, respectively and viability assessed after 4min. at RT. 
2.2.2. Monitoring antigen expression by flow cytometry 
2.2.2.1. Harvesting of cells for analysis of cell receptor/antigen analysis 
For cell receptor/antigen analysis adherent cells were harvested non-enzymatically 
using cell dissociation solution (Sigma, cat.no.CS914). FACS analysis was performed 
with living cells; hence all manipulations were carried out on ice or at 4°C and in the 
presence of sodium azide (0.1 %) to prevent capping, intemalisation or shedding of 
antigen. Appropriate isotype controls (Table 2.8) were included in all assays. 
2.2.2.2. Direct immunofluorescence assay 
Cells were harvested, washed twice with cold wash buffer (BBN) (section 2.1.4.3.1) 
and re suspended to 0.S-1.0xl06 cells.mr! in BBN. 1ml aliquots were transferred into 
round bottomed 12x7Smm plastic tubes ("FACS tubes"), and centrifuged at 400g for 
Smin and the cell pellet was incubated with SO~1 of fluorescently-labelled antibody or 
GST proteins in BBN/PBS for 4S-60min. on ice. Cells were washed Ix with Iml of 
BBN and resuspended with 0.2ml of 2% cold paraformaldehyde solution prior to 
F ACS analysis. 
2.2.2.3. In-direct immunofluorescence assay 
This was perfomed as in 2.2.2.2 except unlabelled antibodies/GST proteins were used 
for the first incubation. Cells were washed twice with 1 ml aliquots of BBN then 
incubated with SO~1 of fluorescently labelled secondary reagent (section 2.1.6) for 
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30min. on ice. The cells were then washed and resuspended with paraformaldehyde 
as described above. 
2.2.3. Immunofluorescence in Lab-Tek® chamber slide 
2.2.3.1. Direct method 
The cells were harvested usmg trypsin:EDTA (section 2.2.1.1), resuspended in 
appropriate medium at 7xl04cell.mrl and 0.5ml aliquots dispensed into the wells of 
an 8-chambered Lab-Tek® slide and cultured overnight. After washing with BSS, 
adherent cells were fixed and permeabilised with acetone (0.5ml. chamber-1 for 5min. 
at RT) and washed twice with PBS. Acetone was removed by aspiration and slides 
washed briefly twice with 0.5ml of Ix PBS, with a third wash in a trough of PBS with 
stirring for 10min using a magnetic stirrer. PBS was removed by aspiration. The cells 
were incubated with 100/11 of an appropriate dilution of FITC-labelled antibody or 
labelled GST protein in a humid atmosphere in the dark for 45-60min. The chambers 
were washed briefly twice with PBS and a third time in a trough of PBS with stirring 
for 8min. Where appropriate, cell nuclei were stained by incubating with 100/11 of 
propidium iodide in PBS for 3min (section 2.1.4.3.9). The chambers were washed 
with 0.5ml of PBS and given a final wash in a trough of PBS with stirring for 15min 
as above. The PBS was removed by aspiration. All these manipulations were carried 
out on ice to avoid the drying of cells. The plastic chamber compartment was 
removed carefully from the slide according to the manufacturer's instruction. The 
cells were mounted using liquid mountant (section.2.1.4.3.12) at 12/1l.chambe(l, 
covered with 22x66mm cover slip and sealed using nail varnish. The slide was stored 
at 4°C until examination under fluorescence microscope. When viewing cells with 
the 100x objective, immersion oil (Cargille, cat. no. 16212 Type FF) was used. 
2.2.3.2. Indirect method 
This was performed as above but cells were incubated with 100/11 of appropriate 
dilution of an unlabelled primary antibody (section 2.1.5)/scFv phage suspension. 
After washing, the cells were incubated with 100/11 of an appropriate dilution of FITC 
labelled secondary antibody (section 2.1.6) for 30min. in dark. Washing, nuclear 
staining and mounting of the cells were as in section 2.2.3.1. 
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2.2.4. Immunofluorescence on cytocentrifuge slide 
2.2.4.1. Direct method 
Shandon cytocentrifuge chambers, filters and microscopic slides were assembled as 
per manufacturer's instructions and inserted in the cytocentrifuge. 
Cells were harvested using cell dissociation solution (section 2.2.2.1) and re 
suspended to lxl05 cells.mr! with suitable culture medium. 100J.lI was added to each 
chamber and cells were deposited on the slide by centrifuging at 500rpm for 5min. 
The slides were air-dried and their position on the slides marked with a diamond 
marker. Cells were fixed and permeabilised in acetone (5min at R T) and the slides 
washed with PBS for 10min. One slide was removed at a time, the area around the 
cells wiped carefully with tissue paper and incubated with 50J.lI of an appropriate 
dilution of FITC labelled mAb (section 2.1.5) or labelled GST proteins and incubated 
for 30min. at RT in a damp container in the dark. After two brief washes in PBS, a 
third wash was done by immersing the slides in a trough of PBS for 10min. with 
stirring. One slide at a time was removed as above, and the nuclei of the cells were 
stained with propidium iodide/bisbenzamide in PBS/water respectively for 3min 
(section 2.2.3.1). The slides were washed briefly twice followed by a final wash in a 
trough of Ix PBS for 15min. using magnetic stirrer. Slides were mounted with 10J.lI 
mounting medium (section 2.1.4.3.12) using 22x22mm cover slips and sealed with 
nail varnish. 
2.2.S.Titration of antibodies and antigens 
2.2.5.1.Titration of FITC conjugated anti CD63 antibody (H5C6) by FACS: Direct 
assay 
RBL2H3-hCD63 cells were harvested non-enzymatatically and the assay was carried 
out as described in section. 2.2.2.2, The cell pellets were incubated with different 
concentrations of FITC conjugated anti CD63 antibody H5C6 in BBN, mixed by 
vortexing and incubated for 45-60min. on ice. The remaining steps are as in section 
2.2.2.2. 
2.2.5.2. Titration of unlabelled anti CD63 antibody (H5C6) by FACS: Indirect 
assay 
Unlabelled anti CD63 antibody (H5C6) was titrated against RBL2H3-hCD63 as 
described in section 2.2.2.3 using different concentrations in BBN. The FITC 
conjugated anti mouse polyvalent immunoglobulins (IgG, IgA & IgM) at 4J.lg.mr l in 
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BBN was used as a secondary antibody. The remaining steps are same as in section 
2.2.2.2. 
2.2.5.3. Titration of Extravidin by FACS 
Mouse KT -5 is a cell line, which is expressing high levels of CD81 was used for the 
titration of Extravidin-FITC. FACS analysis was carried out as described in section 
2.2.2.3 using primary biotin-labelled mouse anti CD81 at 10/1g.mrJ and various 
dilutions of secondary Extravidin-FITC. The remaining steps are as in section 2.2.2.2. 
2.2.5.4. Titration of GST -EC2CD63 against anti CD63 antibody by ELISA 
A flat bottomed 96 well microtitre ELISA plate (Nunc, Maxisorb) was coated with 
100/11 of GST-EC2CD63 at 10/1g.mrJ in carbonate-bicarbonate buffer pH 9.6. 
overnight at 4°C. Excess GST -EC2CD63 was removed by flicking the plate and the 
plate was washed Ix with PBS. The wells were blocked with 300/11 of Blotto (5% 
milk powder, 0.01 % tween 20 in PBS) and incubating for 2hrs at RT. After removing 
blocking agent, the wells were incubated with 100/11 of anti CD63 antibody H5C6 
initially at 1: 10 (150/1g.mr J) and then with doubling dilutions in 1 % milk powder, 
0.01 % tween 20 in PBS. The plate was incubated for Ihr at 37°C, washed 3x with 
PBS, and 100/11 secondary antibody anti mouse IgG-HRP (whole molecule) at 1: 1000 
in dilution buffer was added. The plate was incubated for Ihr at 37°C, washed 2x in 
PBS followed by a final wash using MQ water to remove the trace salt from the plate. 
The binding of antibody was visualized by adding 50/11 of TMB solution (2.1.4.3.4) 
for 20min. at 37°C. The enzyme-substrate reaction was quenched by the addition of 
50/11 of 2M H2S04. The intensity of yellow colour developed by the reaction mixture 
was measured at 450nm using an ELISA plate reader. 
2.2.5.5. Titration of EC2CD63 and GST in GST -EC2CD63 by ELISA 
The correct folding and the optimal concentration of GST-EC2CD63 required for 
coating ELISA plates was determined by coating a plate with 100/11 of GST-
EC2CD63 initially at 1 O/1g.mr J, then doubling dilution in carbonate-bicarbonate 
buffer. After incubating and blocking as above, some rows were incubated with 100/11 
of goat anti GST antibody at 5/1g.mrJ and some rows with ant,i CD63 (H5C6) at 
15/1g.mrJ in dilution buffer (1% milk powder, 0.01% tween 20 in PBS). After 
incubation and washing as above, H5C6 wells were incubated with goat anti mouse 
IgG-HRP at 1 :5000 in dilution buffer, whereas anti GST antibody wells were 
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incubated with anti goat-sheep-HRP at 5Jlg.mr1• The plates were developed as 
described above. 
2.2.5.6 Titration of mouse anti GST -biotin against GST by ELISA 
Plates were coated with GST-EC2CD63, as described above, then wells were 
incubated with 100JlI of goat anti GST biotin antibody initially at 100Jlg.mr1 and 
followed by doubling dilutions in 1 % milk powder, 0.01% tween 20 in PBS. The plate 
was incubated and washed as above, then wells were incubated with a secondary 
Extravidin-HRP at IJlg.mr1 in dilution buffer for Ihr at 37°C. The remaining steps are 
as in section 2.2.5.4. 
2.2.5.7. Titration of mouse anti CD52-FITC antibody by FACS 
Peripheral blood monocytes were harvested using cell dissociation fluid (section 
2.2.2.1) and dilutions of anti CD52-FITC antibody in BBN were titrated by FACS as 
described in section 2.2.2.2. 
2.2.6. Estimation of surface + intracellular antigen levels by flow 
cytometry 
A fix and permeabilisation method was used for the estimation of surface and 
intracellular expression levels of antigens (CD63). Cells were permeabilised using a 
Caltag kit (cat. no. GAS-003), containing a permeabilising agent, which makes 
"pores" in the cell to allow antibodies to gain access. Half of the samples were fixed 
only (to assess surface staining) and half fixed and then permeabilised (to assess both 
surface and cytoplasmic staining). Cells were harvested and dispensed into F ACS 
tubes as described above (2.2.2.2) and 50JlI FITC labelled anti CD63 antibody or 
isotype control was added. Cells were incubated for 20min. on ice. 50JlI reagent A 
(fixative) was added and the tubes incubated for 15min. at room temperature. Cells 
were washed 2x in B/BIN and 50JlI of FITC-Iabelled anti CD63 antibody or isotype 
control and either 50JlI reagent B (permeabilisation reagent) or 50JlI B/BIN (for 
fixed only cells) was added. Cells were incubated at room temperature for 20min. in 
the dark, washed twice in B/BIN and fixed with 200JlI of 1 % paraformaldehyde 
solution before F ACS analysis. Intracellular expression was calculated by subtraction 
of plasma membrane staining from total CD63 levels and expressed as a percentage of 
total CD63. 
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2.2.7. Antibody induced Internalisation assay 
The antibody-induced internalisation of cell surface CD63 was estimated by FACS 
analysis. Levels of primary antibody remaining on the cell surface after incubating 
labelled cells at 37°C were measured. Cells were harvested non-enzymatically and 
resuspended at IOxl06 cell.mr1 in internalisation buffer (BSS containing 0.2% BSA 
and ImM CaCh). SOIlI aliquots (0.Sxl06 cells) were transferred to FACS tubes on ice. 
SOIlI of primary monoclonal antibody at appropriate dilution in internalisation buffer 
was added and the tubes incubated for 30min. on ice. Cells were washed in ice-cold 
internalisation buffer to remove unbound antibody and the cell pellet was resuspended 
in 100111 of the same. Samples were placed in a water bath at 37°C, removed at timed 
intervals and quenched by addition of 2ml ice-cold B/BIN. Following centrifugation, 
remaining cell surface antibody was detected using SOIlI of appropriate dilution of 
anti mouse IgG-FITC in B/BIN. Time zero (total) antibody binding was determined 
using samples that had been incubated with primary antibody on ice throughout. 
Appropriate primary isotype controls were also included. The percentage of antigen 
internalised after each time point (X min.) was calculated as follows: 
Antigen internalised (%)= 100 x MFI (T=O) - MFI (T= xi MFI (T=O) 
2.2.8. Production of recombinant GST -Ee2 tetraspanins 
The Glutathione S-transferase (GST) gene fusion system is an integrated system for 
the expression of fusion proteins from E.coli. The recombinant GST-EC2 proteins of 
tetraspanins were produced from E. coli in our laboratory to assess their functional 
activity. In most cases, these proteins were produced and purified by Dr. Adrian 
Higginbottom or Francine Martin in our group, as described in Higginbottom et ai, 
(2003). An overview of the method is given below. 
2.2.8.1. Production of GST -EC2 fusion proteins 
An aliquot of BL21 RP Codon plus®-RIL E.coli cells was defrosted. The bacterial 
cells were transformed with DNA encoding GST-EC2-tetraspanin @ I III of O.lng.llrl 
for 20111 of bacterial suspension in a pre chilled eppendorfkept on ice. The contents of 
the eppendorf were mixed by gentle swirling and incubated for 30min. on ice and 
gently swirled every 2min. The DNA was transformed into E.coli by heat pulse for 
2Ssec. at 42°C. (The transformation efficiency will decrease sharply if the duration of 
the heat pulse is <20sec. or >2Ssec.). After the transformation, the cells were 
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incubated on ice for 2min. and then inoculated into 500/l1 of pre warmed LB medium 
(section 2.1.4.2). After incubation for Ihr at 37°C with shaking at 220 RPM, 200/l1 of 
transformed bacterial cells was spread on an LB agar plate supplemented with 
carbenicillin to a final concentration of 50/lg.mr1• The plate was incubated overnight 
at 37°C. A single colony from the plate was inoculated into 10ml of LB medium 
supplemented with 50/lg.mr1 of carbenicillin. The cells were cultured overnight at 
37°C in a shaker at @ 220RPM. IOml of the overnight culture was inoculated into 
400ml of fresh LB medium supplemented with 50/lg.mr1 of carbenicillin and the cells 
were grown to log phase in a shaker @ 220RPM until the OD600 of the culture 
reached between 0.2-0.4. The expression of GST protein was induced by 
supplementing 200/l1 of 0.5M IPTG (Sigma, cat.no.l6758) to a final concentration of 
0.5mM and the cells were grown for an additional 4hrs at 37°C in a shaker at @ 
220RPM. The bacterial cells were separated from the culture supernatant by 
centrifugation at 4500g for 20min. and the supernatant was drained completely. The 
wet weight of the cell pellet was determined and frozen (-20°C) overnight before the 
protein was extracted using Bug buster. 
2.2.8.2. Extraction and purification of GST -EC2 tetraspanins 
The frozen cell pellet was thawed on ice, re suspended with Bug buster reagent 
(Novagen,cat.no.70584-3) @ 3ml.gm-1 of wet weight of cell pellet by pipetting up and 
down and by gentle vortexing. This mixture was treated with protease inhibitors 
(Complete MINI®, EDTA free protease inhibitor cocktail tablet (ROCHE, 
cat.no.I0946900) to final concentration of 50/lg.mr1 to prevent the degradation of 
expressed GST proteins by bacterial enzymes. The cell suspension was incubated on a 
shaking platform or rotating mixer at a slow setting for Ihr at RT. The insoluble cell 
debris was removed by centrifugation at I5000g for 20min. at 4°C. The supernatant 
was mixed with -I.33ml of ethanol free glutathione beads in a universal tube, 
incubated at RT for Ihr/over night at 4°C. The contents were transferred into a 
disposable column and the flow-through was discarded. Then the column was washed 
3x with ice cold PBS. The GST protein was eluted from the glutathione beads by 
transferring 0.5ml aliquots of 50mM glutathione in 10mM Tris-HCI pH 8.0 into the 
column. The protein concentration of the eluted fraction was estimated by Bradford 
assay (section 2.2.9.5) and fractions with similar protein content were pooled, 
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dialysed against PBS (,.., 3x 10L dialysis/sample) to remove tris and glutathione. 
Samples were run on SDS gels and subjected to Coomassie staining to determine 
proteins concentration by densitometry using protein standards of known 
concentration for comparison. Western blotting was also carried out using 
conformation-sensitive antibodies to determine the position of correctly folded GST-
EC2 tetraspanins. 
2.2.9. Fluorescein conjugation of proteins 
The FITC conjugation of proteins was carried out essentially as described by Johnson 
(Johnson, 1990). In this research project, anti CD63 antibody (H5C6) and GST-EC2 
tetraspanins/GST were labelled with FITC for immunofluorescence experiments. 
2.2.9.1. Fluorescein labelling of mouse anti CD63 antibody (HSC6) 
30~g fluorescein isothiocyanate (FITC) (Sigma, cat. no. F7250/Sigma, cat. no. R 
1755) per mg of antibody was dissolved in the appropriate amount of conjugation 
buffer (0.5M carbonate/bicarbonate, pH 9.5) in a volume equivalent to 10% of the 
protein. This was mixed by rotating gently on a blood mixer for 2hrs at room 
temperature in the dark. Conjugated protein was separated from unbound dye on a 
Sepharose G-25 column equilibrated with PBS. Sodium azide (0.1 %) was added as 
preservative and the conjugated antibodies were stored in aliquots at -20°C. The 
molar ratio of FITC: protein was determined as described by The and Feltkamp 
(1970), using the formula: 2.87xO.D.49S/ O.D.280-0.35xO.D.49S. Briefly, this is derived 
by assuming E280 for IgG = 1.4, E49s for FITC = 200, m.wt. IgG = 160,000 and m.wt. 
FITC = 390 and takes into account that FITC absorbs at 280nm, with a factor of 0.35 , 
of its absorbance at 495nm. 
Molecular FITC/protein ratio Mol.wt.protein x Conc.FITC mg.mr) 
Mol.wt.FITC Conc.IgG mg.mr) 
= 410 x OD49S: 200 
(OD280 - 0.35 x E49s): 1.4 
The FITC: protein ratios were typically between 1: 1 and 5: 1. 
2.2.9.2. Fluorescein conjugation of GST -EC2 tetrasapanins 
This was performed essentially as described above (section 2.2.9.1). GST-EC2CD63, 
GST-EC2CD9 and GST were labelled in the course of this project. For determining 
molar dye:protein ratios, molecular weights of 37,040, 35,730 and 26,000 were used 
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for GST-EC2CD63, GST-EC2CD9 and GST, respectively. The concentration of 
labelled protein was determined using the Bradford assay (2.2.9.5). 
2.2.9.3. Rhodamine B-isothiocyanate labelling of GST -EC2 tetraspanins 
The GST -EC2CD63 and GST proteins were also labelled with rhodamine B 
isothiocyanate (Sigma, cat. no. R1755) as described in section 2.2.9.1. 
Since the fluorescent dye appeared to interfere with the Bradford assay, protein 
concentrations were measured spectrophotometric ally using extinction coefficients 
derived using Protparam Tool software [from the Swiss Protein Database, 
http://www.expasy.cg]. which is based on the calculation of protein extinction 
coefficients from amino acid sequence data (Gilland Hippel (1989)]. Extinction 
coefficients (E280) of GST-EC2CD63 and GST were estimated as 1.474 and 1.516, 
respectively. Absorbances of GST proteins in 6M guanidium hydrochloride in 0.02M 
phosphate buffer pH 6.5 were measured at 280nm. 
2.2.9.3.1. Determination of degree of labelling (D.O.L)/ molar fluorochrome protein ratio 
of GST proteins labelled with rhodamine BITe 
D.O.L = Amax SIS x M.wt.ofprotein 
Conc. protein (mg.mr l ) x Edye 
Where, Edye =49,0000; Amax SIS of free rhodamine BITC 
* Formula for D.O.L supplied by Molecular probes. 
2.2.9.4. AlexaFluor® 647 labelling of GST -EC2 tetraspanins 
The labelling of GST-EC2CD63 and GST with Alexa Fluor®647 (Molecular probes, 
cat. no. A20006) was carried out as per the manufacturers instruction. 
2.2.9.4.1. Determination of protein concentration of labelled proteins 
The protein concentration of AlexaFluor® 647 labelled GST-EC2CD63 and GST was 
determined spectophotometrically as described above. 
2.2.9.4.2. Determination of degree of labelling (D.O.L)/ molar flurochrome: protein ratio 
ofGST proteins labelled with AlexFluor®647 
D.O.L = Amax515 x M.wt.ofprotein 
Conc. protein (mg.mr l ) x Edye 
Where, Edye =239,0000; Amax SIS of free Alexa Fluor®647. 
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2.2.9.5. Estimation of proteins by Bradford assay 
The Bradford protein assay was used to determine the protein concentration of 
flurochrome labelled GST-EC2 tetraspanins (Bradford (1976) and the information 
from: 
http://www . chemistry .gatech.edul class/peek! 4581 /techniques/bradford/bradord.html.) 
BSA standards (5,10,15,20,30,40 and 50Jlg.ml- l ) were prepared in PBS from the stock 
BSA solution. The test samples, blank and BSA standards for the protein estimation 
were prepared as given in table 2.14 using Bradford reagent kit (BioRad, cat.no.500-
0001). The samples were incubated at RT for 10-30min., transferred into the 
disposable cuvettes and the absorbance of each sample measured at 595nm, a plot of 
absorbance of each BSA standard as a function of its theoretical concentration was 
obtained with the data and the best fit of the data to a straight line in the form of the 
equation 'y = mx + b' was prepared, where y = absorbance at 595nm and x = protein 
concentration. The protein concentration of the test samples were determined from the 
BSA standard graph by extrapolating their absorbance. 
Samples Sample volume Volume of water Volume of Bradford 
(~I) (~I) reagent 
Blank 0 800 200 
BSA standard (5Jlg.mr1) 10 790 200 
BSA standard (10Jlg.mr i ) 20 780 200 
BSA standard (15Jlg.mr1) 30 770 200 
BSA standard (20Jlg.mr1) 40 760 200 
BSA standard (20Jlg.mr i ) 50 750 200 
Test protein 50 750 200 
Table 2.14. Preparation of test samples, blank and standard samples for the Bradford 
protein assay. 
2.2.10. Experiments using peripheral blood monocytes 
2.2.10.1. Isolation of monocytes from blood 
Peripheral blood mononuclear cells were derived from peripheral whole blood of 
healthy, anonymized human volunteers by Ficoll-Paque (Amersham Pharmacia 
Biotech., cat.no.17 -1440-02) density centrifugation as described by Dockrell et aI, 
(2001). The study was approved by the South Sheffield Research Ethics Committee 
(protocol number SSREC/02/299) and all donors gave informed consent to the 
donation of 250ml of blood. Blood was taken by Professor R.C. Read, Division of 
Genomic Medicine, University of Sheffield and preliminary preparation (Ficoll-Paque 
density centrifugation) was also carried out here, since some of the cells were to be 
used in other studies. 
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2.2.10.2. Purification of monocytes by adhesion on plastic 
Monocytes were purified from the contaminating lymphocytes by adhesion to serum 
(FCS)/autologous plasma coated plastic tissue culture grade petri dishes by 
transferring 15ml of mononuclear cell suspension (2-5 x 106 cell. mrl in RPMIl640 -
10% FCS) into each plate. Cells were incubated at 37°C in a 5% CO2 incubator over 
night. Alternatively the mononuclear cells were directly transferred into Lab-Tek® 
chambers slides for immunofluorescence microscopy. Non-adherent cells such as 
lymphocytes and platelets were separated from the over night cultured adherent 
monocytes by aspiration. The plates were washed thoroughly 3x with 10ml of pre 
warmed RPMI (without FCS) to ensure that all non-adherent cells were removed. 
2.2.10.3. Monocyte cell fusion assay 
2.2.1 0.3. 1. Monocyte fusion assay in microtitre plate 
Adhesion-purified monocytes were seeded at 2xl05 cells in 100JlI of culture medium 
into a 96 well microtitre plate and cultured for 72hrs in the presence/absence of Con 
A at 10Jlg.mr1 as described by Takeda and co-workers. The supernatant was 
removed from the plate and the cells were stained with 100JlI of Wright stain (section 
2.1.4.3.3) for 20min. The stain was removed and the plate was air-dried. The plate 
was observed under the light microscope (Takeda et ai, 2003). 
2.2.10.3.2. Monocyte fusion assay in Lab-Tek® chamber slide 
The mononuclear cells were seeded at 5xl05cells.chamber-1 in 0.5ml RPMI-1640-
10%FCS in an 8 chambered Lab-Tek® slide. After overnight culture, non-adherent 
cells were aspirated and the chambers washed 3x with 0.5ml pre-warmed RPMI-1640 
(no FCS) then cultured in RPMI-1640-10%FCS in the presence/absence of 
Concanavalin A (Sigma, cat. no. 17-1440-02) to a final concentration of 10Jlg.mr1 for 
72hrs at 37°C. After the incubation period, the supernatant from the chambers of the 
slide was aspirated and each well washed with 0.5ml of lxPBS. The cells were fixed 
and permeabilised with 500JlI of acetone for 5min. The cells were then labelled with 
appropriate dilution of FITC conjugated antibody and nuclei counter-stained with 
propidium iodide as described in 2.2.3.1. The number of nuclei in fused cells and 
individual nuclei were counted in 6 randomly chosen fields using Nikon Eclipse E400 
immunofluorescence microscope and the fusion index was calculated using a formula: 
Fusion index = no. of nuclei in fused cells/ number of nuclei in total % (Abe, 1983; 
Weinberg et ai, 1984; Takeda et ai, 2003). 
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2.2.10.4. Functional effects of tetraspanins on monocyte fusion 
2.2.10.4.1. Effects of anti tetraspanin antibodieslGST-EC2 tetraspanins on monocytes 
fusion 
The mononuclear cells were seeded at 5xl05 cells.chamber- l in a Lab-Tek® chamber 
slide. In the presence/absence of Con A (l 0Jlg.mr l ) and anti tetraspanin antibodies or 
GST-EC2 tetraspanins or/GST (20Jlg.mr l ) for 72hrs at 37°C. The slide was 
processed, stained with FITC labelled anti CD52 antibody and the fusion index was 
calculated as described in section 2.2.10.3.2. 
2.2.10.4.2. Effect of short incubation ofGST-EC2 tetraspanins on monocyte fusion 
mononuclear cells were seeded into Lab-Tek® chamber slides as previously were 
incubated with GST-EC2 tetraspanins or GST (20Jlg.mr l ) for 30min. at 37°C. The 
recombinant proteins were removed by 5x washing with pre warmed RPMI and the 
cells were cultured in RPMI+ 10%FCS in the presence of Con A (lOJlg.mr l ) for 
72hrs. The slide was processed and the fusion index was calculated as described in 
section 2.2.10.3 2. 
2.2.10.5. Effect of GST -EC2 tetraspanins on functions related to monocyte 
fusion 
2.2.10.5.1. Effect of GST-EC2 tetraspanins on monocyte adhesion: Lab-Tek® chamber slide 
assay 
mononuclear cells were seeded into a Lab-Tek® chamber slides and incubated with 
GST-EC2 tetraspanins (20Jlg.mr l ) for 72hrs at 37°C in the absence of Con A as 
previously described (2.2.10.4.1). The slide was processed and the cells were stained 
with anti CD52 antibody as described in section 2.2.10.3.2. The number of nuclei 
was counted in 6 randomly chosen fields using Nikon Eclipse E400 
immunofluorescence microscope as above. 
2.2.10.5.2. Sulforhodamine B (SRB) protein assay 
The sulforhodamine B (SRB) assay is a rapid, sensitive and inexpensive method for 
measuring the cellular protein content of adherent cells and non-adherent cells in a 96 
well microtitre plates (Skehan et ai, 1990). In this research project the SRB assay was 
adopted to assess the effects of GST-EC2 tetraspanins on cell numbers and adhesion. 
2.2.10.5.2.1. Titration of cell numbers by SRB cell stain assay 
Adherent cells (RBL2H3 and monocytes) and non-adherent (THP-I cells) were 
harvested and seeded into a 96 well microtitre plate (poly-L-Iysine coated/uncoated) 
initially @ 500,000 cells.welr l in 200JlI culture medium (sections 2.1.8.1 &2.1.8.2) 
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and then with doubling dilutions of cell numbers in the following wells. These were 
incubated for 2hrs/4hrs at 37°C in a C02 incubator. (Some wells were incubated only 
with culture medium to measure the background optical density). The cells were fixed 
by layering S0l11 of ice cold SO% TCA on the top of the growth medium to a final 
concentration of 10% TCA. The plate was left undisturbed for Smin. then incubated 
at 4°C for Ihr. The supemates was removed and wells were washed Sx with 200111 of 
MQ water and air-dried. Wells were stained with 100111 ofO.4%(w/v) sulforhodamine 
B sodium salt (Sigma, cat. no. S9012-SG) in 1 % acetic acid for 30min. Unbound dye 
was removed with 1 % acetic acid and the plate was air dried. Cell bound dye was 
solubilized with 100111 of 10mM unbuffered Tris base at pH 10.S for Smin. using a 
gyratory shaker and the OD @ S70nm was measured using an ELISA plate reader. 
2.2.10.5.2.2. Effect of GST-EC2 tetraspanins on monocyte adhesion: SRB assay 
Adherent monocytes were harvested using trypsin: EDT A and seeded into a 96 well 
microtitre plate at Sxl05 cells.welrl in 200111 of medium. A duplicate plate was 
prepared with identical conditions. The plates were incubated with GST -EC2 
tetraspanins to final concentration of 20l1g.mrl for 72hrs at 37°C in the absence or 
presence of Con A (lOllg.mrl). After the incubation period one plate was fixed with 
TCA as described above, whilst the other was washed 3x with 200111 of BSS prior to 
fixation and the SRB assay was carried out. 
2.2.10.5.2.3. Effect of GST-EC2IHis6IEC2 tetraspanins on the aggregation ofmonocytes 
The effect of GST -EC2 or His6_EC2 tetraspanins on monocyte aggregation was tested 
in 96 well microtitre plates, as described by Takeda et al (2003). Adherent monocytes 
were harvested using trypsin: EDTA or Ie ell dissociation solution (section 2.2.2.1). 
The monocytes were seeded into a 96 well microtitre plate at 200,000 cells.weIr
l 
in 
100111 of medium and cultured for 12hrs in the presence of Con A (5I1g·mrl ) and 
GST-EC2 or His6_EC2 tetraspanins (20I1g.mrl). Control wells contained Con A alone 
or no Con A. The number of aggregates containing 4-10 and 10-20 cells were counted 
in 6 randomly chosen fields using an inverted light microscope. 
2.2.10.5.2.4. Effect of GST-EC2 tetraspanins on THP-1 cell aggregation 
THP-l cells were seeded at 80,000 cells in 80111 of culture medium into a 96 well 
microtitre plate pre coated with 100111 of sterile poly L-lysine (50I1g.mrl in carbonate-
bicarbonate buffer, incubated for Ihr at 37 C (poly L-lysine facilitates the adhesion of 
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non-adherent THP-1 cells). The cells were cultured for 24hrs in the presence/absence 
of Con A (5/J.g.mr1) and GST-EC2 tetraspanins or GST at 20, 10 and 2/J.g.mr1• 
Control wells contained Con A alone or no Con A. Aggregates containing 4-10; 10-
20; 20-50; 50-100 and> 1 00 cells were counted in 6 randomly chosen fields as above. 
2.2.10.6. Binding GST ·EC2 tetraspanins with monocytes 
2.2.10.6.1. Binding of GST-EC2 tetraspanins to monocytes: FACS-Indirect assay 
Adherent monocytes in 10cm culture plates were cultured in the absence or presence 
of Con A (10/J.g.mr1) 24hrs. Cells were harvested using cell dissociation solution and 
incubated with unlabelled GST-EC2 tetraspanins/GST (20/J.g.mr1, Ihr at 4°C) 
followed by goat anti GST antibody (l0/J.g.mr1) then Extravidin-FITC (2.25/J.g.mr l) 
as described section 2.2.2.3. 
2.2.10.6.2. Binding offluorochrome labelled GST-EC2 tetrasapanins to monocytes: FACS-
Direct assay 
Monocytes were cultured as above (with/without Con A) for 2hrs. After harvesting, 
cells were incubated with FITC conjugated GST-EC2 proteins or FITC-GST (6/J.g.mr 
I in RPMI-10%FCS) either at 4°C (to assess the surface binding) or at 37°C (to assess 
binding and uptake). The remaining conditions were as described for direct 
immunofluorescence (2.2.2.2.) 
2.2.10.6.3. Binding of GST-EC2 tetraspanins to monocytes: microscopy: Indirect assay 
Mononuclear cells were seeded into Lab-Tek® chamber slides as described previously 
(2.2.10.3.2) and cultured with/without Con A (l0/J.g.mr1) in 500/J.I of medium for 2hrs 
at 37°C. Unlabelled GST-EC2 tetraspanins or GST (20/J.g.mr l in BBN) were allowed 
to bind at 4°C for Ihr. The chambers were then washed 2x with PBS, fixed with 
acetone and processed as described for indirect immunofluorescence (2.2.3.2.). The 
primary antibody used was goat anti GST-biotin (l0/J.g.mr1) followed by Extravidin-
FITC (2.25/J.g.mr l ). 
2.2.10.6.4. Binding of flurochrome labelled GST-EC2 tetrasapanins on monocytes: 
microscopy: Direct assay 
This was carried out as above (2.2.10.6.3) but cells were incubated with 
FITC/rhodamine BITC labelled GST-EC2 tetraspanins or GST (6/J.g.mr l ) in 
RPMI+ 10%FCS either on ice or at 37°C to assess surface binding or binding and 
uptake, respectively. Slides were processed as described above (2.2.10.3.2). 
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2.2.10.6.5. Binding of GST-EC2 fusion proteins on monocytes: ELISA 
Binding of GST-EC2 tetraspanins to monocytes in ELISA (whole cell ELISA) was 
essentially as described by Schober et al (2002). Adherent monocytes harvested using 
trypsin:EDTA were seeded into a 96 well microtitre plate at 3xl05cells.welr l in 200~1 
of medium. After 12hrs in culture in the presence/absence of Con A (10~g.mr\ 
wells were washed with 200~1 of lxPBS, and cells fixed with 200~1 of 0.25% 
glutaraldehyde.weIr l (section 2.1.4.3.4) for 30min. at RT. Glutaraldehyde was 
removed and the plate was immersed in a trough of PBS. After removal of PBS, wells 
were blocked with 300~1 of2% milk power in PBS for 2hrs at 37°C. After removal of 
blocking buffer the wells were incubated with 50~1 of GST-EC2 tetraspanins/GST 
(20~g.mrl) in dilution buffer (1 % milk powder in PBS). After Ihr at 37°C the plate 
was washed 3x with PBS and 50~1 of goat anti GST antibody (5~g.mrl) in dilution 
buffer added. After 1 hr at 37°C, the plate was washed as before and incubated with 
50~1 of anti goat/sheep IgG HRP (5~g.mrl) in dilution buffer for Ihr at 37°C. The 
plate was washed, substrate added and colour developed as described in 2.2.5.4. 
2.2.10.7. Binding of FITC labelled GST-EC2 tetraspanins to oocytes from mice 
2.2.10.7.1. Preparation of zona free oocytesfrom mice 
These experiments were carried out at ARC Centre of Excellence in Biotechnology 
and Reproductive Science, University of Newcastle, Australia under the guidance of 
Dr. Eileen McLaughlin. 
Female Swiss mice (6-8 weeks old) were injected with 10 LU. of Folligon to stimulate 
follicle development. 48hrs later a second injection of Chorulon was given to induce 
ovulation. 12hrs post-Chorulon injection, mice were CO2 euthanaised. The ovaries 
and oviducts were excised and transferred into filter sterilised a-Minimum Essential 
Media (a-MEM) supplemented with 5% FCS, ImM HEPES, 5U.mrl penicillin G and 
5J.lg.m- l streptomycin sulphate (all media components from Gibco). Using a 
dissection microscope (Carl-Zeiss) and fine tip forceps, oviduct tubules were carefully 
pinched allowing the release and collection of cumulus-oocyte complexes (CEOs). 
Oocytes were denuded (removal of surrounding cumulus cells) by incubating them 
with Img.mr l hyalauronidase for 5min followed by 3x washes with 100J.lI of 
medium. Zona pellucidae of oocytes was removed by dissolving with a very brief (15-
25sec) exposure to acidified tyrodes solution (PH 2.2). Oocytes were quickly washed 
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3x with IOO!J.1 media droplets and allowed to recover for 60min incubation at 37°C in 
5% CO2 incubator. After the recovery the oocytes were used for further experiments. 
2.2.10.7.2. Binding of FITC labelled GST-EC2 tetraspanins with mouse oocytes 
Approximately 12-15 oocytes were incubated in IOO!J.1 droplets of GST-EC2CD9-
FITC, GST-EC2CDI51-FITC and GST-FITC to a final concentration of 6!J.g.mr i in 
media; the media alone was included as an additional control. After Ihr at 37°C in a 
5% CO2 incubator the oocytes were washed 3x with IOO!J.1 media droplets, mounted 
on slides with raised coverslips and observed under the Carl-Zeiss confocal 
microscope using 250x magnification. 
2.2.11. Effect of Con A stimulation on the expression of tetraspanins and 
other leucocyte proteins by monocytes 
The expression levels of cell surface membrane proteins by unstimulated/Con A 
stimulated monocytes or THP-l cells were measured by F ACS analysis as described 
in section 2.2.2.2. Adherent monocytes (section 2.2.10.2) or THP-l cells in tissue 
culture plates were cultured without/with Con A (lO/-lg.mr i ) for 2hrs or 72hrs at 
37°C. Cells were harvested and prepared for FACS analysis as described in 2.2.2.2 
using appropriate concentrations of FITC labelled antibodies directed to CD9, CD 11 b, 
CDI4, CDI8, CD29, CD37, CD63, CD81, CD52, CD82, CD151 or FITC labelled 
mouse isotype control (section 2.1.5). 
2.2.12. Characterisation of humanised recombinant scFv phage antibody 
2.2.12.1. Colony insert PCR 
Colony insert PCR is a rapid, direct technique employed on bacterial plaques or 
colonies to check the presence, size and orientation of DNA inserts by amplification 
with flanking primers circumventing all DNA preparation (Giissow et ai, 1989). 
Clones of XLI-Blue cells containing pAKI00 vector with inserted scFv genes were 
streaked on TYE plates supplemented with 100/-lg.mr i carbenicillin and 1% glucose 
and incubated overnight at 37°C. A single colony from the plate was used to check 
for the presence of scFv encoding cDNA inserts. A clone known to contain insert 
encoding an anti alkaline phosphatase scFv was included as a positive control, and a 
clone containing pAKI00 vector only was used as a negative control. The primers 
used for this reactions span the scFv insert and are an M13 primer LMB3 (5'-
CAGGAAACAGCTATGAC-3') corresponding to vector sequence just before the 
insert site and a primer Fdseql (5'-GAATTTTCTGTATGAGG-3') corresponding to 
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sequence at the 3' end of the scFv insert. A single colony from the TYE plate mixed 
with 50!l1 of amplification reaction mix (5!l1 of lOx PCR buffer, 0.4!l1 of 25mM 
dNTP, 4!l1 of25mM Mg2+, 1!l1 of20!lM LMB3 primer, 1!l1 of Fdseq1 primer 20~M, 
0.25 !l1 of 5U. !lr1 Taq polymerase) and the final volume was adjusted to 50!l1 with 
sufficient water. After a hot start (to break down bacterial cell membrane) at 94°C for 
3min., 25 cycles of the following PCR conditions were used: 94°C-30s; 45°C-60s; 
72°C-90s and a final extension at 72°C for 10min. Hold 4°C. Finally 8-1 O~l of the 
PCR product was analysed on a 1 % agarose gel for the presence of insert (~800bp). 
2.2.12.2. Preparation of scFv phage containing supernatant 
On day 1 the 2TYE plates were streaked with clones of XL 1 Blue containing vector 
with/without scFv insert and incubated at 37°C overnight. On day 2 a single colony 
was isolated and inoculated into 5ml of 2TY supplemented with 5!l1 of 25!lg.mr l 
chloramphenicol in a universal tube. The cell suspension was cultured over night at 
37°C in a shaker at 250RPM. On day 3, a sufficient quantity bacterial culture was 
inoculated into a corresponding Falcon tube containing 50ml pre warmed NE medium 
(2TY+ 1 %Glucose+25/lg.mr l chloramphenicol) to achieve OD600 between 0.05-0.l. 
The cells were cultured at 37°C in 1L flask with shaking at 250 RPM until the OD6oo 
reached ~ 0.5. The OD600 was recorded for the next 2hrs. The bacterial clone 
cultured in log phase was infected with 20-fold excess of VCSM13 helper phage 
(Stratagene) and protein expression was induced by adding 25/l1 of 1M IPTG (section 
2.1.4.3.11). 
The number of helper phage to be used for the infection of bacterial cells was 
calculated from the OD6oo of the culture. The OD6oo and their corresponding bacterial 
cell numbers are given below. 
00600 
1 
0.8 
0.6 
0.4 
0.2 
Bugs.mr' 
8.0 X 108 
6.4 X 108 
4.8 x 108 
3.2 X 108 
l.6 X 108 
Table. 2.15. The OD600 of bacterial culture and their 
corresponding cell numbers . 
No. of phage particles to be used = No. of bugs. mr l x vol. of culture x 20 
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The phage-infected bacterial cells were incubated for 30min at 37°C in a water bath 
(to facilitate the infection of helper phage). The culture was then supplemented with 
an additional 100ml LE medium (NE+50I-11 1M IPTG). The cells were cultured in 
shaker for 2hrs at 26°C at 225rpm. The phage-infected bacteria were selected by the 
addition of 901-11 of 50l-1g.mrl kanamycin (final concentration of 30I-1g.mrl). The 
culture was grown over night at 26°C with shaking at 225rpm. On day 4 the cell 
suspension was transferred into a labelled Beckman centrifuge tube and centrifuged at 
10,800g for 12min. at 4°C. (The centrifugation was repeated if the supernatant was 
not clear). The supernatant was decanted and transferred into another 250ml Beckman 
tube and mixed with 1/5 volume of cold PEG4000INacl (Sambrook et al, 2001) with 
respect to the volume of supernatant. After thorough mixing this was left on 1.5 to 
3hrs, centrifuged at 15000g for 25min and the supernatant discarded. The tubes were 
inverted, left on a paper towel and the droplets of supernatant drained for 10min. The 
inner upper half of the Beckman centrifuge tubes was wiped with paper towel. The 
phage pellet was re suspended with 20ml of sterile MQ water + 4ml PEG4000INacl 
(1/5 Volume) in an Oakridge tube and incubated on ice for 30-45min. The tubes were 
centrifuged for 20min at 15000g, the supernatant discarded and the tube was inverted 
and dried for 10min at RT as before. Finally the phage particles were re suspended in 
3ml of sterile Ix PBS and an aliquot of 1.5ml was transferred into eppendorfs and 
centrifuged for 1 min. at 10,000g to remove the residual bacteria from the phage 
particles. This step was carried out twice or until the phage preparation was freed 
from bacterial contaminants. Clear supernatant was transferred into fresh eppendorfs 
and stored at 4°C with 0.1 % sodium azide. 
2.2.12.3. Quantification of scFv phage 
Initial binding experiments were carried out using crude phage preparations, using 
phage-containing vector with no insert prepared under identical conditions as a 
negative control. With a view to standardising the number of phage particles in each 
binding experiments the quantification of phage preparation was carried out using (a) 
colony count (b) spectrophotometric method. 
2.2.12.3.1. Colony count method 
The number of infective phage particles present in the phage preparation can be 
estimated by colony counting method. However, this method does not give an 
estimate of number of phage that are able to bind, and falls off rapidly with time, 
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where as an antibody binding is stable for several weeks or even months (Steinberger 
et ai, 2001). 
10/l1 of stock XLI Blue was inoculated into 10ml of prewarmed 2TY supplemented 
with 10 /lg.mr! of tetracycline. The culture was grown over night at 37°C in a shaker 
at 225rpm. 20/ll of overnight cultured XLI Blue was sub cultured into another 10ml 
of prewarmed 2TY supplemented with 10/lg.mr! of tetracycline in falcon tube. The 
cells were grown in log phase at 37°C in a shaker at 225rpm until the OD6oo reached ~ 
0.5. Dilutions (10-3,10-4,10-5,10-6 and 10-7) of phage were made in sterile lxPBS. 1/l1 
of diluted phage was mixed with 49/l1 of log phase XLI Blue in sterile eppendorfs 
and incubated for 30min. at 37°C in a water bath. This mixture was spread into 2TYE 
plates supplemented with 1 % glucose and 25/lg.mr! chloramphenicol. The plates 
were incubated overnight at 37°C. The number of colonies developed in the plate was 
counted and the number of infective phage particles present mr! of phage preparation 
was estimated by using the formula: Number of colonies x dilution factor x 1000. 
2.2.12.3.2. Spectrophotometric method 
Quantification of phage was carried out by spectrophotometric method as described 
by Bonnycastle et al (2001). This method determines the number of phage particles, 
rather than just those that are infective. So as to get a concentration of approximately 
1 0!2 phage particles.mr!, the phage prep was diluted at 1 :20 in lxPBS and its OD269 
and OD32o was measured using a spectrophotometer. The number of phage particles 
present in phage prep was determined using the formula: 
Phage particles.mr! = (Adjusted A269) x (6xl0!6) 
(Number of nucleotides in the phage genome) 
Where, adjusted A269 = measured A269 - measured A320; the number of nucleotides 
present in scFv phage genome is 7,307. 
2.2.12.3.3. Titration of anti CD63 antibodies by whole cell ELISA 
The melanoma cell lines Mewo or Mel-17 were harvested using 1: 10 trypsin: EDT A 
solution (section 2.2.1.1). The cells were seeded into a 96 well microtitre plate at 
lxl05 cells.welr! in 100/ll of medium and cultured overnight. The medium was 
removed and the cells fixed and blocked as described in section 2.2.10.6.5. The cells 
were incubated with 50111 of unlabelled primary antibodies such as H5C6, LP9 or 
BEM-l and 50111 of secondary antibody anti mouse IgG-HRP (whole molecule) and 
developed as described in 2.2.5.4. 
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2.2.12.3.4. Binding ofscFv phage to whole cells -three stage ELISA 
Seeding and fixing of RBL2H3 cells, Mewo or Mel-17 in 96 well microtitre plate was 
as in 2.2.12.3.3. The cells were blocked with 300~1 of 0.2% gelatin solution in 
IxPBS for 1-2hrs in an incubator at 37°C, blocking agent removed and then wells 
incubated with 50~1 scFv phage for Ihr at 37 C. After washing, anti MI3 biotin-
labelled antibody at 1 ~g.mrl in dilution buffer was added and incubated for Ihr at 
37°C. After washing, Extravidin-HRP at 0.5~g.mrl in dilution buffer was added. 
Positive control wells were coated with 50~1 of anti CD63 antibody (H5C6) at 
5~g.mrl and followed by anti mouse IgG-HRP (whole molecule) at 1:5000 in dilution 
buffer. After Ihr incubation at 37 C the colour was developed and the OD@450nm 
was measured. 
2.2.12.3.5. Binding ofscFv phage to whole cells-two stage ELISA 
Seeding and fixing ofRBL2H3 cells, Mewo or Mel-17 was as in section 2.2.12.3.3. 
The cells were blocked with 300~1 of blocking buffer 2% milk powder in lxPBS for 
1-2hrs at 37°C. After removing blocking agent, cells were incubated with 50~1 of 
scFv phage but the cells in +ve control wells were incubated with H5C6 at 14~g.mrl 
in dilution buffer. The plate was incubated for 1 hr at 37 C, washed as in section 
2.2.10.6.5 and phage treated wells were coated with HRP labelled secondary anti M13 
antibody at I :5000 in dilution buffer. The positive wells were coated with 50~1 of anti 
mouse IgG-HRP (whole molecule) at 1 :5000 in dilution buffer. After incubation for 
Ihr at 37°C the plate was washed 3x with PBS+0.05% tween 20, Ix wash with PBS 
and a final wash with MQ water. After Ihr incubation at 37 C the colour was 
developed and the OD@450nm was measured. 
2.2.12.3.6. Binding ofscFv phage with GST-EC2 tetraspanins: ELISA 
The binding of scFv phage on immobilized GST -EC2 tetraspanins was tested by 
ELISA as per the method described by Azorsa et al (1999) and Schober et al (2002). 
The coating of GST -EC2CD63 in 96 well microtitre plate, blocking and washings are 
same as in section 2.2.5.4. The wells were incubated with 50~1 of scFv phage in 1% 
milk powder + 0.01% tween 20 in PBS. The positive wells were coated with anti 
CD63 antibody (H5C6) at 14~g.mrl in dilution buffer. After Ihr incubation at 37°C, 
the plate was washed (section 2.2.5.4) and coated with a secondary antibody anti 
MI3-HRP conjugate at 1:5000 in dilution buffer. The positive control wells were 
treated with anti mouse IgG-HRP in 1 :5000 dilution buffer. After Ihr incubation at 
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37 C the colour was developed and OD@450nm was measured as described III 
section.2.2.5.4. 
2.2.12.3.7. Inhibition ELISA 
The coating of 96well microtitre plates with GST-EC2CD63, incubation, blocking 
were as in section 2.2.5.4. 50111 of scFv phage (at the dilution shown to give 50% 
maximal binding in the normal ELISA) was incubated with IOOIlI of serially diluted 
free GST-EC2CD63 in 1 % milk powder and 0.01 % tween 20 in PBS. The 
concentration of antigen (GST-EC2CD63) was initially at 0.5mg.mr l then doubling 
dilutions in dilution buffer. The plate was incubated for Ihr at 37°C and the washing, 
coating with secondary anti MI3-HRP antibody and developing, and measuring 
OD450nm are same as in section 2.2.5.4. 
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CHAPTERS 
EFFECTS OF TETRASPANINS EC2 REGIONS 
AND ANTI TETRASPANIN ANTIBODIES ON 
MONOCYTE FUSION 
3.1. INTRODUCTION 
As described in chapter 1, tetraspanin membrane proteins have been implicated in 
various cell fusion processes, such as sperm-egg fusion (Chen et ai, 1999; Le Naour et 
ai, 2000; Higginbottom et ai, 2003); muscle cell fusion (Tachibana and Hemler, 1999) 
and the formation of viral syncytium (Pique et ai, 2000). In this chapter, the role of 
tetraspanins in mononuclear phagocyte fusion was investigated. A recent report from 
Takeda and co-workers has suggested a role for tetraspanins proteins in the fusion of 
mononuclear phagocyte to form multinucleated giant cells (MGCs) (Takeda et ai, 
2003); Antibodies to CD9 and CD81 enhanced the formation of Con A induced 
monocyte fusion whereas no effect was observed with an anti CD63 antibody. 
Conversely, a GST fusion protein containing the large extracellular loop of CD9 
(GST -EC2CD9) inhibited MGC formation. Stimulation of monocytes with Con A 
appeared to down-regulate the expression of CD9 and CD81, whereas the expression 
of CD63 was upregulated. The formation of integrin-CD81 and integrin-CD9 
complexes was also down regulated. The authors also demonstrated that mononuclear 
phagocytes from CD9/CD81 double knockout mice showed a spontaneous MGC 
formation and concluded that tetraspanins CD9 and CD81 act as negative regulators 
of MGC formation (Takeda et ai, 2003). This is in contrast to their role in sperm:egg 
fusion, where antibodies to CD9 and recombinant CD9EC2 regions inhibited the 
fusion (Takahashi et ai, 2001). 
3.1.1. Functional studies using anti tetraspanin antibodies 
The functional properties of tetraspanins have been elucidated by various approaches. 
Among these, anti tetraspanin antibodies are important tools but they have number of 
disadvantages as they may recognise different epitopes and can act in multiple ways. 
The wide range of cellular responses stimulated by antibodies is thought to be due to 
perturbation not just of the specific tetraspanins, but also of the 'microdomains' in 
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which the tetraspanins are embedded. In most studies intact antibodies have been 
used, resulting in cross-linking of tetraspanins, with capping and internalisation likely 
consequences. Co-ligation of Fc receptors may also occur, causing FcR-related 
signalling events that are unrelated to normal tetraspanin functions (reviewed by 
Moseley, 2005). Higginbottom and co-workers, for example, showed the 
consequences of using whole molecule antibodies and their co-ligation with FCERI 
using anti CD9 antibodies with CD9 transfected RBL cells (Higginbottom et ai, 
2000). Higginbottom and co-workers showed that the anti CD9 antibodies induced 
secretion by the transfected cells, but that this effect was dependent on the interaction 
of Fc region of the antibodies with the FCERI naturally expressed by RBL2H3 cells 
(Higginbottom et ai, 2000). Since monocytes express high levels of Fcr receptors 
(Riemann et ai, 2005) it may not be appropriate to use intact antibodies to study the 
functional properties of monocytes. However, to see if we could reproduce the 
findings described by Takeda and co-workers, studies with anti tetraspanin antibodies 
are described in this chapter. Alma-l and 602.29 are mouse IgG 1 anti CD9 antibodies 
(Azorsa et ai, 1999; Andrews et ai, 1981). H5C6 is a mouse IgG 1 anti CD63 antibody 
(Azorsa et ai, 1991). Fab fragments of this antibody were prepared by papain 
digestion and protein A-Sepharose purification and shown to be free of contaminating 
IgG, Fc or F(ab')2 fragments by SDS-PAGE and western blotting (G. Mal, Ph.D 
thesis, University of Sheffield, 2005). LP9 is an IgM anti CD63 antibody, prepared in 
house (Smith et ai, 1995). BEM-l is an IgA anti-CD63 antibody prepared in house 
(McCullough et ai, 1997). 
3.1.2. Functional studies using EC2 fusion proteins 
As an alternative to antibodies, the functional properties of tetraspanins are being 
studied by using recombinant tetraspanin large extracellular loop (EC2) domains, 
usually as fusion proteins with glutathione S-transferase (GST). It is likely that the 
tetraspanin EC2 domains form dimers or higher multimers (Kitadokoro et ai, 2001), 
as proposed for full length tetraspanins (Hemler, 2003) and have a similar structure to 
native EC2 domains as demonstrated by the binding of conformation-dependent 
antibodies to both forms. The EC2 domains are critical to many, or perhaps all, 
tetraspanin specific activities described to date and probably act by clustering proteins 
at the cell surface into functional complexes (Boucheix and Rubinstein, 2001). 
Recombinant soluble EC2 domains appear to interfere with the formation of these 
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complexes, so inhibiting tetraspanin related cellular activities. Various studies have 
effectively used recombinant EC2 regions to assess the functional properties of 
tetraspanins. Thus GST -EC2CD9 was shown to inhibit sperm-oocyte fusion and the 
residues 173-175 (SFQ) in large extracellular loop were demonstrated to be essential 
to the sperm-egg fusion (Zhu et aI, 2002). Higginbottom and co-workers also 
demonstrated that both recombinant mouse and human GST-EC2CD9 fusion protein 
were potent inhibitors of mouse sperm-egg fusion (Higginbottom et aI, 2003). The 
role of the large extracellular loop of CD81 in its interaction with hepatitis C virus 
envelope glycoprotein E2 was demonstrated using recombinant GST-EC2CD81 and 
these proteins significantly inhibited E2 binding to hCD81 expressed at the surface of 
rat or human cells (Flint et aI, 1999; Higginbottom et aI, 2000; Petracca et aI, 2000). 
As described in chapter 1 the role of CD9EC2 regions in the adhesion and pericellular 
fibronectin matrix assembly of CD9 transfected CHO cells was demonstrated using 
soluble GST-EC2CD9 protein (Cook et aI, 1999). Most recently, in collaboration with 
Dr. Cecilia Cheng-Mayer (Aaron Diamond AIDS Research centre, New York) we 
have found that recombinant GST-EC2 tetraspanins such as CD63 and CD9 strongly 
inhibited the HIV -1 infection of human macrophages (unpublished work). Also, as 
mentioned above, Takeda and co-workers found that GST-EC2CD9 inhibited the Con 
A induced fusion of monocytes to form MGCs (Takeda et aI, 2003). Recombinant 
EC2 regions have also been used for epitope mapping of monoclonal antibodies 
(Tomlinson et aI, 1993) and for raising antibody against hEC2 domains of CD9, 
CD63, CD53, CD81, A15 or CO-029 (Azorsa et aI, 1999). It appears that GST-EC2 
regions of tetrapanins are recognised by conformation specific antibodies and reduced 
forms of GST -EC2 tetraspanins are non reactive (Azorsa et aI, 1999; Hadlock et aI, 
2000 and our un published data). Recently, a His6-tagged fusion protein of 
hEC2CD81 has been used to solve the crystal structure of the large extracellular loop 
of human CD81 (Kitadokoro et aI, 2001). 
3.1.3. Functional studies using monocytic leukaemic cell line and 
macrophages from C09 WT and C09-1- mice 
The findings of Takeda and co-workers lead us to further investigate the role of 
tetraspanins in the fusion of monocytes. Most of the experiments described in this 
chapter relied on fresh human monocytes obtained from volunteers. However getting 
a good supply of fresh human monocytes is difficult and there may be considerable 
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variation between donors. Therefore attempts were also made to use the monocytic 
cell line THP-l for the fusion assay. This cell line has been often used as a model 
system for functional studies of monocytes such as differentiation of monocytes into 
macrophages (Auwerx et ai, 1991; Schwende et ai, 1996; Kohro et ai, 2004). 
Compared to other human monocytic cell lines (HL-60, U937, KG-I, or HEL), the 
differentiated THP-l cells are believed to behave more like native monocyte-derived 
macrophages (Auwerx et ai, 1991). 
Similarly the role of CD9 on monocyte fusion was evaluated by using a macrophage 
cell line derived from CD9WT and CD9 knockout mice since these cells were 
successfully used to study the functional properties of human and murine pregnancy 
specific glycoproteins 17 (PSGs) (Ha et ai, 2005). 
3.1.4. Production and characterisation of GST -EC2 proteins 
The production of the GST-EC2 proteins and their characterisation was described in 
previous publications from our group (Higginbottom et ai, 2003) and is detailed in 
section 2.2.8. Correct folding of the proteins was determined by using conformation 
dependent antibodies, and is also indicated by their biological activity in other 
systems. 
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3.2. RE5UL T5 
3.2.1. Monocyte cell fusion assay 
3.2.1.1. Assay in microtitre plates 
As mentioned in section 2.2.10.3.1 , preliminary experiments with monocytes 
followed the procedures described by Takeda and co-workers (Takeda et ai, 2003). 
The monocytes were isolated, cultured and stimulated in 96 well micro titre plates and 
subsequently stained with Wright stain. Although cell fusion was observed, staining 
of cells was not clear and the numbers of nuclei in fused cells were difficult to 
enumerate (Fig.3.2.1). Hence we tried an alternative approach, culturing the 
monocytes in Lab-Tek® chamber slides and staining cells using FITC labelled 
antibodies to achieve better cell morphology and allow more accurate counting. 
(A) (B) 
Fig.3.2.1. Light microscopic images of monocytes stained with Wright stain. 
Monocytes at 2xl05 cells in IOOIlI of culture medium were plated into a 96 well 
microtitre plate and cultured for 72hrs in the presence/absence of Con A at 1 0Ilg.ml- 1: 
Monocytes alone (A); in the presence of Con A (B). The cells were stained as 
described in section 2.2.10.3.l and the images were captured with a Nikon inverted 
microscope using 40x objective. 
3.2.1.2. Assay in Lab-Tek® chamber slides 
The monocytes were separated from the blood as mentioned in section. 2.2.10.1 and 
allowed to adhere to Lab-Tek® chamber slides. The purity of monocytes was assessed 
by staining with monocyte-specific markers such as FITC labelled anti CD 14 or 
CD68 antibodies by immunofluorescence microscopy and the results indicated that ~ 
80-90% of the slide-adherent cells were monocytes. The adherent cells were 
stimulated with Con A as described in section 2.2.10.3.2. After 72hrs, the cells were 
fixed, stained with a FITC-Iabelled primary antibody and the nuclei stained with 
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propidium iodide. Various FITC labelled antibodies (anti CD 14, anti CD52, anti 
CD63 and CD68) were compared for their staining efficiency using fresh and thawed 
frozen stocks of monocytes (Audran et ai, 1995) as described in section 2.2.10.3.2. 
These antibodies were chosen on the basis of their specificity and expression levels of 
corresponding antigens on the monocytes. CD14 is a glycosyl-phosphatidylinositol 
(GPI) linked glycoprotein predominantly expressed on the cell surface of monocytes 
(Barclay et ai, 1997). 
Surface expression of CD63 in monocytes is relatively low, but it has good 
intracellular expression (our unpublished observation). CD52 is an unusually short 
glycoprotein bearing GPI protein and leukocyte marker; its surface expression levels 
are very high on monocytes (Barclay et ai, 1997). CD68 is a highly glycosylated 
lysosomal-associated membrane protein (lamp); its expression is less on the surface 
and more in the lysomes and endosomes of monocytes (Barclay et ai, 1997). 
From the staining studies with different antibodies it was observed that although 
freeze-thawed monocytes were stained well with FITC labelled anti CD63 (H5C6) 
and anti CD 14 antibodies, their appearance on Con A stimulation was atypical of 
fresh monocytes. Thus, although they provided a convenient source of cells, frozen 
monocytes were not further used. Hence we used fresh monocytes for staining studies 
with FITC labelled anti CD52, anti CD63 and anti CD68 antibodies. Both anti CD52 
and anti CD63 antibodies have given good staining with unstimulated and Con A 
stimulated monocytes; in contrast to these the anti CD68 antibody (monocyte marker) 
showed good staining with unstimulated monocytes but less staining with Con A 
stimulated monocytes. Even though the anti CD63 antibody is good for staining of 
unstimulated and Con A stimulated cells it was not suitable for the experiments 
involving recombinant GST-EC2CD63. Hence among all the antibodies tested the 
anti CD52 was selected as a suitable antibody for staining of unstimulated and Con A 
stimulated monocytes (Fig.3.2.2). To achieve optimum staining of monocytes with 
anti CD52-FITC antibody, the antibody was titrated by F ACS analysis as described in 
section 2.2.5.7. The result showed that 5/lg.mr1 of antibody was the optimum 
concentration (Fig.3 .2.3). 
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(E) 
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Fig.3.2.2. Immunofluorescence images of monocytes (fresh/freeze-thawed) cultured 
for 72hrs in Lab-Tek® chamber slides. The cells were fixed and stained with FITC-
labelled monoclonal antibodies and propidium iodide as described in section 
2.2.10.3.2. A, C, E, G, I-unstimulated; B, D, F, H, J- stimulated with Con A at 
10Ilg.mr l . The antibodies used were: anti CD68 (A) and (B); anti CD52 (C) and (D); 
anti CD63 (E) and (F); anti CD14 (G) and (H); anti CD63 (I) and (1). A-F corresponds 
to freshly prepared monocytes, (G)-(1) thawed, frozen monocytes. The images were 
captured with a Nikon Eclipse E400 immunofluorescence microscope using 20x 
objective. 
O~--------r--------,---------r--------~-------' o 2 4 6 8 10 
Cone . of anti CD52 -FITC (1l9 .m r1) 
Fig.3.2.3. Titration of anti CD52-FITC antibody against monocytes. The FAC 
analysis was carried out as described in section 2.2.5.7. 
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The stimulation of monocytes with Con A leads to fusion and produced mostly 
Langhans' type of MGCs with a circular peripheral arrangement of nuclei or 
horseshoe shaped arranged nuclei; occasionally we noticed some MGCs which 
resembled foreign body type MGC with scattered nuclei (Vander Rhee et ai, 1979; 
Anderson, 2000; Mizuno et ai, 2004). This varied between experiments and donors. 
The approximate numbers of nuclei in each fused cell were between 50-100 and this 
also varied between donors. Typical fusion indices (no. of nuclei in fused cells/ 
number of nuclei in total % (Abe, 1983; Takeda et ai, 2003)) were 75-95%. 
The Con A stimulated monocytes/MGCs appeared strongly adherent to the culture 
surface. By contrast the monocytes cultured under the same conditions in the absence 
of Con A did not fuse and they were less adherent i.e. they were more easily detached 
from the culture surface during slide processing. 
3.2.2. Effects of anti tetraspanin antibodies on MGC formation 
In preliminary experiments with antibodies to tetraspanins, it was apparent that some 
of these reagents greatly affected the size of the MGCs formed e.g. anti CD9 antibody 
Alma-l induced the formation of very large MGCs containing hundreds of nuclei 
(Fig.3.2.5(C)). The fusion index term does not provide a particularly good measure of 
this effect, since the percentage of nuclei present in fused cells may remain high 
irrespective of the size of the MGCs (Fig.3.2.4(A)). Hence in the subsequent 
experiments with antibodies the fusion rate was estimated as a measure of number of 
nuclei in fused cells in randomly chosen fields. Based on the preliminary studies, the 
effects of anti CD9 antibodies (Alma-l and 602.29) and anti CD63 antibodies (BEM-
1, H5C6, 16.1, 16.5, LP9 and Fab fragments ofH5C6) on Con A induced monocyte 
fusion was tested (2.2.10.3.2). 
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Fig. 3.2.4. Effects of anti CD9 and anti CD63 antibodies on Con A induced monocyte 
fusion. Monocytes in Lab-Tek® chamber slides were stimulated with Con A 
(10~g.mrl) and cultured for 72hrs in the presence or absence of antibodies (20~g.mrl 
except for BEM-1, used at 40~g.mrl) as mentioned in section 2.2.10A.1. Fusion 
index (A); numbers of nuclei in multi nucleated giant cells (B) were calculated from 6 
randomly chosen field after staining with anti CD52-FITC antibody as described in 
section 2.2.10.3.2. The data in Fig.3.2AA is a means of 1 experiment. The data in 
Fig.3.2AB represents means of 4 independent experiments in duplicate with Alma-1 
and H5C6 and 2 independent experiments with other antibodies in duplicate carried 
out with monocytes of different blood donors. The level of significance between the 
Con A control and different treatments was tested by unpaired t test, where * * * 
Significant at P<0.0001; ** Significant at P<O.OO1. 
The effects of co-incubating the monocytes with the anti-tetraspanin antibodies are 
shown in Fig.3.2.4. The anti CD9 antibodies strongly enhanced the fusion of Con A 
stimulated monocytes and produced MGCs with large numbers of nuclei relative to 
Con A alone control. By contrast anti CD63 antibodies strongly inhibited the fusion. 
The effects of anti CD9 antibodies (Alma-1 and 602.29) are in agreement with the 
findings of Takeda and co-workers (Takeda et ai, 2003). By contrast, all of the anti-
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CD63 antibodies significantly inhibited the fusion whereas Takeda and colleagues 
found no effect with an anti CD63 antibody. Although some MGCs formed in the 
presence of anti CD63 antibodies, these contained significantly fewer nuclei. 
Interestingly, inhibition of fusion was also observed with IgM (LP9) and IgA (BEM-
1) anti CD63 antibodies, as well as Fab fragments ofH5C6 anti CD63 antibody. 
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Fig.3.2.S. Effects of anti tetraspanin antibodies on Con A induced monocyte fusion. 
The conditions were as described in Fig.3.2.4. The monocytes incubated without Con 
A (A); Con A (B); Con A + anti CD9 antibody-Alma-l (C); Con A + anti CD9 
antibody-602.29 (D); Con A + anti CD63 antibody-BEM-l (E); Con A + anti CD63 
antibody-HSC6 (F); Con A + anti CD63 antibody-16.1 (G); Con A + anti CD63 
antibody-16.S (H); Con A + anti CD63 antibody-LP9 (I) ; Con A + Fab fragments of 
anti CD63-HSC6 (J). The images were captured with a Nikon Eclipse E400 
immunofluorescence microscope using 20x objective. 
3.2.3. Production and characterisation of GST -EC2 proteins 
The expression, isolation and purification of GST -EC2 tetraspanins such as CD9 and 
CD63 were carried out as described in section 2.2.8 . For functional assay described 
subsequently, production was carried out by Dr. Adrian Higginbottom or Francine 
Martin in the group. However, the results of a production carried out by myself are 
shown below. GST-EC2CD9 and GST-EC2CD63 were prepared in two batches of 
400ml culture and the yield of GST-EC2CD9 was 21.6mg.L- 1; 12.9mg.L- 1 
respectively, and of GST-EC2CD63 3.Smg.L- 1; 0.64mg.L-1 respectively. The 
concentration of the proteins was determined by densitometry. The bands at 35KDa 
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and 37KDa are corresponding to GST-EC2CD9 and GST-EC2CD63, respecti ely. 
The band at approximately 25KDa is free GST. Bands between 25-35KDa are 
presumed to be break down products of the GST-EC2 proteins. (The identity of these 
bands has been determined many times previously by Western blotting, but was not 
done in this instance). The bands below 25KDa and above 37KDa are the 
contaminants of the GST preparations and it may vary from preparations to 
preparation. For the functional studies described below, GST-EC2CD9 and GST-
EC2CD63 yields were typically 15mg.L-1 and 2-1 Omg.L-1, respectively. The 
concentration of GST-EC2 varied from 20-60% of total protein. 
37KDa~ 
35KDa~ 
25KDa~ 
1 2 3 4 5 6 7 8 9 
Fig.3.2.6. Expression of GST-EC2CD9 and GST-EC2CD63 fusion proteins. The 
concentration of the proteins was determined by coomassie stained gel using 
densitometry. Lane 1: GST; Lane 2&3: GST-EC2CD9; Lane 4&5: GST-EC2CD63 ; 
Lane 6: BSA std (IOmg); Lane 7: BSA std (5mg); Lane 8: BSA std (2.5mg) and Lane 
9: BSA std (Img). GST-EC2CD9 and GST-EC2CD63 were prepared in two batches. 
The bands corresponding to 25KDa is GST; the band at 35KDa (Red arrow) 
corresponding to GST-EC2CD9 and band at 37KDa (green arrow) GST-EC2CD63 , 
were used for densitometry. 
3.2.4. Effect of GST -EC2 tetraspanins at 201Jg.mr1 on MGC formation 
To further investigate the role of different tetraspanins on Con A induced 
mononuclear phagocyte fusion, the effects of a range of GST-EC2 tetraspanins 
proteins was tested. The GST-EC2 tetraspanins were co-incubated with monocytes 
and Con A for 72hrs in the fusion assay system as described above (Figs.3.2.4 and 
3.2.5). Following staining, the fusion index (no. of nuclei in fused cells/ number of 
nuclei in total %) was determined. 
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Fig.3.2.7. Effects of different GST-EC2 tetraspanins on Con A induced monocyte 
fusion. Monocytes in Lab-Tek® chamber slides were stimulated with Con A 
(lO~g.mrl) for 72hrs in the presence or absence of GST-EC2 tetraspanins or GST 
control as described in section 2.2.10.4.1. The cells were stained with anti CD52-
FITC and PI as described in section 2.2.10.3.2. The number of nuclei in fused and un-
fused cells was counted in 6 randomly chosen fields. Fusion index (no. of nuclei in 
fused cells/ number of nuclei in total xl 00) was calculated. The results with Con A, 
GST, GST-EC2CD63 and GST-EC2C153A are the means of 17 experiments in 
duplicates carried out with monocytes from 12 blood donors; the results of GST-
EC2CD9 are the means of 12 experiments with monocytes from 12 blood donors and 
the results of other GST -EC2 tetraspanins are the means of 3 experiments with 
monocytes from 3 different blood donors. The level of significance between the Con 
A control and different treatment was tested by unpaired t test, where * * * Significant 
at P<O.OOOl; * Significant at P<O.Ol; NS=Non significant. 
From the results it was observed that GST-EC2CD9 and GST-EC2CD63 showed a 
strong and a highly significant (P<O.OOl) inhibitory effect on Con A induced 
monocyte fusion when compared with Con A alone. The inhibitory effect observed 
with GST -EC2CD9 is in agreement with Takeda and co-workers (Takeda et aI, 2003). 
GST proteins alone had no effect on monocyte fusion. In addition GST -EC2CD9 
mutant C153A (a mutation of one the cysteines thought to be involved in EC2 
disulphide bond formation, which is not recognised by conformation-dependent 
antibodies) showed a mild inhibitory effect (P<O.Ol). The other GST-EC2 
tetraspanins CD81 , CD82, CD 151 and mouse CD9 did not show any effect on Con A 
induced monocyte fusion. 
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Fig.3.2.8. Effect of recombinant GST-EC2CD63 at 20llg.mr (0.6IlM) on Con A 
induced monocyte fusion. The conditions were similar as described in Fig.3.2.4. The 
images were captured with a Nikon Eclipse E400 immunofluorescence microscope 
using 20x objective. Monocytes alone (A); Con A (B); Con A+ GST-EC2CD63 (C). 
3.2.5. Dose/response effect of GST -EC2CD63 
Since a role for CD63 in MGC formation had not previously been observed, some 
further experiments concentrated on GST-EC2CD63. Since an inhibitory effect was 
observed with GST-EC2CD63 at 20llg.mr1 (equivalent to O.57IlM) on Con A induced 
monocyte fusion, the dose/response effects of GST-EC2CD63 were examined. 
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Fig.3.2.9. Dose response effects of GST-EC2CD63 on Con A induced monocyte 
fusion. The monocytes in Lab-Tek® chamber slide were stimulated with Con A 
(lOf..l.g.mrI ) for 72hrs in the presence or absence of GST-EC2CD63 at different 
concentrations and the remaining conditions were same as in Fig.3 .2.7. The results of 
GST-EC2CD63 are the means of 6 experiments carried out with monocytes from 5 
blood donors. 
Analysis of the results shows that the concentration of GST-EC2CD63 that has half 
the maximal inhibitory effect (ICso) is 160ng mri or 4.3nM, although as shown later 
there were some variations in the potency observed between experiments (Fig.3.2.9). 
3.2.6. Effect of short incubation of GST -EC2CD63 and GST -EC2CD9 on 
MGC formation 
Since the GST-EC2CD63 and GST-EC2CD9 strongly inhibited the fusion of Con A 
stimulated monocytes at 20f..l.g.mrl , the effect of a short incubation of GST-EC2 
tetraspanins on monocyte fusion was tested as described in section 2.2.1 OA.2. In this 
study the monocytes were incubated with GST-EC2 tetraspanins for 30min. at 37°C. 
After washing to remove the proteins, cells were cultured in presence of Con A for 
72hrs. From the data it was observed that there was still some slight inhibition of the 
fusion process, suggesting that the tetraspanins does not need to be present throughout 
the incubation period of 72hrs. 
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Fig.3.2.10. Effect of short incubation of GST-EC2CD63 and GST-EC2CD9 on Con A 
induced monocyte fusion. The experiment was carried out as described in section 
2.2.10.4.2. The level of significance between the Con A control and different 
treatment was tested by unpaired t test, where ** Significant at P<0.05 ; NS=Non 
significant. The results are the means of 2 experiments carried out with monocytes 
from 2 blood donors. 
3.2.7. Effect of Hiss-tagged tetraspanins at 20J,lg.mr1 on MGC formation 
Although GST alone had no effect on MGC formation, we wished to investigate the 
effects of tetraspanin EC2s where this fusion protein was absent. Highly purified 
His6-tagged EC2 tetraspanins (CD9, CD63 and CD81) were obtained from our 
collaborators Christopher Liu and Richard Hynes (Massachusetts Institute of 
Technology, U.S) and tested for their effects on Con A induced monocyte fusion . In 
this study the above His6-EC2 tetraspanins were tested at 20llg.mrl against Con A 
stimulated monocytes. In addition the effect of GST -EC2CD63 was also tested in 
parallel with His6-EC2CD63 for comparison. 
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Fig.3.2.11. Effects of His6-EC2 tet:aspanins o? Con A ~duced monocyte ~sion. 
Monocytes in Lab-Tek® chamber shdes were stunulated WIth Con A (l Ollg·ml ) fo r 
72hrs in the presence or absence of His6-EC2/GST-EC2 tetraspanins at 20llg·mr l as 
described in section 2.2.10.4.1. The results are the means of 4 experiments carried out 
with monocytes from 2 blood donors. The level of significance between the Con A 
h *** S· ·fi control and treatment group was tested by unpaired t test, w ere 19ru lcant at 
P<O.OOOl ; * Significant at P<O.Ol ; NS=Non significant at P<0.05. 
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A strong highly significant inhibition in fusion was observed with His6-EC2CD63 
(P<O.OOOI) when compared to the Con A control, where as His6-EC2CD9 showed a 
slight, but significant (P<O.OI) inhibition. No inhibition in fusion was observed with 
His6-EC2CD81. These results are in general agreement with results observed with the 
GST-EC2 proteins, although GST-EC2CD9 appeared to inhibit fusion more strongly. 
The inhibitory effect of His6-EC2CD63 and GST-EC2CD63 were similar at 20l-lg.ml-1 
3.2.8. Dose/response of His6-EC2CD63 and EC2CD63 
The dose/response effect of His6-EC2CD63 and EC2CD63 (generated by thrombin 
cleavage of GST-EC2CD63) on monocyte fusion was examined as described ill 
section 2.2.10.4.1. The dose/response effect of GST-EC2CD63 was examined ill 
parallel for comparison. 
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Fig.3.2.12. Dose response effect of His6-EC2CD63IEC2CD63/GST -EC2CD63 on 
Con A induced monocyte fusion. Monocytes in Lab-Tek® chamber slide were 
stimulated with Con A (l0I-lg.mr1) for 72hrs in the presence or absence of His-
EC2CD63IEC2CD63/GST-EC2CD63. The results of His6-EC2CD63 are the means of 
5 experiments carried out with monocytes from 3 blood donors; EC2CD63 are the 
means of 4 experiments carried out with monocytes from 3 blood donors ; GST-
EC2CD63 are the means of 4 experiments carried out with monocytes from 3 blood 
donors. 
All preparations of recombinant CD63 inhibited MGC formation. The EC2CD63 
showed an ICso value of 69ng.mr1 or 5.8nM. The latter value is similar to that 
observed overall with the GST-EC2CD63 (section 3.2.5). However, in this set of 
experiments, the GST-EC2CD63 was less potent (ICso of 2.5I-lg.mr 1 or 68nM). 
Possible reasons for these types of variations are discussed in Discussion 3.3. The 
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His6-EC2CD63 gave very potent inhibition, that was not titrated out in these 
experiments. This was unexpected, and ideally this titration would have been 
repeated. 
3.2.9. Effect of bacterial lipopolysaccharide (LPS) on monocyte fusion 
Since recombinant proteins were used for these studies, there were concerns that LPS 
present as a contaminant in GST-EC2 tetraspanin preparations (produced in E. coli) 
might inhibit the fusion of monocytes (Takashima et aI, 1993). Therefore, we 
investigated the effects of bacterial cell wall protein LPS at 20, 10 and 2llg.mr1 on 
unstimulated or Con A stimulated monocytes as described in section 2.2.10.4 .1. 
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Fig.3.2.13. Effect of bacterial lipopolysaccharide (LPS) on monocyte fusion. 
Monocytes in Lab-Tek® chamber slide were stimulated with/without Con A (10Ilg·mr 
I) for 72hrs in the presence or absence of LPS at 2 Ilg.mr I. The results are the means 
of 2 experiments carried out in duplicate with monocytes from 1 blood donor. 
From this study it was observed that LPS did not show any inhibitory effect on the 
fusion of monocytes. By contrast, LPS alone at 2llg.mr1 induced the fusion of 
monocyte in the absence of Con A. The fusion index shown by LPS (2Ilg.ml-1) in 
presence of Con A was 92.89%, very close to the fusion index of Con A control 
(92.99%). LPS alone at 2llg.mrl induced fusion in the absence of Con A and its 
fusion index was 71.69%. The size of the MGCs produced by LPS in the absence of 
Con A was smaller (4 -10 nuclei) than the MGCs produced in presence of Con A. In 
addition LPS produced Langhans type of MGCs with Con A stimulated monocytes (~ 
>50 nuclei); this effect is similar to the effect reported with muramyl dipeptide 
(Mizuno et aI, 2001). Interestingly LPS promoted the adhesion of monocytes to the 
culture surface in the absence of Con A. The size of MGCs produced by LPS in 
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presence of Con A was very large when compared to the MGCs of Con A stimulated 
monocytes alone. Thus it appears that LPS may actually enhance Con A induced 
fusion. 
Fig. 3.2.14. Effect of LPS on unstimulated and Con A stimulated monocytes. The 
conditions were as described in Fig.3 .2.4. Monocytes alone (A); Con A (10~g.ml-l) 
(B); No Con A+LPS at 2Jlg.ml-I(C); Con A+ LPS at 2Jlg.ml-1• (D). The images were 
captured with a Nikon Eclipse E400 immunofluorescence microscope using 20x 
objective. 
3.2.10. Studies on the rate of MGC formation 
The rate at which the multinucleated giant cells (MGCs) are forming in response to 
Con A stimulation was examined at different time points (24hrs, 48hrs and 72hrs). 
These study showed that although optimum (i.e. largest size) MGC formation was 
observed after 72hrs (in agreement with previous reports (Chiozzi et aI, 1997)), 
smaller MGCs were observed after 24hrs. The effects of GST-EC2 tetraspanin on the 
formation of MGC at these stages were examined. As shown in Fig.3.2.15 inhibition 
of MGC formation by GST -EC2CD63 and GST -EC2CD9 was observed from 24hr 
onwards. Slight inhibition by GST-EC2CD9CI53A was observed only after 72hrs. 
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Fig.3.2.15. Effect of GST-EC2 tetraspanins on rate of MGCs formation. The 
experiment was carried out as described in section 2.2.10.4.1 in Lab-Tek chamber 
slide using 20~g.mrl concentration of GST-EC2 tetraspanins; fusion index was 
calculated on day 1, day 2 and day 3. The results are the means of 2 experiments 
carried out with monocytes from 2 different blood donors. The level of significance 
between Con A and different treatments were tested by unpaired t test where * * * 
Significant at P<O.OOOI ; ** Significant at P<O.OOI ; NS=Non significant at P<0.05. 
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Fig. 3.2.16. Effect of tetraspanins on rate of MGCs formation. The experiment was 
carried out as described in section 2.2.10.4.1 in Lab-Tek® chamber slide consecutively 
for three days: day 1, day 2 and day 3. The cells were stained with anti CD52-FITC 
antibody and nuclei stained with propidium iodide as described in section 2.2.10.3.2. 
The images were captured with Nikon Eclipse E400 immunofluorescence microscope 
using 20x objective. Con A alone (A); Con A+ GST-EC2CD9 (B); Con A+ GST-
EC2CD63 (C); Con A+ GST-EC2CI53A (D); GST (E). 
Similarly the rate at which the multinucleated giant cells (MGCs) are forming in 
response to Con A stimulation was examined after 2hrs. 2hrs of Con A stimulation 
induced aggregation and there was evidence of monocyte fusion within these 
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aggregates (fusion index of 30-40%). The fused cells neither resembled Langhans or 
FBGC types of MGCs. This suggests that some fusion occurs within a short period of 
time in response to Con A but these do not yet correspond in morphology to MGCs 
(Fig.3.2.17). 
(A) (B) 
Fig.3.2.17. Effect of2hrs Con A treatment on monocytes. The experiment was carried 
out as described in section 2.2.10.3.2 in Lab-Tek® chamber slide. The cells were 
stained with anti CD52-FITC antibody and nuclei stained with propidium iodide. The 
images were captured with a Nikon Eclipse E400 immunofluorescence microscope 
using 20x objective. Unstimulated monocytes (A); 2hrs Con A stimulated monocytes 
(B). An arrow represents the fusing/fused monocytes. 
3.2.11. Studies with THP-1 cells and macrophages from CD9WT and 
CD9-1- mice 
3.2.11.1. Stimulation of THP-1 cells with Con A 
An attempt was made to stimulate the monocytic leukaemic cell line THP-1 with Con 
A to fuse in Lab-Tek® chamber slides pre-coated with/without poly L-Iysine 
(50J.lg.mr i ) (poly L-Iysine allows THP-l cells, which normally grow in suspension, to 
become adherent). THP-l cells were incubated with Con A at different final 
concentrations and monitored for up to 72hrs as described in section 2.2.10.3.2. At all 
concentrations, Con A induced aggregation of THP-l cells, but not fusion. 
3.2.11.2. Stimulation of THP-1 cells with Con A conditioned medium 
Previous experiments showed that Con A was not capable of inducing the fusion of 
THP-l cells hence an another attempt was made to fuse THP-l cells with Con A 
conditioned medium (a supernatant from monocytes and lymphocytes cultured in the 
presence of Con A for 2hrs or 72hrs), since Con A conditioned medium is known to 
be capable of inducing the fusion of monocytes (Postlethwaite et ai, 1982; Weinberg 
et ai, 1984; Most et ai, 1990). In this assay the monocytes cultured for 24hrs, 48hr 
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and 72hrs in presence of Con A conditioned medium by replacing the whole of the 
culture medium. The results showed that Con A conditioned medium did not induce 
the fusion of THP-1 cells. 
3.2.11.3. Studies with macrophages from CD9WT and CD9-1- mice 
Attempts to induce the fusion of macrophages derived from CD9-1- (knockout) and 
CD9WT mouse were made (The macrophage cell lines were kindly provided by 
Gabriela Dveksler, Dept. PathoL Uniformed Services University of Health Sciences, 
Bethesda, MD, US) (Ha et ai, 2005). Cells were cultured in Lab-Tek® chamber slides 
with Con A at a final concentration of 10~g.mrl as described in 2.2.10.3.2 for 2hrs, 
24hrs, 48hrs and 72hrs. Concentrations of cells were varied from 1-
5x105cells.chambe(l. However no fusion of macro phages from CD9WT and CD9KO 
mouse was observed. Con A caused some aggregation of macrophages of CD9-1-
mouse but not with the cells from CD9WT mouse (Fig.3.2.18). 
Fig.3.2.18. Effect of Con A stimulation on ~D9WT and ~D9K~ mouse ma~rophages . 
2x 1 05 cells were seeded in to a Lab-Tek chamber slIdes, stunulated WIth Con A 
(10~g.mrl) for 2hrs. CD9WT + No Con A (A) ; .CD9W~ +. Con A (B); CD9KO + ~o 
Con A (C); CD9KO + Con A (D). The light ffilcroscopiC lffiages were captured WIth 
Nikon inverted microscope using 20x objective. 
116 
Preliminary microscopic observation indicated that Con A might be preferentially 
promoting division of CD9-1- macrophages. Therefore the effect of Con A on 
proliferation of macrophages from CD9WT and CD9-1- mouse was assessed by SRB 
assay (2.2.10.5.2.1). No significant difference in cell numbers between the no Con 
AlCon A treated CD9WT and CD9-1- cells was observed. 
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Fig.3.2.19. Effect of Con A on cell proliferation of macrophages from CD9-1- and 
CD9WT mouse by SRB assay. Cells were plated at 9 x 104 cells.welr l in 96 well 
microtitre plate, with/without Con A (final concentration of IOflg.ml-l) for 24hrs at 
37°C. The cells were fixed with TCA and SRB assay was carried out as described in 
section 2.2.10.5.2.1. The results are the means of 1 experiment carried out in 
quadruplicate. 
An attempt was made to induce fusion of CD9KO and CD9WT mouse macrophages 
with various concentrations of TNF -a (instead of Con A) for 24hrs, 48hrs and 72hrs at 
37°C as per the method described in section 2.2.10.3.2. The study showed that TNF-a 
was not capable of inducing the monocyte fusion. 
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3.3. DISCUSSION 
3.3.1. Monocyte cell fusion assay 
The data presented in this chapter details the role of anti tetraspanin antibodies and 
GST fusion proteins of EC2 tetraspanins on monocyte fusion. Initially monocyte 
isolation, culture, stimulation in 96 well microtitre plates and staining with Wright 
stain were carried out as described by Takeda and co-workers (Takeda et ai, 2003). 
Although cell fusion was observed, staining of cells was not clear and the numbers of 
nuclei in fused cells were difficult to enumerate. Thereafter experiments were carried 
out in Lab-Tek® chamber slides; the cell membrane and nuclei stained with FITC 
labelled antibody (anti-CD52) and propidium iodide respectively. 
The effect of Con A on monocytes was tested using this system. Con A induced the 
monocytes to become MGCs, which were mainly Langhans' type (with a circular 
peripheral arrangement of nuclei or horseshoe shaped arranged nuclei) although some 
foreign body type were also seen (Van der Rhee et ai, 1979; McNally and Anderson 
et ai, 1995; Mizuno et ai, 2004). The variations in the type ofMGCs formed might be 
due to variability between the experiments such as different batches of Con A or more 
likely, the use of monocytes from different donors. As described in chapter 1, 
Langhans' type and foreign type MGCs are thought to be mainly induced by Thl and 
Th2 type cytokines, respectively (Anderson, 2000). Contaminating lymphocytes were 
certainly present and it might be expected that they would produced cytokines in 
response to Con A stimulation, and the type produced might influence the type of 
MGCs formed. It has been reported that there were highly significant inter-individual 
variations in the production of different cytokines (IL-l~, IL-2, TNF-a, IL-I0, INF-y ) 
when the mononuclear cells were stimulated with Con A or LPS. This suggested that 
the level of production of this cytokine is characteristic of an individual (Yaqoob et 
ai, 1999). Similarly Whitney and co-workers found a significant gender bias in 
expression of IFN -GR2, the ~ chain of the INF -y receptor complex in peripheral blood 
mononuclear cells, which has been implicated as a potentially important factor in 
determining the number of functional receptor complexes that transduce INF -y signals 
(Whitney et ai, 2003). 
In addition it was noted that Con A-induced MGCs strongly adhere to the culture 
surface compared with unstimulated monocytes. McNally and Anderson reported 
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increased expression of ~1 integrins during the formation of foreign body type MGCs 
in vitro, and showed that whilst ~2 integrins were important in initial adhesion of 
monocytes, both ~1 and ~2 integrins were involved in adhesion of MGCs (McNally 
and Anderson 2002). 
As discussed in chapter 1 (1.2.4.) different researchers have suggested different 
mechanisms involved in Con A induced MGC formation. Con A conditioned medium 
i.e. supernatant of Con A stimulated peripheral blood mononuclear cells readily 
caused generation of MGCs (Abe et ai, 1986; Most et ai, 1990) and this effect was 
completely abrogated by monoclonal antibody to IFN-y (Most et ai, 1990). Purified 
recombinant IFN-y from E.coli also produced MGCs from monocyte (Weingberg et 
ai, (1984). In contrast, it was reported that MGCs could be formed by incubating 
highly purified monocytes with Con A alone (Takashima et ai, 1993). In this system 
it was claimed that INF -y produced by contaminating lymphocytes was not 
responsible for Con A induced MGC formation, since formation was not inhibited by 
anti- INF-y antibodies (Takashima et ai, 1993). Instead the authors found that TNF-a 
plays a central role in MGC formation, since antibodies to this cytokine caused 
inhibition. This was not addressed in our study, but the rate of formation and type of 
MGCs (mainly Langhans, containing high numbers of nuclei) were consistent with 
that described by Takashima and co-workers. 
3.3.2.Effects of monoclonal antibodies 
In the first instance the effect of anti CD9 and anti CD63 antibodies was tested on 
MGC formation. The anti CD9 antibodies Alma-l (Azorsa et ai, 1999) and 602.29 
(Andrews et ai, 1981) strongly enhanced the fusion of Con A stimulated monocytes 
and produced larger MGCs with many nuclei compared with the Con A control. By 
contrast, anti CD63 antibodies H5C6 (IgG) (Azorsa et ai, 1991), 16.1, 16.5 (Skubitz 
et ai, 1996), LP9 (IgM) (Smith et ai, 1995), BEM-l (IgA) (McCullough et ai, 1997) 
and the Fab fragment of H5C6 inhibited MGC formation and produced MGCs with 
few nuclei. It is very interesting that the IgG, IgM and IgA anti tetraspanin antibodies 
showed similar inhibitory effects and the results suggest that the inhibitory effect of 
the anti CD63 antibody is not mediated through Fc gamma receptors. In addition, the 
finding that highly purified Fab fragments inhibit MGC formation demonstrates that 
inhibition is independent of antibody cross-linking. The Fab fragments of H5C6 
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appeared to show a better inhibition of fusion than the whole molecules IgG; 
however, the molar concentration of Fab antibody (OAJlM) is 3x higher than the 
whole IgG molecule (0.14JlM) in these experiments. The exact mechanism in which 
the anti tetraspanin antibodies are affecting MGC formation is presently unknown. 
The results that we observed with the anti CD9 antibodies are in agreement with 
Takeda and co-workers (Takeda et aI, 2003). However our studies showed that anti 
CD63 antibodies strongly inhibited the Con A induced MGC formation whereas they 
found no effect with their anti CD63 antibody. The difference in results may be due 
the fact that different anti-CD63 antibodies were used, that may differ potency or in 
the epitopes recognised. As discussed in chapter 1 (1.1.5.2.) cell surface CD63 is 
rapidly internalised on antibody cross-linking (Audran et aI, 1995; Barrio et aI, 1998). 
The rate of internalisation is little reduced even when monovalent Fab fragments are 
used (Mantegazza et aI, 2004; G. Mal , PhD Thesis, University of Sheffield, 2005). 
Inhibition of MGC formation by anti-CD63 antibodies might therefore be due to 
internalisation of CD63 or a molecule that it interacts with. 
3.3.3. Effects of EC2 tetraspanins 
Based on the observations with anti tetraspanin antibodies, the effects of GST-EC2 
tetraspanins (CD9, CD63, CD81, CD82 and CD151) on MGC formation was tested. 
In addition, murine CD9 EC2 and a CD9 EC2 mutant (CI53A) were tested. Cysteine 
153 is likely to be involved in formation of the subloop structure of CD9-EC2 
(Kitadokoro et aI, 2001) and this mutant is not recognised by conformation-dependent 
antibodies. The GST-EC2CD9 and GST-EC2CD63 showed a strong and highly 
significant inhibitory effect at 20Jlg.mr l (0.57JlM and 0.55JlM respectively). No 
effect was observed with GST-EC2CD81, GST-EC2CD82, GST-EC2CDI51 and 
mouse GST-EC2CD9. There is therefore some evidence of sequence specificity for 
CD9, since mouse CD9 shows 77% sequence identity with human in the EC2. A 
slight inhibitory effect was observed with the GST-EC2CD9 mutant C153A, 
indicating that regions outside of the variable sub loop region of CD9 EC2 might be 
involved. GST-EC2CD9 mutant C153A also showed some inhibitory effect on the 
infection of macrophages by HIV-l infection (Ho et aI, unpublished observation), 
indicating that it may have some biological activity. 
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Takeda and co-workers also showed that GST-EC2CD9 human inhibited MGC 
formation, whereas GST-EC2CD9 mouse had no effect. However, they showed that 
anti CD81 antibodies, like anti CD9 antibodies, enhanced fusion. If, as they argued, 
both CD9 and CD81 were acting as negative regulators of fusion, it might be expected 
that GST-EC2CD81 would also inhibit. This was not the case in our studies. The 
GST-EC2CD81 used here was correctly folded, as determined using conformation 
specific antibodies. It has also been shown to have biological activity in other assays 
such as inhibition of HCV protein E2 binding (Higginbottom et ai, 2000) and 
inhibition of HIV -1 infection of human monocytes (Ho et ai, 2005 manuscript 
submitted). Our results are therefore not consistent with a negative regulatory role for 
CD81 in MGC formation. The enhancement of fusion observed by Takeda et ai, with 
anti CD81 antibodies may have been due to indirect effects e.g. due to the association 
of CD81 with CD9 in TEMs (Takeda et ai, 2003). 
The effect of a short incubation with GST-EC2CD63 and GST-EC2CD9 on Con A 
stimulated monocyte fusion was tested. Monocytes were pre incubated with the GST-
EC2 tetraspanins for 30 min. at 37°C, then the cells were washed to remove excess 
GST-EC2 before being cultured for 72hrs in presence of Con A. The results showed 
slight inhibition of MGC formation, suggesting that the tetraspanins does not need to 
be present throughout the incubation period. If time had permitted, it would have been 
useful to repeat this, removing the GST-EC2s after various time points. 
Although GST alone had no effect on MGC formation, it was possible that the GST 
component of GST-EC2CD63 and GST-EC2CD9 might affect their biological 
activity. To investigate this, MGC formation assays using highly purified His6 tagged 
EC2CD63, CD9, CD81 and GST-EC2CD63 at 20J.1g.mr I was carried out. In addition 
CD63 EC2 generated from GST-EC2CD63 by thrombin cleavage (by Francine Martin 
of the group) was tested. His6 protein samples were obtained from collaborators 
Christopher Liu and Richard Hynes (Massachusetts Institute of Technology, U.S). 
These had been purified and analysed by reverse-phase HPLC connected to an LCQ 
electro spray mass spectrometer (Finnigan-MAT, San Jose, CA), which allows 
purification of correct conformers. The folding of the proteins was also tested by 
using conformation specific antibodies. His6-EC2CD63 showed a highly significant 
(P<O.OOOl) inhibitory effect, which is comparable with GST-EC2CD63 but His6-
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EC2CD9 showed little (P<O.Ol) inhibition; no effect was observed with His6-
EC2CD81. The reduced effect with His6-EC2CD9 may indicate that GST enhances 
the activity of EC2CD9. 
Dose/response effects were investigated for GST-EC2CD63, EC2CD63 (generated by 
thrombin cleavage from GST-EC2CD63) and His6-EC2CD63. GST-EC2CD63 and 
EC2CD63 gave similar levels of inhibition overall, with IC50 values in the nanomolar 
range. This indicates a very potent effect on MGC formation. Interestingly, the GST-
EC2CD63 has been also shown to inhibit HN infection of macrophages at the 
nanomolar concentrations (P. Monk, Academic Unit of Neurology, University of 
Sheffield, personal communication and see chapter 5). However, the dose/response 
curves did highlight some variations between sets of experiments. This may be partly 
due to donor variation, and some individuals may be more sensitive to inhibition of 
MGC formation by tetraspanin EC2s. However, it is likely that there may also be 
variations between different batches of the same recombinant tetraspanin. Hence 
although correctly folded protein was checked for using conformation-sensitive 
antibodies, the proportion of correctly folded protein may have varied between 
preparations. Also some free GST was present in the preparations and the amount of 
this might vary between batches. As found above, free GST had no effect on MGC 
formation, but it might be affecting the activity of GST-EC2s. The His6-EC2CD63 did 
not titrate out well in these experiments and it would be useful to repeat this if more 
His6-EC2CD63 was available. 
It is also interesting that complete inhibition of MGC formation was not observed, 
even at the higher concentrations of GST-EC2s. However, MGCs at these higher 
concentrations tended to be much smaller and contain fewer numbers of nuclei as 
seen in microscopy images (e.g. Figures 3.2.8. and 3.2.16). In retrospect, it may have 
also been useful here to compare the number of nuclei present in MGCs, rather than 
using the conventional fusion index term. 
3.3.4. Effects of LPS in monocyte fusion 
It has been reported that bacterial proteins can affect MGC formation. Muramyl 
dipeptide (MDP) from bacterial cell walls evokes epitheliod cell granulomas (Eishi. Y 
1994) and MDP has significantly increased the MGC formation when used with 
conditioned medium from Concanavalin A stimulated peripheral blood monocytes 
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(Mizuno et ai, 2001). In contrast Takashima and co-workers reported that in spite of 
the ability to activate monocytes to produce TNF-a, lipopolysacharide (LPS) inhibited 
MGC formation (Takashima et ai, 1993). Since GST-EC2 tetraspanins were 
produced from the E. coli, we were concerned that LPS could be a possible 
contaminant present in some GST-EC2 preparations. Therefore, the effect of LPS on 
monocyte fusion was tested, since CD 14 of monocyte acts as a receptor for LPS and 
induces the synthesis of TNF -a (Barclay et ai, 1997). High concentration of LPS in 
the presence of Con A did not inhibit the fusion; by contrast, LPS treated cells showed 
a higher fusion index than untreated cells. The treatment of monocytes with LPS 
produced Langhans type of MGCs in presence of Con A and this effect is similar to 
muramyl dipeptide (Mizuno et ai, 2001); LPS alone in the absence of Con A 
produced much smaller MGCs. Interestingly, LPS appeared to promote the adhesion 
of monocytes to the culture surface. This might be due its interaction with CD 14, 
promoting the adhesive activity of CDII b/CDI8, since these types of interaction have 
been observed with neutrophils (Barclay et ai, 1997). It is concluded that the 
inhibitory effect shown by GST-EC2CD63 and GST-EC2CD9 on Con A induced 
MGC formation is not due to LPS contaminants of GST of proteins. 
3.3.S.Rate of MGC formation 
The rate of MGC formation was examined. As reported by others, although MGC 
formation was maximal at 72hrs, MGCs could be observed within 24hrs (Takashima 
et ai, 1993; Takeda et ai, 2003). Inhibition ofMGC formation by GST-EC2CD63 and 
GST -EC2CD9 was observed form 24hrs onwards, showing that the proteins are active 
before this time. 
The effect of Con A stimulation on MGCs formation was examined after 2hrs of Con 
A stimulation. The result showed that 2hrs. Con A stimulation induced monocyte 
aggregation and cell fusion, but the fused cells neither resembled Langhans' nor 
FBGC types of MGCs. It may be that the formation of MGCs with typical 
morphology takes longer, or that more time is needed for the concentration of 
cytokines involved in cell fusion to increase. 
3.3.6. Studies with monocyte cell lines 
Since it was difficult always to get a good supply of fresh human monoc)1es from 
volunteers, some attempts were made to see if MGC formation could be induced from 
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cell lines. The THP-1 cell line was chosen, since it is thought to have the most mature 
phenotype of commonly available monocyte cell lines (Auwerx et ai, 1991). Con A 
alone induced aggregation of THP-1 cells, but no fusion. Fusion was also not induced 
with Con A conditioned medium, which is presumed to contain cytokines that induce 
fusion (Takashima et ai, 1993; Most et ai, 1990; Mizuno et ai, 2000). It may be that 
THP-1 cells lack components of the fusion mechanism (e.g. cell surface fusion 
receptors), or require different stimulants to blood monocytes. 
An attempt was made to induce fusion in a macrophage cell lines derived from CD9-1-
(knockout) and CD9WT mice. These cell lines were used successfully by Dr.Dveksler 
to study the functional properties of pregnancy specific glycoproteins (PSGs) (Ha et 
ai, 2005). No fusion of macrophages from CD9 WT and CD9-1- mouse was observed 
with Con A, but some aggregation of CD9-1- cells but not CD9 WT was observed. 
Since TNF-u is reported to promote MGC formation (Takashima et ai, 1993), the 
effects of this cytokine were also investigated, but no fusion was observed. Takeda et 
ai, (2003) reported enhanced fusion in vitro with macrophages from CD9-1- mice. 
However, they used freshly isolated alveolar and bone marrow macrophages and 
stimulated them with 1u25(OH)2D3 and splenocyte conditioned medium. If different 
agents had been tested it may have been possible to induce fusion of the CD9-1-
macrophage cell line in vitro. 
Overall, our results with anti CD9 antibodies enhancing MGC formation of Con A 
stimulated monocytes and EC2CD9 inhibiting are in agreement with Takeda and co-
workers. They are consistent with their hypothesis that CD9 normally plays a negative 
role in monocyte fusion (Takeda et ai, 2003). In contrast, we found an inhibitory 
effect with anti CD63 antibodies and EC2CD63 on Con A stimulated monocytes. This 
suggests a positive role for CD63 in MGC formation. The inhibition of MGC 
formation seen with the EC2 regions indicates that they may interact directly with a 
type of receptor that is involved in controlling fusion. However it is also possible that 
the recombinant EC2 proteins may be affecting processes in MGC formation that 
precede fusion such as cell adhesion, aggregation etc. Investigations into this form the 
basis of experiments described in the next chapter. 
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CIIAP'l~ER 4 
EFFECTS OF EC2 TETRASPANINS ON 
FUNCTIONS RELATED TO MONOCYTE FUSION 
4.1. INTRODUCTION 
This chapter explores the possible involvement of tetraspanins in functions related to 
fusion. The results described in the previous chapter indicated that tetraspanin CD63 
and CD9 playa role in MGC formation. At this stage, however, it was not clear 
whether the tetraspanins were involved in the monocyte fusion mechanism, or events 
that precede this. In order for MGC formation to occur, monocytes must be adherent, 
and able to come together to reach a "critical density" (cell aggregation) (Vignery, 
2000). The experiments described in this chapter therefore attempted to investigate 
whether the GST-EC2 tetraspanins might be affecting these functions. 
4.1.1. Cell adhesion 
Cell adhesion is an important step involved in monocyte mediated MGCs formation 
(McNally et ai, 1995; McNally et ai, 2002; Brodbeck et ai, 2002). Adhesion of 
monocytes to glass/plastic surfaces in vitro is believed to be due to interactions of 
monocytes receptors with proteins, such as ECM components, that have been 
adsorbed to the surfaces (McNally and Anderson, 1994; Jenney and Anderson, 1999). 
Adhesion to ECM proteins is mediated predominantly by integrins. For monocytes, 
the ~ 1 (CD29) integrin family are known to be involved in attachment to ECM 
proteins: a1~1 and a2~1 (collagens and laminins), a4~1 (fibronectin), a5~1 
(fibronectin) and a6~1 (laminins) (de Fougerolles and Koteliansky, 2002). The last 
three integrins are well expressed by monocytes, whereas a 1 ~ 1 is induced on 
activation (de Fougerolles and Koteliansky, 2002). Monocytes also express ~2 
integrins, aM~2 (CD11b/CD18) and aX~2 (CD11c/CD18) that are reported to interact 
with a wide range of ligands including C3bi and fibrinogen (Barclay et ai, 1997) that 
may adsorb to the surfaces from serum (McNally and Anderson, 2002). Boissyand 
co-workers reported that avfJ3 (CD51 and CD61) is a key integrin expressed by 
monocytes, which is mediating adhesion of multinucleated osteoclasts during bone 
resorption and stimulation (Boissy et ai, 1998). 
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CD9 is reported to associate with all of the ~ 1 integrins described above and 
associations of CD63 with a3~1, a4~1 and a6~1 have been observed (see chapter 1, 
1.1.4.2; reviewed in Berditchevski, 2001; Tarrant et ai, 2003). There is evidence that 
CD63 associates with ~2 integrins on leukocytes (Skubitz et ai, 1996; Mantegazza et 
ai, 2004). Whilst tetraspanins are generally not thought to be involved in static cell 
adhesion mediated by integrins, there is evidence that they affect cell spreading. 
morphology and integrin-dependent migration (Hemler, 2003). The involvement of 
tetraspanins in adhesion-dependent signalling might be linked with their ability to 
recruit certain signalling enzymes into the integrin complexes (see chapter 1. 1.1.4.3: 
Berditchevski, 2001). 
McN ally and Anderson have investigated monocyte membrane proteins that mediate 
adhesion during the formation of FBGC in vitro. In their system, adherent monocytes 
are allowed to differentiate in culture for 3 days, and then FBGC formation is induced 
by addition of IL-4 (McNally and Anderson, 2002). Using specific antibodies, they 
demonstrated that initially adhesion of monocytes to culture surfaces (within 1hr of 
plating) was specifically inhibited by anti ~2 integrin antibodies, but not by anti ~ 1 
integrin antibodies. However, macrophage/FBGC adhesion following IL-4 treatment 
was reduced by both anti ~2 and anti ~ 1 antibodies. Whilst anti ~2 antibodies also 
appeared to inhibit FBGC formation, this was not the case for anti ~2 antibodies. The 
authors concluded that whilst initial monocyte adhesion was strongly dependent on ~2 
integrins, the ~ 1 and ~2 integrins play a co-operative role in cell adhesion during 
macrophage fusion and FBGC formation (McNally and Anderson, 2002). Consistent 
with this, they observed expression of ~2 integrins on both initially adherent 
monocytes and macrophagelFBGCs, whereas ~ 1 staining was not observed initially 
but increased during macrophage differentiation and fusion. In fusing macrophages, 
~ 1 integrins were observed throughout the cytoplasm. In multinucleated FBGCs, ~ 1 
integrins were observed to be most concentrated in central cytoplasmic areas 
(McNally et ai, 2002). 
It is not known whether ~ 1 and ~2 integrins play similar roles in the adhesion and 
formation of Langhans' giant cells. However, Takeda and co-workers found that 
antibodies to ~ I and ~2 integrins inhibited the adhesion of monocytes induced with 
Con A. Anti ~2 antibodies were also shown to inhibit MGC formation of monocytes 
cultured with IFN-y containing mononuclear cell supernatants (Most et ai, 1990: 
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Gasser and Most, 1999). However, this may have been due to inhibition of cell 
aggregation, since anti ICAM1 antibodies were also inhibitory to some extent (Most 
et ai, 1990). 
4.1.2. Cell proliferation/cytotoxicity 
In order to fuse, monocytes must also reach a "critical cell density" (Vignery, 2003). 
Since monocytes are not thought to undergo proliferation in vitro (Weinberg et ai, 
1984) this is likely to be achieved by migration of the plated cells to form aggregates. 
However, in the Con A induction system used here, it is likely that contaminating T 
lymphocytes will divide in response to the mitogen (Baral et ai, 2004; Rashid et ai, 
2005) and that this may be critical in generating sufficient cytokines for MGC 
formation. The possibility that the recombinant proteins were having cytotoxic effect 
was also considered. Hence the effect of GST -EC2 tetraspanin on monocyte adhesion 
and cell numbers or cytotoxic effects was measured by SRB (Sulforhodamine B) 
assay. The SRB assay is a rapid, highly sensitive and inexpensive method of 
measuring the cell numbers in 96 well microtitre plate as a function of protein content 
of cells using a spectrophotometer by measuring the OD@570nm. The relationship of 
cell protein content is linear with cell number over a broad range of cell densities 
(Skehan et ai, 1990). The proliferation/cytotoxicity assay was not carried out using 
pure populations of monocytes since the monocyte preparations always contained 
contaminating lymphocytes, hence the Con A may affect the cell numbers of 
lymphocytes. 
4.1.3. Cell migration and aggregation 
There are numerous reports that tetraspanins are involved in the motility of various 
cells types (see chapter 1, 1.1.5.1; reviewed by Berditchevsky, 2001). Most recently 
Mantegazza and co workers reported that mAb directed to CD9, CD63, CD81 and 
CD82 increased the chemokine-induced migration of immature dendritic cells 
(Mantegazza et ai, 2004). Similarly, there is a great deal of evidence that tetraspanins 
play a role in homotypic or heterotypic cell:cell interactions (Berditchevski, 2001; 
Yanez-Mo et ai, 2001). Whilst Takeda and co-workers reported that their anti 
tetraspanin antibodies had no inhibitory effect on monocyte aggregation in response 
to Con A, it was possible that the recombinant EC2 regions might affect cell:cell 
interactions. Masumoto and co-workers reported that antibody to CD9 significantly 
induced the aggregation of eosinophils (Matsumoto et ai, 1999); anti CD9 antibodies 
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are also involved in aggregation and activation of platelets through interaction with Fc 
receptors (Worthington et ai, 1990). 
4.1.4. Membrane expression of tetraspanins 
In the present chapter we analysed the involvement of tetraspanins and integrins on 
monocyte fusion by comparing their expression levels during normal and fusogenic 
conditions. Takeda and co-workers found that under the normal culture conditions the 
expression of CD9 and CD81 were up regulated, reached a peak at ~2day, and were 
sustained until 3 day after incubation. CD63 also appeared to be gradually up 
regulated. The up regulation of CD9 and CD81 was inhibited when the monocytes 
were cultured in the presence of Con A; in contrast to these, the up regulation of 
CD63 was enhanced in the presence of Con A. Takeda and co-workers further 
reported that during normal culture conditions, the complexes of CD9 and CD81 with 
integrins ~l and ~2 were also up-regulated but during the fusogenic conditions in 
presence of Con A the tetraspanin-integrin complexes were down regulated (Takeda 
et ai, 2003). The overall expression of ~l and ~2 was reported to be little affected. By 
contrast, as mentioned previously, McNally and Anderson reported that there was 
little expression of ~l integrin initially in their system, but that expression increased in 
culture/fusogenic conditions (McNally and Anderson, 2002). Takeda and co-workers 
used immunoprecipitation and immunoblotting techniques to analyse the effect of 
Con A on the expression pattern of tetraspanins CD9, CD63 and CD81 and its 
association with integrins in monocytes. Thus they were looking at total cellular 
expression. We used F ACS analysis to try to assess the cell surface expression levels 
oftetraspanins and integrins. 
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4.2. RESULTS 
4.2.1. Effect of GST-EC2 tetraspanins on monocyte adhesion: Lab-Tek® 
chamber slide assay 
To investigate possible effects of the GST -EC2 tetraspanins on adhesion, initially 
their effects on adhesion of unstimulated monocytes were assessed by incubating with 
monocytes in Lab-Tek® chamber slides for 72hrs as described in 2.2.10.5.l. 
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FigA.2.1. The effect of GST-EC2 tetraspanins on the adhesion of unstimulated 
mono cyte s cultured at 5 x 105 cells.chamber-l in a Lab-Tek® chamber slide 
with/without GST-EC2 tetraspanins/GST at 20Jlg.mr l for 72hrs (section 2.2.10.5.1). 
The slide was processed and stained with FITC labelled anti CD52 antibody as 
described in section 2.2.10.3.2. The numbers of cells were counted in 6 randomly 
chosen fields. The results are the means of 2 experiments carried out in duplicate with 
monocytes from 2 blood donors. The level of significance between the monocyte 
alone and different treatments was tested by unpaired t test, where * * Significant at 
P<0.005 ; * Significant at P<0.05. Unpaired t test showed no significant enhancement 
of adhesion by GST-EC2CD63 and GST-EC2CD9 when compared to GST control. 
The results showed that both GST-EC2CD9 and GST-EC2CD63 did not inhibit the 
adhesion of monocytes. Interestingly these recombinant proteins significantly 
(P<0.005) enhanced the adhesion of monocytes compared to monocytes alone or 
monocytes incubated with GST (P<0.05). The effect of GST -EC2 tetraspanins on 
adhesion of Con A stimulated monocytes was not examined, since Con A induces the 
formation of MGCs, which are strongly adherent on Lab-Tek® chamber slides relative 
to normal monocytes, as described in chapter 3. Since the GST-EC2CD63 and GST-
EC2CD9 inhibit the formation of the strongly adherent MGCs, the results would be 
biased. 
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We further investigated whether lower concentrations of tetraspanins affect the 
adhesion of monocytes by examining the dose/response effect of GST -EC2CD63 on 
adhesion of unstimulated monocytes. 
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FigA.2.2. The dose response effect of GST-EC2 tetraspanins on the adhesion of 
unstimulated monocytes cultured at 5 x 105 cells.chambe{i in a Lab-Tek® chamber 
slide with/without different concentrations of GST-EC2CD63/GST (20Jlg.mri) for 72 
hrs (section 2.2.10.5.1), the slide was processed and stained with FITC labelled anti 
CD52 antibody as mentioned in section 2.2.10.3.2. The numbers of cells were counted 
in 6 randomly chosen fields. The results are the means of 2 experiments carried out in 
duplicate with monocytes from 2 blood donors. The level of significance between the 
monocyte alone and different treatments was tested by unpaired t test, where * * 
Significant at P<0.005; * Significant at P<0.05. 
The results of the dose/response study with GST-EC2CD63 showed that down to 
2Jlg.mr i GST -EC2CD63, there was still some enhancement of adhesion of 
unstimulated monocytes. 
4.2.2. Titration of cell number by SRB cell stain assay 
Estimating cell numbers by counting microscopically was laborious. Therefore we 
decided to use an alternative quantitative method, the SRB assay (section 
2.2.10.5.2.1), to investigate the effect of GST-EC2 tetraspanins on overall cell 
numbers and monocyte adhesion. This method estimates cell number as a function of 
the total protein present in the wells of a microtitre plate (Skehan et ai, 1990). Before 
using the SRB assay with monocytes, trial experiments were carried out with an 
adherent cell line (RBL2H3) and a non-adherent cell line (THP-l ) to optimise 
experimental conditions and to check that the relationship between cell numbers and 
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optical density was linear. Adherent and non-adherent cells were used since we were 
unsure how strongly adherent the 'monocyte' population (which is likely to contain 
contaminating lymphocytes) would be in culture. The RBL2H3 cells were harvested 
(section 2.2.1.1) and the cell numbers were titrated by SRB assay as described in 
section 2.2.10.5.2.1. The cells were fixed with TCA to final concentration of 10% 
after the cells had been allowed to settle for 2hrs at 37°C as recommended by Skehan 
and co-workers for adherent cells (Skehan et ai, 1990). 
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Fig.4.2.3. Titration of RBL2H3 cell numbers by SRB assay. The experiment was 
carried out as described in section 2.2.10.5 .2.1 in an uncoated 96 well microtitre plate. 
The cells were allowed to settle for 2hrs at 37°C and fixed with TCA to a fmal 
concentration of 10%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
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FigA.2A. Titration of THP-1 cell numbers by SRB assay. The experiment was carried 
out as described in section 2.2.10.5.2.1 in a poly L-Iysine coated 96 well microtitre 
plate. The cells were allowed to settle for 2hrs at 37°C and fixed with TCA to a final 
concentration of 16%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
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FigA.2.5. Titration ofTHP-1 cell numbers by SRB assay. The experiment was carried 
out as described in section 2.2.10.5.2.1 in an uncoated 96 well microtitre plate. The 
cells were allowed to settle for 2hrs at 37°C and fixed with TCA to a final 
concentration of 16%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
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FigA.2.6. Titration of THP-l cell numbers by SRB assay. The experiment was carried 
out as described in section 2.2.10.5.2.1 in a poly L-Iysine coated 96 well microtitre 
plate. The cells were allowed to settle for 4hrs at 37°C and fixed with TCA to a final 
concentration of 10%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
2.0 
1.5 
0.5 
4hrs settling+10% TCA fixation in 
an un coated plate 
O.O~----~-----r----~----~----~~----r-----~----~ 
o 25 50 75 100 125 150 175 200 
Cell nurn bers(x103) 
FigA.2.7. Titration ofTHP-l cell numbers by SRB assay. The experiment was carried 
out as described in section 2.2.10.5.2.1 in an uncoated 96 well microtitre plate. The 
cells were allowed to settle for 4hrs at 37°C and fixed with TCA to a final 
concentration of 10%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
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FigA.2.8. Titration of THP-1 cell numbers by SRB assay. The experiment was carried 
out as described in section 2.2.10.5.2.1 in a poly L-lysine coated 96 well microtitre 
plate. The cells were allowed to settle for 4hrs at 37°C and fixed with TCA to a final 
concentration of 16%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
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FigA.2.9. Titration ofTHP-1 cell numbers by SRB assay. The experiment was carried 
out as described in section 2.2.10.5.2.1 in an uncoated 96 well microtitre plate. The 
cells were allowed to settle for 4hrs at 37°C and fixed with TCA to a [mal 
concentration of 16%. The results are the mean OD@570nm of 1 experiment carried 
out in quadruplicate. 
The results of SRB assay with RBL2H3 (FigA.2.3) cells showed a linear relationship 
between cell numbers and optical density. Hence an attempt was made to titrate the 
cell numbers of non-adherent THP-1 cells as described in section 2.2.10.5.2.1. either 
in poly L-Iysine coated or uncoated 96 well microtitre plates. After 2hrs of incubation 
at 37°C the cells were fixed with TCA to a [mal concentration of 16% as 
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recommended by Skehan and co-workers for non-adherent cells (Skehan et aI, 1990). 
The THP-l cells did not titrate very well (FigA.2A) and (FigA.2.5). Hence, in 
additional experiments the THP-l cells were allowed to settle for 4hrs at 37°C and 
then fixed with TCA to a final concentration of 10% (FigA.2.6 and FigA.2.7). A 
linear relationship between the cell numbers and optical density was then obtained. In 
addition another titration with identical condition but using 16% TCA was tested 
(FigA.2.8 and FigA.2.9). Although a linear relationship was observed between cell 
numbers and absorbance, deviations between duplicate values were noticed. From 
these studies it was observed that 10% final concentrations of TCA was an ideal 
concentration for fixing the THP-l cells. These results showed that the SRB assay 
could be used as a quantitative measure of cell number, for both adherent and non-
adherent cells. 
Based on these observations the cell numbers of monocytes were titrated as described 
in section 2.2.l 0.5.2.1. and a linear relationship between the cell numbers and 
OD@570nm was obtained (FigA.2.1 0). 
3. 
E 2. 
I:: 
o 
~ 1.5 
01. 
o. 
4hrs settling+10°IciT"CA fixation in 
an un coated plate 
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FigA.2.10. Titration of monocyte cell numbers by SRB assay. The experiment was 
carried out as described in section 2.2.10.5.2.1. The non-adherent cells from the 
overnight-cultured peripheral blood monocytes were removed by three washings with 
pre warmed RPMI and the adherent monocytes were harvested using 0.25% trypsin: 
EDTA solution as described in section 2.2.l.l. The cells were plated into an uncoated 
96 well microtitre plate, allowed to settle for 4hrs at 37°C and fixed with TCA to a 
final concentration of 10%. The results are the mean OD@570nm of 1 experiment 
carried out in quadruplicate. 
4.2.3. Effect of GST-EC2 tetraspanins on monocyte adhesion: SRB assay 
The SRB assay was used to investigate the effect of GST -EC2 tetraspanins on overall 
cell numbers and monocyte adhesion. In these experiment monocytes were cultured in 
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96 well microtitre plates as described in 2.2.10.5.2.2 for 72hrs. After the incubation 
period one plate was fixed with TCA without washing and the other plate was washed 
3x with BSS to remove any non-adherent cells prior to fixation (Fig.4.2.l1). The 
SRB assay was then performed. 
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Fig.4.2.11. The effect of GST-EC2 tetraspanins on cell number and adhesion of 
unstimulated monocytes. Monocytes were plated at 5 x 105 cells.welr i in a 96 well 
microtitre plate and incubated with GST-EC2 tetraspanins (20llg.mri) for 72 hrs at 
37°C as described in section 2.2.10.5.2.2. The cells were fixed with TCA without 
washing with BSS (A); after 3x washing with BSS (B). SRB assay was carried out as 
described in section 2.2.10.5.2.2. The results are the mean absorbance of 3 
experiments carried out in quadruplicate with monocytes from 3 different blood 
donors. The level of significance between the no addition control and different 
treatment was tested by unpaired t test, where: NS=Non significant at P<0.05. 
The results show that GST-EC2CD63, GST-EC2CD9, GST-EC2C153A and GST did 
not have any significant effect on the adhesion of unstimulated monocytes. In 
addition, the GST-EC2 tetraspanins did not show any significant effect on monocyte 
cell numbers as is evident for the plate where cells were not removed by washing. 
This indicates that the recombinant proteins are not affecting monocyte viability or 
proliferation. There was around 3x reduction in overall cell numbers for the washed 
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plate compared to the unwashed plate, reflecting the loss of cells during washing. This 
indicates that a large proportion of the cells are not strongly adherent. The EC2 
tetraspanins did not induce significant further loss of cells when compared to 
monocytes alone, but in this assay they did not enhance adhesion. 
4.2.4. Effect of GST/EC2 tetraspanins on cell numbers of Con A 
stimulated monocytes: SRB assay 
The experiment described above (section 4.2.3) was repeated using monocytes that 
were stimulated with Con A (lOJlg.ml-1) for 72hrs. Again the effects of GST-
tetraspanins on overall cell number, and on adhesion, were determined using the SRB 
assay. 
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Fig. 4.2.12. Effect of GST-EC2IEC2 tetraspanins on cell number of Con A stimulated 
monocytes. The monocytes were stimulated with Con A (lOJlg.ml-1) and cultured in 
presence/absence of GST-EC2IEC2 tetraspanins (20Jlg.mr l ) for 72hrs at 37°C as 
described in section 2.2.10.5.2.2. The cells were fixed with TCA without washing 
(A); after 3x washing with BSS (B). The SRB assay was carried out as described in 
section 2.2.l 0.5.2.2. The results are the mean absorbance of 3 experiments carried out 
in quadruplicate with monocytes from 3 different blood donors. The level of 
significance between no Con A and Con A; Con A and different treatments was tested 
by unpaired t test, where * Significant at P<0.05 ; NS= Non significant at P<0.05 . 
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From the results of the SRB assay where the plate was not washed, Con A does not 
seem to induce proliferation of monocytes significantly, although a slight increase in 
cell number was seen for all Con A stimulated cells. In addition, co-incubating these 
cells with tetraspanins does not significantly affect overall cell numbers i.e. the 
tetraspanins do not show any cytotoxic or anti-proliferative effect on Con A 
stimulated monocytes. From the results of the SRB assay where the plate was washed, 
Con A appeared to induce a slight increase in adhesion of monocytes but this was not 
significant. In addition, the GST-EC2 tetraspanins neither significantly increased nor 
decreased the adhesion of Con A stimulated monocytes. However, after washing, 
there were significantly fewer cells in wells that had been incubated with EC2CD63 
(generated by thrombin cleavage of GST-EC2CD63), indicating that these cells were 
less adherent. Since MGCs are observed to be strongly adherent, it is not clear 
whether this is due to a direct effect on adhesion, or due to inhibition of MGC 
formation or it might be due to the 3x higher molar concentrations of EC2CD63 was 
used when compared to other GSTEC2 proteins. 
4.2.5. Effect of GST -EC2 tetraspanins on the aggregation of monocytes 
In the present study we assessed the effect of GST-EC2 tetraspanins on the 
aggregation of Con A stimulated monocytes as described in section 2.2.10.5.2.3. In 
addition, the effect of His6-EC2CD63 and EC2CD63 was investigated. Initially 
attempts were made to examine the effects of tetraspanin EC2s on aggregation 
induced by 10/lg.mr l Con A. However, since this induced a high degree of cell 
fusion in the control (no tetraspanin, or GST alone) it was difficult to monitor effects 
on aggregation alone. Therefore, the cells were stimulated with 5/lg.mr1 Con A and 
effects on aggregation monitored after 12hrs incubation, as described by Takeda and 
co-workers (Takeda et aI, 2003). 
The initial aggregation assays were carried out with monocytes harvested by using 
trypsin:EDT A. The number of aggregates with <4 cells were counted as described 
(Takeda et aI, 2003), and it appeared that the tetraspanins caused some inhibition of 
aggregation (Fig.4.2.13). However, microscopic observation showed that the results 
were misleading: GST-EC2 tetraspanins in the presence of Con A (5/lg.mr 1) 
produced larger aggregates of <20 monocytes, which lead to an overall reduction in 
the number of small aggregates (between 4-10 monocytes) in the chosen field during 
the counting than Con A control. In addition, monocytes without any treatment also 
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showed some degree of aggregation. Therefore, this experiment was repeated with 
monocytes that had been harvested non-enzymatically and aggregates of 4-10 and 10-
20 cells were recorded separately (Fig.4.2.14). 
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Fig.4.2.13. Effect of GST-EC2/EC2IHis6-EC2 tetraspanins on the aggregation of 
monocytes. The monocytes were harvested using trypsin: EDT A, plated at 2x 1 05 
cells.welr i in a 96 well micro titre plate and the assay was carried out as described in 
section 2.2.10.5.2.3. The number of aggregates with <4 monocytes were counted from 
6 randomly chosen fields. The results are the mean value of 3 experiments carried out 
in quadruplicate using monocytes from 3 different blood donors. 
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Fig.4.2.14. Effect of GST-EC2IEC2IHis6-EC2 tetraspanins on the aggregation of 
monocytes. The monocytes were harvested using cell dissociation solution, plated at 
2x105 cells.welr i in a 96 well microtitre plate and the assay was carried out as 
described in section 2.2.10.5.2.3. The number of aggregates between 4-10 and 10-20 
monocytes was counted from 6 randomly chosen fields. The results are the mean 
value of 1 experiment carried out in triplicate. 
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The results of this aggregation assay indicate that GST-EC2IEC2IHis6-EC2CD63 and 
GST-EC2CD9 increased the aggregation of Con A stimulated monocytes. In this 
experiment, there were slightly increased numbers of small aggregates with GST-
EC2CD63, His6-EC2CD63 and EC2CD63 treatments relative to GST-EC2CD9, GST-
EC2C153A and GST alone. In addition, GST-EC2CD63, His6-EC2CD63, EC2CD63 
and GST-EC2CD9 showed more large aggregates than control GST-EC2C153A and 
Con A. This indicates that tetraspanins CD9 and CD63 do not inhibit the aggregation 
of monocytes, which is prerequisite for the fusion of monocytes. By contrast, CD9 
and CD63 EC2s appear to show some enhancement of Con A induced aggregation. 
4.2.6. Effect of GST -Ee2 tetraspanin on THP-1 cell aggregation 
As described in chapter 3, Con A stimulation of the monocytic leukaemic cell line 
THP-l induced aggregation, but not fusion. The effect of the GST-EC2s on Con A 
induced aggregation of THP-l cells was therefore investigated. In initial aggregation 
assays cells were incubated with 10~g.mrl Con A and GST-EC2 tetraspanins 
(20~g.mrl) for 72hrs and then the number of aggregates with more than 4 cells were 
recorded. No clear difference was observed between the GST-EC2 tetraspanin treated 
cells and the controls since at 1 O~g.mrl Con A, huge aggregates of THP-l cells 
formed in all groups. A reduced concentration of Con A (5~g.ml-l) was then used and 
the effects of different concentrations of GST -EC2 proteins monitored after 24hrs. 
The aggregates were scored according to size (Fig.4.2.15) and the light microscopic 
images are shown in Fig.4.2.16. 
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Fig.4.2.15. Effect of GST -EC2 tetraspanins on the aggregation of THP-l cells. The 
cells were plated at 80,000 cells.weIr l in a 96 well microtitre plate, incubated with 
Con A (5Ilg.mrl) and GST-EC2 tetraspanins/GST at 20llg.ml-1 (A); IOllg.mrl (B); 
2llg.mrl (C) for 24hrs at 37°C as described in section 2.2.10.5.2.4. The numbers of 
aggregates in different categories were counted from 6 randomly chosen fields. The 
results are the mean value of 1 experiment carried out in quadruplicate. 
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For Con A stimulated THP-1 cells, GST-EC2CD63, GST-EC2CD9 and GST-
EC2C153A at 20~g.mrl and 10~g.mrl produced low numbers of small aggregates (4-
10) and a higher number of large aggregates (10-20; 20-50 and 50-100) than the Con 
A alone control. In addition, GST also has a slight effect on aggregation. The 
aggregation was reduced at 2~g.ml-l concentrations of GST-EC2 tetraspanins. From 
these results it was observed that Con A alone at 5~g.ml-l induces some aggregation 
of THP-1 cells and GST-EC2CD63, GST-EC2CD9 and GST-EC2C153A appear to 
enhance aggregation at concentrations down to 1 O~g.mrl. 
Fig. 4.2.l6. Effect of GST-EC2 tetraspanins on the aggregation of THP-1 cells. The 
assay was carried out with GST proteins at 20~g.ml-l as described in section 
2.2.10.5.2.4 in the presence/absence of Con A (5~g.ml-l). No addition (A); Con A 
(B); GST-EC2CD63 (C); GST-EC2CD9 (D); GST-EC2C153A (E); GST (F). The 
light microscope images were captured with Nikon inverted microscope using 20x 
objective. 
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4.2.7. Effect of Con A stimulation on the expression of tetraspanins and 
other leucocyte proteins by monocytes 
To try to further elucidate the role oftetraspanins in monocyte fusion, their expression 
levels on monocytes with and without Con A stimulation were examined by F ACS 
analysis. The expression of integrins CD18 (~2 subunit), CD29 (~1 subunit), CDllb 
(CR3 a subunit) was also examined, along with the monocyte marker CD 14 and the 
lymphocyte/monocyte marker CD52. The expression study was carried out by F ACS 
analysis as discussed in section 2.2.11 using appropriate FITC labelled antibodies. 
(a) 2hrs Con A stimulation 
During the F ACS analysis it was noticed that there were four distinct cell populations 
in our preparation of unstimulated monocytes and five distinct cell populations with 
the Con A stimulated cells (Fig.4.2.17 A and B), gateable on the basis of their 
granularity and size. The populations were identified using the anti CD 14 and anti 
CD52 antibodies, and the well-known scatter profiles of monocytes and lymphocytes. 
Populations Rl and R4 have the expected characteristics of monocytes and 
lymphocytes, respectively. However the population of cells labelled R2 also stains 
positively for CDI4, but has a slightly different scatter profile and expresses 
significantly more CD52 than Rl. This population seems to increase in number on 
Con A stimulation. The R5 population is negative for CD 14, but positive for CD52 
and presumably represents another lymphocyte sUbpopulation since lymphocytes 
express low levels of CD 14 and high levels of CD52 (Barclay et ai, 1997). On Con A 
stimulation, another population R3, of very large CD14 positive cells is apparent. 
These presumably represent fusing cells. The results of F ACS analysis concurs with 
evidence from microscopy that 2hrs of Con A stimulation has induced the monocytes 
to start fusing (Fig.3.2.17). The histogram represents only the MFI of CD 14 +ve 
populations. (The lymphocytes (R4) expressed very low levels oftetraspanins; R5 had 
some CD9 (MFI=32.37) and CD81 (MFI=13.81), and this did not change on Con A 
stimulation). The level of expression of CD63 on normal monocytes was surprisingly 
low (MFI=17.21) and there was moderate expression of CD9 (MFI=127.83). The R3 
gate contains very few cells in the unstimulated population, which presumably 
represent larger than average monocytes. Their overall expression profile is very 
similar to the Rl cells, but the cells are more brightly stained, presumably because of 
their increased size. 
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On 2hrs Con A stimulation, most markers expressed on surface of Rl and R2 cells 
increased slightly, except CDI8, CD 11 b and CDI4, which decrease. All markers 
increase on R3 cells, but this may simply be increased staining due to increased cell 
size (although relative to other markers, CDI8 and CD29 appear to increase more on 
Con A stimulated cells). Similarly the effect of 72hrs of Con A stimulation on the 
expression levels of CD9, CD63, CD81, CD82, CDIIb, CDI4, CD18, CD29 and 
CD52 on monocytes was tested by F ACS as described in section 2.2.11. 
(b) 72hrs Con A stimulation 
The surface expression ofCD9, CD81, CDI4, CDI8, CD29 and CD52 in RI cells are 
considerably increased during nonnal culture at 37°C, whereas CD63, CDllb and 
CD82 show little increase. The pattern of expression is similar on cells included in the 
R3 gate, but higher, presumably due to the larger size of the cells. Thus these larger 
cells do not represent a separate population. Interestingly, after 72hrs of culture in the 
presence of Con A, all markers with the exception of CD63, CD52 and CD82 (which 
is low in any case), appear to be down-regulated on RI cells. The R3 cells exhibit a 
similar profile, although CD29 expression is high, comparable to unstimulated cells. 
The R3 population is relatively low in numbers in the 72hrs Con A stimulated cells, 
compared with 2hrs stimulation. This may be due to loss of very large MGCs, which 
are difficult to harvest and may not pass through the FACS machine (Fig.4.2.18.). 
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FigA.2.17. Expression levels of leucocyte membrane proteins on 2hrs cultured 
leucocytes in the presence/absence of Con A. The experiment was carried out as 
described in section 2.2.11 using appropriate FITC labelled antibody. The cells were 
separated on the basis of their granularity and size: Rl=Monocytes (CDI4 +ve); 
R2=Monocytes (CDI4 +ve); R3=MGCs (CDI4 +ve); R4=Lymphocytes (CDI4 -ve) 
and R5=Unknown lymphocyte population (CD 14-ve). Scatter profiles of 
unstimulated (A); 2hrs Con A stimulated (B) leucocytes; expression levels of 
leucocyte membrane proteins on 2hrs cultured monocytes (C); 2hrs Con A stimulated 
monocytes (D). The results of C and D are the mean values of 2 experiments carried 
out in duplicate with monocytes from 2 different blood donors. MFI of isotype control 
subtracted from the test MFI. 
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The mean fluorescence intensities of 2hrs and 72hrs expression studies are given in 
table 4.2.1 and 4.2.2. 
(A) 
Membrane R1 R2 R3 R4 R5 
protein 
CD63 4.95 ± 2.7 6.69 ± 4.2 17.21 ± 12.3 1.16±0.1 2.72 ± 1.3 
CD9 21 .74 ± 6.2 36.26 ±14.3 127.83 ± 53.8 3.48 ± 1.3 32.37 ± 18.9 
CD29 29.81 ± 6.8 29.27 ± 6.6 79.63 ± 30.9 7.97 ± 0.9 40.85 ± 37.5 
CD81 23.05 ± 1.8 27.69 ± 2.1 83.61 ± 7.2 11.82 ± 1.3 13.81 ± 4.7 
CD18 29.45 ± 2.0 22.05 ± 3.3 58.80 ± 6.6 7.36 ± 0.5 6.34 ± 1.6 
CD11b 9.13 ± 0.3 5.63 ± 0.1 21.09 ± 1.0 1.35 ± 0.0 1.32 ± 0.1 
CD14 68.70 ±11 .7 33.88 ± 9.5 182.19±51 .3 1.18±0.1 2.54 ± 0.8 
CD52 28.68 ± 3.8 81 .15±18.1 118.99 ± 37.6 19.89±1.0 58.80 ± 11 .1 
CD82 3.96 ± 0.1 7.74 ± 1.9 11.02 ± 1.7 1.19 ± 0.1 4.58 ± 0.3 
(B) 
Membrane R1 R2 R3 R4 R5 
protein 
CD63 8.09± 5.1 9.87 ± 6.9 58.22 ± 13.0 2.67 ± 1.1 3.62 ± 2.2 
CD9 32.17 ± 7.4 42.98 ± 7.2 204.83 ± 5.3 12.63 ± 2.8 33.16 ± 6.2 
CD29 36.60 ±12.5 38.38 ±19.3 193.77 ± 11 .2 9.97 ± 3.4 24.04 ±13.8 
CD81 18.61 ± 2.0 25.96 ± 4.4 123.33 ± 51 .0 7.75±1 .0 11.42± 3.1 
CD18 17.94 ± 0.4 16.40 ± 1.4 195.16 ± 6.9 6.37 ± 0.1 6.38 ± 0.3 
CD11b 4.13±0.0 3.43 ± 0.0 41.38 ± 0.8 1.56 ± 0.0 1.32 ± 0.0 
CD14 33.75 ± 9.9 24.44 ± 5.9 366.23 ±204.7 1.78±0.2 2.80 ± 0.5 
CD52 34.82±11 .1 90.36 ± 8.8 219.68± 15.9 23.31 ± 0.7 56.88 ± 3.9 
CD82 3.46 ± 0.1 11.65± 0.1 32.30 ± 2.1 1.63 ± 0.1 4.74± 0.1 
Table 4.2.1. Expression levels of leucocyte membrane proteins on 2hrs cultured 
leucocytes in the presence/absence of Con A. The experiment was carried out as 
described in section 2.2.11 using appropriate FITC labelled antibody. The cells were 
separated on the basis of their granularity and size: Rl =Monocytes (CD 14 +ve); 
R2=Monocytes (CD14 +ve); R3=MGCs (CD14 +ve); R4=Lymphocytes (CD14 -ve) 
and R5=Unknown lymphocyte population (CD14 -ve). Expression levels (MFI) of 
leucocyte membrane proteins on 2 hrs cultured monocytes (A); 2hrs Con A stimulated 
monocytes (B). The results of A and B are the mean MFI of2 experiments carried out 
in duplicate with monocytes from 2 different blood donors. MFI of isotype control 
subtracted from the test MF!. 
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Fig.4.2.18. Expression levels of leucocyte membrane proteins on 72hrs cultured 
monocytes in the presence/absence of Con A. The experiment was carried out as 
described in section 2.2.11 using appropriate FITC labelled antibody. The cells were 
separated on the basis of their granularity and size: Rl =Monocytes (CD 14 +ve); 
R2=Monocytes (CDI4 +ve); R3=MGCs (CDI4 +ve); R4=Lymphocytes (CDI4 -ve) 
and R5=Unknown lymphocyte population (CD 14 -ve). Scatter profiles of 72hrs 
cultured unstimulated (A); 72hrs Con A stimulated (B) leucocytes; Expression levels 
of leucocyte membrane proteins on 72hrs cultured monocytes (C); 72hrs Con A 
stimulated monocytes (D). The results of C and D are the mean values of 2 
experiments carried out in duplicate with monocytes from 2 different blood donors. 
MFI of isotype control subtracted from the test MF!. 
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(A) 
Membrane R1 R2 R3 R4 R5 
protein 
CD63 8.11 ± 3.9 14.45 ± 9.1 14.83 ± 6.1 1.14±0.1 3.33 ± 1.6 
CD9 206.09 ± 61 .2 92.92 ± 6.9 461 .71 ± 123.8 4.76 ± 0.5 28.69 ± 4.7 
CD29 73.33 ± 10.9 70.13 ± 36.6 103.08 ± 25.4 11 .27 ± 1.8 26.45 ±19.2 
CD81 151 .99 ± 50.3 59.33 ± 13.4 252.83 ± 49.7 16.47 ± 0.9 16.52 ± 1.5 
CD18 49.03 ± 0.3 19.74 ± 0.1 68.83 ± 4.2 3.73 ± 0.0 5.69 ± 0.3 
CD11b 12.55 ± 0.0 4.29 ± 0.3 19.14± 0.8 1.16 ± 0.0 1.35± 0.1 
CD14 206.01 ± 32.2 24.42 ± 4.7 305.86 ± 97.4 1.16±0.1 2.96 ± 0.3 
CD52 57.40 ± 2.7 179.37± 21.4 144.66 ± 11 .7 17.64 ± 3.7 51 .31 ± 5.5 
CD82 5.94 ± 0.5 18.98 ± 0.5 14.30 ± 0.3 1.26 ± 0.1 5.43 ± 0.6 
(B) 
Membrane R1 R2 R3 R4 R5 
protein 
CD63 12.87 ± 6.6 26.76 ± 18.4 51 .75 ± 30.5 2.24 ± 0.8 6.04 ± 3.9 
CD9 38.07 ± 3.2 67.00 ± 2.5 95.51 ± 30.3 9.38 ± 1.4 46.84 ± 1.6 
CD29 36.57 ± 4.4 71 .26±15.7 108.79 ± 15.5 8.27 ± 1.2 40.02 ±17.7 
CD81 27.62 ± 0.6 28.06 ± 1.6 85.66 ± 9.8 6.25 ± 0.2 8.94 ± 3.3 
CD18 11.00 ± 0.4 10.44 ± 0.2 36.37 ± 1.3 2.02 ± 0.1 3.21 ± 0.3 
CD11b 2.33 ± 0.1 2.73 ± 0.1 8.31 ± 0.1 1.13±0.0 1.17±0.0 
CD14 5.22 ± 0.5 5.75 ± 1.0 15.81 ± 1.5 1.26 ± 0.1 1.83 ± 0.4 
CD52 54.42 ± 1.6 88.86 ± 4.9 155.93 ± 51 .5 13.87 ± 3.8 37.79 ±12.6 
CD82 5.78 ± 0.2 8.58 ± 0.1 18.00 ± 1.0 1.45 ± 0.2 2.76 ± 0.3 
Table 4.2.2. Expression levels of leucocyte membrane proteins on 72hrs cultured 
leucocytes in the presence/absence of Con A. The experiment was carried out as 
described in section 2.2.11 using appropriate FITC labelled antibody. The cells were 
separated on the basis of their granularity and size: R1 =Monocytes (CD 14 +ve); 
R2=Monocytes (CD14 +ve); R3=MGCs (CD14 +ve); R4=Lymphocytes (CD14 - ve) 
and R5=Unknown lymphocyte population (CD 14-ve). Expression levels (MFI) of 
leucocyte membrane proteins on 72hrs cultured monocytes (A); 72hrs Con A 
stimulated monocytes (B). The results of A and B are the mean MFI of 2 experiments 
carried out in duplicate with monocytes from 2 different blood donors. MFI of isotype 
control subtracted from the test MFI. 
4.2.8. Comparison of tetraspanin expression on THP-1 cells and 
monocytes 
As described in section 3.2.11.1 Con A did not induce the fusion of THP-1 cells, 
although it did promote aggregation of these cells. Hence the expression levels of 
tetraspanins on unstimulated/Con A stimulated non-fusogenic THP-1 cells and 
fusogenic monocytes were compared in identical experimental conditions by F ACS 
analysis (Fig.4.2. 19 and 4.2.20). 
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Fig.4.2.19. Expression levels of tetraspanins on 2hrs cultured THP-1 cells in the 
presence/absence of Con A (lOllg.mr i ). The experiment was carried out as described 
in section 2.2.11 using appropriate FITC labelled antibody. Scatter profiles of 2hrs 
cultured unstimulated (A); 2hrs Con A stimulated (B) THP-1 cells. Expression levels 
of tetraspanin proteins on 2hrs unstimulated/Con A stimulated THP-1 cells (C). The 
results ofCD9, CD63, CD81 and CD1S1 are the mean values of2 experiments carried 
out in triplicate; the result of CD37 was from a single experiment. The level of 
significance was tested by unpaired t test by comparing the MFI of unstimulated cells 
with Con A stimulated cells in R1, where ***Significant at P<O.OS; NS=Non 
significant at P<O.OS. 
Unstimulated THP-l cells showed higher expression levels ofCD63 (MFI=27.06) and 
CDlSl (MFI=3S.08) when compared to other tetraspanins i.e. the expression ofCD63 
and CD1S1 were around S times more than the expression of CD9. However, after 2 
hrs of Con A stimulation little increased expression levels of CD9, CD63 , CD37 and 
CD81 were observed, whilst there was no change in expression CD82 and CD lSI. 
However, the increased expression was only significant for CD63. 
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FigA.2.20. Expression levels of different tetraspanins on unstimulated/Con A 
stimulated monocytes. The experiment was carried out as described in section 2.2.11 
using appropriate FITC labelled antibody. R1 =Monocytes (CD14+ve); 
R2=Monocytes (CD14 +ve); R3=MGCs (CD14 +ve); R4=Lymphocytes (CD14 -ve) 
and R5=Unknown lymphocyte population (CD 14-ve). The results are the mean 
values of 1 experiment carried out in triplicate. The level of significance was tested by 
unpaired t test by comparing the MFI of unstimulated cells in R1 and Con A 
stimulated cells in R3, where *** Significant at P<O.OOOl; * Significant at P<O.05. 
Compared with THP-1 cells unstimulated monocytes examined at the same time 
under identical conditions express much higher levels of CD9 (MFI=111.10). CD63, 
CD37, CD81, and CD151, however, are more weakly expressed by monocytes in R1 
and no expression of CD82 was observed. The monocytes population (R1) of Con A 
stimulated cells did not show much change in expression values of these tetraspanins. 
In contrast to these increased expression levels of CD9 (MFI=363.00), CD63 
(MFI=37.8), CD37 (MFI=92.69) and CD81 (MFI=96A) with Con A stimulated cells 
in R3 gated cells were seen and these results are in agreement with the observations 
made in section 4.2.7. No expression ofCD82, CD151 was observed (FigA.2.20). The 
higher fluorescence with Con A stimulated cells in R3 may simply be increased 
staining due to increased cell size. 
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4.3. DISCUSSION 
4.3.1. Effects of EC2 tetraspanins on adhesion of monocytes 
This chapter explored the involvement of tetraspanins in functions related to 
monocyte fusion. The effects of the GST -EC2 tetraspanins on monocyte adhesion was 
tested since many reports provide evidence for the involvement of tetraspanins in 
adhesion-dependent signalling mediated by integrins (reviewed in Berditchevski, 
2001). Initially, the effects of the recombinant proteins were investigated on cells 
grown on chamber slides. The results of our study showed that both GST-EC2CD9 
and GST-EC2CD63 at higher concentration (20~g.mrl) did not inhibit the adhesion 
of monocytes cultured in the absence of Con A. Interestingly these proteins 
significantly enhanced the adhesion of monocytes in Lab-Tek® chamber slides, and 
this effect was seen with GST -EC2CD63 concentrations down to 2~g.mrl. 
In order to confirm the adhesion assay results from Lab-Tek® chamber slides another 
quantitative colorimetric method, the SRB assay (Skehan et ai, 1990) was used to 
estimate the effect of GST-EC2 tetraspanins on monocyte adhesion in 96 well 
microtitre plates as a function of cell numbers. Preliminary experiments confirmed 
that this assay gave a linear relationship between OD and cell number. The results of 
the adhesion assay by the SRB method indicated that GST-EC2 tetraspanins did not 
have any significant inhibitory effect on adhesion of monocytes cultured in the 
absence of Con A. However, there was no apparent enhancement of adhesion by 
GST-EC2CD9 or GST-EC2CD63 in this assay. The differences between the results 
on chamber slides and microtitre plates may have been due to the differences in 
surface chemistry of surfaces the monocytes adhere to. Extensive studies by Anderson 
and co-workers indicate that surface chemistry affects the adhesion of monocytes and 
fusing/fused macrophages, presumably due to difference in the type and conformation 
of proteins that are adsorbed (Jenney et ai, 1998; McNally and Anderson, 2002). 
In addition the SRB assay was also used to examine the effect of GSTIEC2-
tetraspanins on Con A stimulated monocytes. It is apparent that Con A stimulation 
slightly increased the adhesion of monocytes, possibly through increased 
expression/activation of integrins. None of the GST -EC2 proteins significantly 
inhibited adhesion of Con A induced monocytes at concentration that gave strong 
inhibition of MGC formation. However, reduced cell numbers were observed for Con 
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A induced monocytes incubated with EC2CD63 alone (generated from GST-
EC2CD63 by thrombin cleavage). Thus, part of the effect of this protein on MGC 
formation might be due to an effect on cell adhesion. However, we had observed in 
chamber slides that MGCs were strongly adherent, and less likely to be removed 
during slide processing than single cells (chapter 3, 3.2.1.2). The apparent effect of 
cleaved CD63EC2 on adhesion might alternatively be resulting from potent inhibition 
of MGC formation by this preparation. Also, at the same protein concentration 
(20J..Lg.m1-1), 3x higher molar concentrations of EC2CD63 was used for this assay 
when compared to GST-EC2CD63. 
In contrast to our studies, Takeda and co-workers tested the effects of antibodies to 
tetraspanins CD9 and CD81 on adhesion of monocytes in presence of Con A 
(10J..Lg.mr1) usmg MTT (3-( 4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium 
bromide) assay. They reported that antibodies to CD9 and CD81 did not have any 
effect on adhesion but anti ~l and anti ~2 integrin antibodies significantly inhibited 
monocyte adherence to the tissue-culture treated surfaces, consistent with the known 
adhesive functions of these integrins. From these observations we conclude that GST-
EC2CD63 and GST -EC2CD9 do not inhibit MGC formation due to inhibition of 
adhesion. 
4.3.2. Effects of EC2 tetraspanins on cell numbers 
The effect of GST-EC2 tetraspanins on overall cell number was also assessed by SRB 
assay. These experiments were designed to investigate any possible anti-proliferative 
or cytotoxic effects of the recombinant proteins, and looked at cell numbers prior to 
vigorous washing to remove loosely adherent cells. Neither GST-EC2 tetraspanins 
nor Con A or a combination of both induced significant proliferation or showed any 
cytotoxic effect on monocytes since overall cell numbers were similar between 
treatments. Although Con A is a T cell mitogen (Baral et ai, 2004; Rashid et ai, 
2005) it did not appear to induce the proliferation of monocytes. This effect was 
supported by our additional studies using macrophages from CD9KO and CD9WT 
mice (section 3.2.11.3). We therefore conclude that the effects of GST-EC2CD9 and 
GST-EC2CD63 on MGC formation are not due to anti-proliferative or cytotoxic 
activity. 
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4.3.3. Effects of EC2 tetraspanins on aggregation of monocytes and 
THP-1 cells 
The aggregation of monocytes is prerequisite for the fusion process (Vignery et ai, 
2000; Takeda et ai, 2003). Hence we analysed the effects of various recombinant EC2 
tetraspanins on the aggregation of monocytes. As detailed in 4.2.5, there were some 
initial problems with setting up and scoring this assay. After these problems were 
resolved, the results indicated that there was no inhibition of Con A induced 
aggregation by the recombinant proteins. By contrast, there was an indication that 
CD9 and CD63EC2s enhanced aggregation. Takeda and co-workers reported that anti 
CD9 and CD81 antibodies did not have any effect on aggregation of Con A stimulated 
monocytes (Takeda et ai, 2003), whereas anti ~2 integrins were inhibitory. By 
contrast, other workers have shown that anti CD9 antibodies activate and induce the 
aggregation of platelets (Wright et ai, 1994) and eosinophils (Matsumoto et ai, 1999). 
In addition the effect of different concentrations of GST-EC2 tetraspanins on the 
aggregation of THP-l cells in presence of Con A (5Jlg.mr l ) was tested. Again no 
inhibition of aggregation was observed. By contrast, as the concentration of GST-
EC2CD63 and GST -EC2CD9 increased the aggregation of THP-l cells also 
increased. The results of the aggregation assay with THP-l cells concur with results 
from the monocyte aggregation assay. We conclude that the effect of the recombinant 
CD9 and CD63EC2 proteins on MGC formation is unlikely to be due to inhibition of 
aggregation, or of the movement of cells coming together to form aggregates. 
4.3.4. Expression levels of leucocyte membrane proteins 
Attempts were made to investigate the possible involvement of tetraspanins and other 
leucocyte membrane proteins in fusion of monocytes by comparing their expression 
levels on the surface of unstimulated and Con A stimulated (2hrs and 72hrs) 
monocytes by F ACS analysis. It has been reported that the expression levels of 
tetraspanins and integrins were modulated under fusogenic conditions (McNally and 
Anderson, 2002; Takeda et ai, 2003). From the scatter profile of F ACS analysis it 
was observed that there were four distinct cell populations of leucocytes in our 
preparation of unstimulated cells and five distinct cell popUlations with Con A 
stimulated cells. These populations were gated on the basis of their granularity and 
size and were identified using anti CD14 and anti CD52 antibodies. The populations 
R 1 and R2 in unstimulated cell preparations are monocytes since both stain with anti 
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CD14 antibody. However, the R2 cells have a slightly different scatter profile and are 
smaller than Rl cells. They express less CD14 and more CD52 than Rl cells. They 
might possibly correspond to the pro-inflammatory (CDI4+ CDI6+) subpopulation of 
monocytes (Ziegler-Heitbrock et ai, 1993; Geissmann et ai, 2003). Staining with anti 
CD 16 antibody would be needed to try to verify this. On 2hrs Con A stimulation, a 
population of large CD14 + ve cells (R3) was observed, that presumably correspond to 
the fusing monocytes observed microscopically (section 3.2.10). For the Rl cells, 
CD9, CD63, CD81, CD29 and CD52 showed a slight Increase on 
Con A stimulation, whereas CD 14 and integrin CD 18 and CD 11 b staining decreased 
by approximately 50%. All markers increased on the R3 population of cells; however 
this may be largely due to increased cell size. CD63 staining, however, which was 
low on unstimulated Rl cells, does appear to have increased more relative to other 
markers. Because increased cell size results in increased staining by FACS, it is 
difficult to relate the data unequivocally to increased expression of the different 
markers. In retrospect, immunofluorescence microscopy may have given a better 
indication of changes in expression. Alternatively, immunoblotting of cell lysate 
samples containing equivalent amounts of protein could have been used. 
Similarly the expression pattern of all of the above membrane proteins was assessed 
using monocytes cultured for 72hrs in presence/absence of Con A, The expression of 
CD9, CD81, CDI4, CDI8, CD29 and CD52 were increased during normal culture 
condition at 37°C for 72hrs. The increase in the expression of the tetraspanins CD9 
and CD81 is particularly marked after 72hrs in culture. This is in agreement with the 
findings of Takeda and co-workers, who used immunoblotting to look at changes in 
protein expression. However, for cells treated with Con A for the same period of 
time, decreased expression levels of CD9, CD81, CDI4, CD29 and CD18 proteins 
were observed for Rl cells, whereas CD63 increased and levels of CD52 and CD82 
were similar to untreated cells. The population gated as R3 on 2hrs Con A induced 
cells was much less evident after 72hrs, possibly due to the formation of very large 
MGCs that were difficult to harvest or did not pass through the F ACS machine. The 
cells gated as R3 showed a similar overall staining profile to the Rl cells. The 
decreased expression of CD9 and CD81, and increased expression of CD63 on Con A 
treatment is again agreement with the findings of Takeda and co-workers. 
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Interestingly, Wang et al have investigated the role of inflammation and macrophage 
activation in the regulation of CD9 expression (Wang et ai, 2002). It was found that 
the expression of CD9 on primary cultures of murine peritoneal macrophages was 
down regulated by IFN-y. This down regulation was concentration dependent and 
maximal by 48hrs. The mechanism by which IFN -y decreases CD9 expression 
appears to be through the stat-l signalling pathways, since stat-l knockout mice did 
not demonstrate any reduction in CD9 expression by IFN-y treatment. It is possible 
that cytokines such as IFN-y produced on Con A stimulation may lead to the down-
regulation ofCD9 observed here and by Takeda et al (2003). 
Although THP-l cells are non-fusogenic in response to Con A stimulation (section 
3.2.11.1) they undergo aggregation. Hence F ACS analysis was carried out to assess 
the differences in expression pattern of tetraspanins in THP-l cells and monocytes 
with and without 2hrs Con A stimulation. The THP-l cells weakly express the 
tetraspanins and on stimulation with Con A there is little change in expression. By 
contrast the surface expression of tetraspanins in monocytes is higher than THP-l 
cells and expression increases on treatment with Con A. The low expression of 
tetraspanins ofTHP-l cells may in part explain why they are unable to form MGCs. 
The overall observation from this chapter is that recombinant tetraspanins EC2s did 
not alter the functions related to monocytes fusion such as cell adhesion, aggregation 
and cell numbers. From these we could conclude that the inhibitory effect shown by 
GST-EC2IEC2IHis6-EC2CD9 and CD63 on Con A induced monocyte fusion could be 
due to direct effect on fusogenic receptors of monocytes or alterations in the 
organisation of essential micro domains for the fusion process. To address these issues 
we were motivated to carry out studies described in the next chapter to assess whether 
these tetraspanins exert their effects by direct binding to monocytes. 
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CHAPTER 5 
INVESTIGATION OF EC2 TETRASPANIN 
BINDING TO MONOCYTES 
5.1. INTRODUCTION 
As described in chapter 3, the GST fusion proteins EC2CD63 and EC2CD9 showed a 
profound inhibitory effect on the fusion of Con A stimulated monocytes. This did not 
appear related directly to inhibition of adhesion or aggregation. To investigate their 
role further, attempts were made to determine if the recombinant proteins were 
binding specifically to monocytes. Initially attempts were made to investigate binding 
using indirect techniques, using antibodies directed against the GST protein. Due to 
non-specific binding of antibodies clear binding was not detected. The GST proteins 
were therefore labelled directly with fluorescent dyes, and their binding to monocytes 
investigated. 
Recently FITC, AlexaFluor 647® and rhodamine BITC labelled GST-EC2CD63 and 
GST proteins have been sent to our collaborator Dr. Cecilia Cheng-Mayer (Aaron 
Diamond AIDS Research Centre, New York, US) for their investigations on the role 
of tetraspanins in HIV -1 infection of human macrophages (Ho et ai, manuscript 
submitted). They had previously found that recombinant GST -EC2 domain of human 
tetraspanins CD9, CD63, CD81 and CD151 potently inhibited CCR5 (R5) HIV-1 
infection of macrophages with ICso values of O.11-1.2nM, in contrast to a weak 
inhibition by GST alone or by mouse CD9EC2. In addition these proteins also 
inhibited macrophage infection by virions pesudotyped with CXCR4 (X4) tropic 
HIV -1 or VSV -G glycoproteins at higher concentrations and showed a partial 
inhibitory effect on the infection of PBMC by R5 and VSV-G was but not X4 
pseudotyped viruses. The tetraspanins did not decrease CD4 or co-receptor 
expression. The study using the labelled proteins also showed the specific uptake of 
tetraspanin proteins by virus-infected cells. There were some instances of HIV -1 co-
localising with CD63. The binding of the flurochrome labelled proteins in their 
experimental system was assessed by F ACS analysis and by fluorescent microscopy 
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and some of the results are presented in section 5.2.2.5. In addition we tested the 
binding efficiency of FITC labelled GST-EC2CD9, GST-EC2CD151 and GST on 
mouse oocytes in collaboration with Dr. Eileen McLaughlin, ARC Centre of 
Excellence in Biotechnology and Reproductive Science, University of Newcastle, 
Australia and preliminary results are shown in section 5.2.2.6. It is known that CD9 
plays an important role in sperm-egg fusion, but the involvement of CD 151 is 
unknown. 
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5.2. RESULTS 
5.2.1. Binding of GST -EC2 tetraspanins to monocytes: Indirect 
assays 
5.2.1.1. Indirect immunofluorescence on unstimulated monocytes 
Attempts were made to assess the binding of GST-EC2 tetraspanins to monocytes 
using indirect immunofluorescence. In the initial attempts, fresh/matured (120hrs 
cultured) unstimulated monocytes were incubated with GST-EC2CD63, GST-
EC2CD9, or GST (10 and 20J!g.mr1) followed by goat anti GST and rabbit anti goat 
IgG-FITC in Lab-Tek® chamber slides as described in section 2.2.10.6.3. No 
difference in fluorescence between monocytes incubated with recombinant proteins or 
secondary and tertiary reagent alone was observed. Despite careful titration of the 
antibodies, and attempts to block non-specific binding by pre-incubating monocytes 
with rabbit serum no differential binding of EC2 proteins above background could be 
discerned microscopically (data not shown). Similarly labelled monocytes were 
analysed by FACS. No difference in fluorescence intensities (MFls) was observed 
between controls (cells incubated with B/BIN) and test samples (cells incubated with 
GST-fusion proteins), confirming observations made by microscopy. 
Since high backgrounds were observed using these antibodies, a different 
combination of secondary and tertiary reagent was used: mouse monoclonal anti GST 
antibody labelled with biotin followed by Extravidin-FITC. It was assumed that a 
monoclonal antibody would show greater specificity, and mouse IgG 1 antibodies 
show little binding to human monocytes Fc receptors (Partridge et aI, 1986; Woof et 
aI, 1986). Following titration of the reagents, they were used to assess binding of 
GST-recombinant proteins to monocytes cultured in Lab-Tek® chamber slides as 
described previously. No difference in staining pattern was observed between the tests 
and negative control (cells incubated with BBN instead of recombinant protein). The 
Extravidin-FITC showed strong non-specific binding with monocytes even at low 
concentrations (~2J!g.mrl). It is likely that the Extravidin-FITC binds to intracellular 
biotin molecules of monocytes when the cells are fixed and permeabilised with 
acetone. To avoid this problem binding experiments were carried out by fixing the 
cells with 2% paraformaldehyde rather than using acetone as a fixative. However. no 
differential binding of tetraspanins EC2s was clearly observed. 
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5.2.1.2. Indirect immunofluorescence on Con A stimulated monocytes 
We surmised that tetraspanin EC2s might only bind to Con A stimulated monocytes. 
Also, since inhibition of MGC formation by the tetraspanin EC2s occurred within 24 
hrs (section 3.2.10), we reasoned that any binding would occur fairly early after Con 
A stimulation. To investigate this, we carried out further binding assays by FACS 
analysis using Con A stimulated (24hrs) monocytes. The indirect binding assay was 
carried out (section 2.2.10.6.1) with GST-EC2CD9, GST-EC2CD63, GST-
EC2C153A and GST and using mouse anti GST biotin at Illg.mrl and Extravidin-
FITC at 2.25Ilg.mrl as secondary and tertiary reagents, respectively. During the 
FACS analysis we observed three different cell populations, which were Rl 
(monocytes); R3 (MGCs) and R4 (lymphocytes). (In this experiment, the R2 and R5 
populations of cells described in section 4.2.7. and 5.2.2.3 were not evident). 
o~--------------------------~ 
- R3 . . 
FSC~ 
Fig.5.2.1.Scatter profile of flow cytometry analysis with Con A stimulated 
monocytes. The cells were separated on the basis of their granularity and size: 
Rl =Monocytes (CDI4 +ve); R3=MGCs (CDI4 +ve); R4=Lymphocytes (CDI4 -ve). 
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Fig.5.2.2. Binding of GST-EC2 tetraspanins/GST to Con A stimulated monocytes. 
The monocytes were stimulated with Con A (lOllg.ml- l) for 24hrs at 37°C. The 
indirect binding assay was carried out as described in section 2.2.10.6.1 using mouse 
anti GST biotin antibody at IOllg.mrl and Extravidin-FITC at 2.5Ilg.ml-l . The results 
are the means of 1 experiment carried out in duplicate. Where R 1 =Monocytes (CD 14 
+ve); R3=MGCs (CDI4 +ve); R4=Lymphocytes (CDI4 -ve). 
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It appeared that the cell population R3 corresponding to MGCs showed very slightly 
higher binding values with GST -EC2CD9 than controls GST -EC2CD9-C 153A, GST 
and BBN. No such difference was observed from cells in populations R1 and R4, 
which correspond to monocytes and lymphocytes respectively. Unstimulated 
monocytes tested under identical condition did not show binding (data not shown). 
This suggested that Con A stimulation may affect the binding of GST-EC2 
tetraspanins. However, it was difficult to determine if differential binding of GST-
EC2 tetraspanins was occurring when similar experiments were carried out on 
monocytes cultured in chamber slides (data not shown). 
5.2.1.3. Whole cell ELISA on monocytes 
Whole cell ELISA (section 2.2.10.6.5) was used as an alternative method to 
investigate tetraspanin EC2 binding to monocytes. The binding of GST-EC2CD9, 
GST-EC2CD63, GST-EC2CD9-C153A and GST alone on unstimulated and Con A 
stimulated monocytes were tested. Monocytes were cultured in 96 well microtitre 
plates for 12hrs, fixed with 0.25% glutaraldehyde and the binding of GST-
recombinant proteins assessed using goat anti GST antibody and mouse anti 
goat/sheep HRP as described in section 2.2.10.6.5. 
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Fig.5.2.3. Binding studies with GST-EC2 tetraspanins/GST on unstimulated /Con A 
stimulated monocytes by whole cell ELISA. Monocytes were cultured in the presence 
or absence of Con A (10~g.mrl) for 12hrs as described in section 2.2.10.6.5. GST-
EC2CD63/CD9/C153A1GST was tested at 20~g.ml-l , and binding was detected using 
goat anti GST and mouse anti goat/sheep HRP antibodies. The OD@450nm was 
measured using a plate reader. The results are the mean absorbance of 1 experiment 
carried out in duplicate. 
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GST-EC2CD63 showed a slightly higher binding value with Con A stimulated 
monocytes as compared to GST-EC2CD9, GST-EC2C153A and GST control. No 
differences in binding values were observed between the test and control with 
unstimulated monocytes. However, a problem with this assay system was that during 
processing, monocytes detached from the 96 well microtitre plates, giving rise to 
variable results when attempts were made to repeat this. 
5.2.1.4. Whole cell ELISA on THP-1 cells 
As an alternative to using peripheral blood monocytes, attempts were made to 
investigate binding of GST-EC2 tetraspanins to the monocytic leukaemic cell line 
THP-1. These cells were stimulated to adhere by culturing them in 96 well microtitre 
plates pre coated with poly-L-Iysine at 50Jlg.ml-1. 
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Fig.5.2.4. Binding studies with GST-EC2 tetraspanins/GST on unstimulated or Con A 
stimulated THP-1 cells by whole cell ELISA. THP-1 cells were cultured in the 
presence or absence of Con A (lOJlg.mr 1) for 12hrs as described in section 2.2.10.6.5 . 
GST-EC2CD63/CD9/C153A1GST was tested at 20Jlg.ml-1, and binding was detected 
using goat anti GST and mouse anti goat/sheep HRP antibodies. The OD@450nm 
was measured using a plate reader. The results are the mean absorbance of 1 
experiment carried out in triplicate. 
The results showed slightly higher binding values with GST-EC2CD63 and GST-
EC2CD9 on both unstimulated and Con A stimulated THP-1 cells relative to GST 
alone (Fig.5.2.4). However, since the THP-1 cells could not be induced to undergo 
MGC formation (Section 3.2.11.1), the relevance of this low level of binding to 
monocyte fusion is unclear. 
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5.2.2. Binding of GST -EC2 tetraspanins to monocytes: Direct 
assays 
5.2.2.1. Labelling GST -EC2CD9, GST -EC2CD63 and GST with fluorescent dyes 
After the problems encountered in trying to use indirect binding assays to investigate 
the binding, direct labelling of these proteins with fluorescent dye (FIT C) was 
attempted as described in section 2.2.9.2. The labelling appeared successful and the 
protein concentrations of the labelled proteins (estimated by Bradford assay as 
described in section 2.2.9.5) and the estimates of the molar FITC:protein ratio is 
shown in table.5.2.1. 
Labelled Protein 
GST-EC2CD9-FITC 
GST -EC2CD63-FITC 
GST-FITC 
GST-EC2CD63-rhod BITC 
GST -rhod BITC 
GST-EC2CD63-AlexaFluor® 647 
0.40 
0.36 
0.40 
1.08 
1.70 
1.40 
Molar flurochrome: Protein ratio 
4.2:1 
4.8:1 
4.8:1 
1.5:1 
1.4:1 
3.5:1 
GST-AlexaFluor® 647 1.60 1.8:1 
Table.5.2.1. The proteins concentration and molar FITC/rhodamine-BITCI Alexa 
Fluor® 647: Protein ratio of labelled GST fusion proteins. 
The possible consequences of FITC labelling of GST-EC2CD9 and GST-EC2CD63 
on proper folding was assessed by testing the biological activity of the FITC labelled 
proteins at 20/lg.mr' concentrations on Con A induced monocyte fusion assay in Lab-
Tek® chamber slides as described in section 2.2.10.4.1. After 72hrs of incubation at 
37°C light microscope images were captured. 
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(~) (lJ) 
Fig.5.2.5. Biological activity of FITC labelled GST-EC2CD63 on Con A stimulated 
monocytes. The experiment was carried out as described in section 2.2.1 0.4.1 with 
20~g.mrl GST-EC2CD63-FITC. The light microscope images were captured with 
Nikon inverted light microscope using 20x objective. Con A stimulated monocytes 
(A); Con A stimulated monocytes with GST-EC2CD63-FITC (B). 
The FITC labelled GST-EC2CD63 showed strong inhibition of Con A induced MGC 
formation compared to Con A control (Fig.5.2.5). This finding indicates that the FITC 
labelling conditions do not affect the biological activity of the proteins. Similarly the 
GST-EC2CD63 and GST were labelled with rhodamine B isothiocyanate (rhodamine-
BITC) and with AlexaFluor 647® as described in section 2.2.9.3 and 2.2.9.4 and the 
biological activity of the labelled proteins was tested (section 2.2.10.4.1). Labelling 
appeared successful and the estimates of protein concentration were determined using 
Protparam Tool software [from the Swiss Protein Database, http://www.expasy.cg. 
which is based on the calculation of protein extinction coefficients from amino acid 
sequence data (Gilland Hippel (1989)] as described in section 2.2.9.3.1 (since the dyes 
interfere with the Bradford assay). The protein concentration and molar dye:protein 
ratios are given in table.5.2.1. The labelled proteins were biologically active 
(Fig.5 .2.6&Fig.5 .2. 7). 
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Fig.5.2.6. Biological effect of rhodamine-BITC labelled GST-EC2CD63 and GST on 
Con A induced monocyte fusion. The experiment was carried out as described in 
section 2.2.10.4.1 with/without rhodamine labelled GST proteins at 20~g.rnl-l. The 
cells were stained with FITC labelled anti CD52 antibody and the nuclei stained with 
propidium iodide. The results are the mean values of 1 experiment carried out in 
triplicate. 
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Fig.5.2.7. Biological effect of AlexaFluor 647® labelled GST-EC2CD63 and GST on 
Con A induced monocyte fusion. The experiment was carried out as described in 
section 2.2.10.4.1 with/without AlexaFluor 647® labelled GST proteins at 20~g.mrl. 
The cells were counter stained with FITC labelled anti CD52 antibody and the nuclei 
stained with propidium iodide. The results are the mean values of 1 experiment 
carried out in triplicate. 
5.2.2.2. Binding of labelled GST -EC2 tetraspanins to monocytes: microscopy 
Binding assays with FITC labelled GST-EC2CD63, GST-EC2CD9 and GST were 
carried out with monocytes cultured for 2hrs in the presence/absence of Con A in 
Lab-Tek® chamber slides as discussed in section 2.2.10.6.4. The FITC labelled 
proteins were used at 6~g.mrl and 3~g.mrl since at 20~g.rnl-1 the fluorescence 
observed was too bright. 
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Little binding of GST-EC2CD63-FITC and GST-EC2CD9-FITC was observed with 
unstimulated monocytes. However, on Con A stimulated cells, binding of GST-
EC2CD63-FITC and GST-EC2CD9-FITC was observed. The fluorescence intensity 
was stronger than for GST-FITC binding. Although the staining with FITC labelled 
GST-EC2CD63 and GST-EC2CD9 appeared good, a bright fluorescence was 
concentrated only in certain regions of stimulated/fused cells. It was thought that this 
might be a cluster of receptors/binding motifs for GST-EC2CD63/GST-EC2CD9, 
which emerged and accumulated on the stimulated cell surface after Con A 
stimulation (Fig.5.2.8). 
Fig.5.2.8. Binding of FITC labelled GST proteins to monocytes in Lab-Tek chamber 
slides. The experiment was carried out as described in section 2.2.10.6.4 using live 
cells at 4°C with FITC labelled GST-EC2CD63/CD9/GST at 6flg.rnl-l . After fixation 
the nuclei of the cells stained with propidium iodide. Unstimulated monocytes (A-C); 
Con A stimulated monocytes (D-I). Treatments: GST-EC2CD63-FITC (A, D&G); 
GST-EC2CD9-FITC (B, E&H); GST-FITC (C, F&I). The images were captured with 
Nikon Eclipse E400 immunofluorescence microscope using 20x objective (A-F); 40x 
objective (G-I). 
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The binding of FITC labelled GST-EC2CD63 on 2hrs Con A stimulated monocytes 
was also assessed with Deltavision restoration microscopy using Lab-Tek chamber 
slide preparation. The nuclei of stained cells were counter stained with propidium 
iodide or bisbenzimide. The quality of the images was disappointing, but GST-
EC2CD63-FITC again showed a strong localised binding to some of the stimulated 
cells (Fig.5.2.9). 
(A) (B) 
Fig.5.2.9. Binding of FITC labelled GST proteins to monocytes in Lab-Tek® chamber 
slides. The experiment was carried out as described in section 2.2.10.6.4 with FITC 
labelled GST-EC2CD63 at 6Jlg.mr1. The nuclei of the cells stained either with 
propidium iodide or bisbenzimide (Hoechst dye) as described in section 2.2.10.3.2, 
where nuclear staining with propidium iodide (A): bisbenzimide (B). The images 
were captured with Deltavision restoration microscope using 100x objective. 
The binding of FITC labelled GST-EC2CD9/CD63 and GST on Con A stimulated 
monocytes was also assessed using cytospin slide preparation. In this experiment the 
monocytes were stimulated with Con A to a final concentration of 10Jlg.mr l for 2hrs 
(section 2.2.11), the cells were harvested (section 2.2.2.1) and the cytospin slides were 
prepared as mentioned in section 2.2.4.1 by incubating the fixed and permeabilised 
cell smear with FITC labelled GST-EC2CD9/CD63 and GST control. The 
immunofluorescence images were captured using a Nikon Eclipse E400 
immunofluorescence microscope at 100x objective. 
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Fig.S.2.10. Binding ofFITC labelled GST-EC2 tetraspanins/GST control on 2hrs Con 
A stimulated monocytes by direct cytospin slide preparation. The cells were fixed in 
slides with acetone as described in section 2.2.4.1 and incubated with SOIlI of FITC 
labelled GST-EC2CD63/GST at 6llg.mrl for Ihr at 4°C. The nuclei of cells were 
stained with propidium iodide and the slide was processed as mentioned in section 
2.2.4.1. The different treatments are: Con A stimulated monocytes stained with GST-
EC2CD63-FITC (A)&(C); GST-FITC (B)&(D). The immunofluorescence images 
were captured with Nikon Eclipse E400 immunofluorescence microscope using 100x 
objective. 
Stronger binding was observed with FITC labelled GST-EC2CD63 than GST on Con 
A stimulated monocytes (Fig.S .2.10). In this case, all cells appeared to be stained but 
it was not really possible to determine from these images what cell structures are 
stained. 
A final attempt was made to use Deltavision restoration microscopy to investigate the 
binding of rhodamine BITC labelled GST -EC2CD63 and GST proteins on 2hrs Con 
A stimulated monocytes in Lab-Tek® chamber slides. The cells were counter stained 
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with anti CDS2-FITC antibody as described in section 2.2.10.3.2. The Deltavision 
restoration microscopy images were captured using the IOOx objective. 
Fig.S.2.II. Binding of rhodamine BITC labelled GST proteins on Con A stimulated 
monocytes. The experiment was carried out as described in section 2.2.10.6.4 with 
rhodamine BITC labelled GST-EC2CD63/GST at 6~g.mrl. The cells were counter 
stained with FITC labelled anti CDS2 antibody as described in section 2.2.10.3.2. The 
images were captured with Deltavision restoration microscope using IOOx objective. 
Where Con A stimulated monocytes with GST-EC2CD63-rhodamine BITC (A); 
GST-rhodamine BITC (B). The blue arrows represent the nuclei of fusing/fused 
monocytes. 
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The GST-EC2CD63 rhodamine BITC showed some preferential binding with 2hrs 
Con A stimulated monocytes relative to GST-rhodamine BITC (Fig.S .2.II ). Again, 
all cells here appeared to give some staining. There appeared to be granular staining 
with GST -EC2CD63 around the nucleus of Con A stimulated cells. Unfortunately, the 
anti CDS2 counter stain did not give bright staining here. We were unable to repeat 
this experiment to obtain clear images of the cellular structure due to problems with 
Departmental Deltavision microscopy facility during the later stages of the project. 
5.2.2.3. Binding of labelled GST-EC2 tetraspanins to monocytes: FACS analysis 
To assess binding of GST-EC2s quantitatively flow cytometry (FACS) analysis was 
used (section 2.2.10.6.2). Monocytes were cultured in the presence or absence of Con 
A for 2hrs prior to harvesting and analysis of binding. As described in section 4.2.7, 
scatter profiles of unstimulated and Con A stimulated monocytes (Fig.S.2.12) 
indicated that there were four distinct cell populations for unstimulated cells and five 
distinct cell populations with Con A stimulated cells . 
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Fig.S.2.12. Scatter profiles of flow cytometry analysis with unstimulated and Con A 
stimulated monocytes. The cells were separated on the basis of their granularity and 
size: RI=Monocytes (CDI4 +ve); R2=Monocytes (CDI4 +ve); R3=MGCs (CDI4 
+ve); R4=Lymphocytes (CDI4-ve) and RS=Unknown lymphocyte population (CDI4 
-ve). Unstimulated (A); 2hrs Con A stimulated (B) leucocytes. 
As described in chapter 4, based on their scatter profiles and staining with the 
monocyte marker (anti CDI4) and lymphocyte/monocyte marker (anti CDS2) the 
cells and their corresponding regions are: Rl =monocytes; R2=monocytes; 
R3=MGCs; R4=lymphocytes and RS=unknown lymphocyte population. The 
population RS is CD 14 negative and CDS2 positive hence it is not a monocyte 
population but it could be another lymphocyte population. In addition Con A 
stimulation appears to induce increased cell numbers of the RS population when 
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compared to unstimulated cells in the same gate. The percentages of cells gated in the 
different regions are given table 5.2.2. 
Leucocytes 
Unstimulated 
Con A stimulated 
Total numbers of cells in different populations (%) 
R1 R2 R3 R4 R5 
47.06 3.16 0.49 47.42 1.82 
25.43 10.00 27.45 30.50 6.57 
Table.5.2.2. Total numbers of cells in different populations (%) gated during the 
FACS analysis of leucocytes. R1=Monocytes (CD14 +ve); R2=Monocytes (CD14 
+ve); R3=MGCs (CD14 +ve); R4=Lymphocytes (CD 14-ve) and R5=Unknown 
population (CD14 -ve). 
From these studies it is clear that changes in monocyte morphology occur upon 
stimulation with Con A and this result reconfirms the observation that made in section 
4.2.7. Our study mainly focussed on the binding of FITC labelled GST-EC2 
tetraspanins on large multinucleated giant cells of monocytes (MGCs) apart from 
other cell populations. 
The binding of GST-EC2CD9/GST-EC2CD63 and GST was tested on monocytes that 
had/had not been stimulated with Con A for 2hrs. Binding was assessed at 4°C and 
37°C. The mean fluorescence intensity of five different positive cell populations was 
measured. 
~-------------------------------------------------------, 
Fig.5.2.13. Binding ofFITC labelled GST-EC2CD63 and GST control on 2hrs Con A 
stimulated monocytes. The plot shows the number of gated cells (counts) as a function 
of their fluorescence intensity (FL1-H) in R3 (MGCs), where GST-EC2CD63-FITC 
binding shift (Green); GST-FITC binding shift (Blue). 
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Fig.5.2.14. Binding of FITC labelled GST-EC2CD63, GST-EC2CD9 and GST to 
cells cultured in the presence/absence of Con A (10f.1g.mrl for 2hrs). Binding of 
recombinant GST-EC2 tetraspanins (6f.1g.mr l) and GST (12f.1g.mrl) was assessed at 
4°C or 37°C as described in section 2.2.10.6.2 by FACS. Where Rl=Monocytes 
(CDI4+ve); R2=Monocytes (CD 14+ve); R3=MGCs (CDI4+ve); R4=Lymphocytes 
(CDI4-ve) and R5=Unknown lymphocyte population (CD 14-ve). Unstimulated 
(A&C); 2hrs Con A stimulated (B&D) leucocytes. Binding study at 4°C (A&B); 37°C 
(C&D). 
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The FITC labelled GST proteins showed little binding to unstimulated monocytes in 
any of the gated regions. Whilst cells in Rl showed little change in binding on Con A 
stimulation, CD 14 +ve cells in gates R3 and R2 showed around five fold more intense 
staining with GST-EC2CD63-FITC, three fold more with GST-EC2CD9-FITC and 
two fold more with GST-FITC than unstimulated cells. 
At 37°C, the binding of GST-EC2CD9/GST-EC2CD63 and GST was very little 
increased for unstimulated cells. On Con A stimulation, there is an increase in 
fluorescence intensity relative to 4°C, but the overall pattern observed is similar (i.e. 
GST-EC2CD63 >GST-EC2CD9>GST) for R2 and R3 monocytes. This indicates that 
there is selectivity in binding/uptake of the GS T -EC2 tetraspanin proteins. 
To reconfirm the binding results with FITC labelled proteins the binding assay was 
carried out with AlexaFluor 647® labelled GST-EC2CD63 and GST at 4°C on 
unstimulated and Con A stimulated monocytes by F ACS as described in section 
2.2.10.6.2. There was some binding of the AlexaFluor 647® labelled proteins to all 
populations of unstimulated cells (Fig.5.2.15). However, on Con A stimulation, 
greater binding of labelled GST-EC2CD63 to the monocyte (Rl, R2 and R3) 
populations was observed relative to the GST control. 
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Fig.5.2.15. Binding of AlexaFluor 647® labelled GST-EC2CD63 and GST to cells 
cultured in the presence/absence of Con A (lOJ.!g.mr l for 2hrs). Binding of 
recombinant proteins (6J.!g.mr l ) was assessed at 4°C as described in section 2.2.10.6.2 
by FACS. Where Rl=Monocytes (CDI4+ve); R2=Monocytes (CDI4+ve); R3=MGCs 
(CDI4 +ve); R4=Lymphocytes (CDI4-ve) and R5=Unknown lymphocyte population 
(CD 14-ve). Unstimulated (A); 2hrs Con A stimulated (B) leucocytes. The results are 
the mean value of 1 experiment carried out in triplicate (A); 2 independent experiment 
in triplicate (B). 
To determine if this binding was specific, attempts were made to block the binding of 
GST-EC2CD63-Alexa to Con A stimulated cells with excess unlabelled recombinant 
proteins. 
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Fig.S.2.16. Specificity of binding of GST-EC2CD63-Alexa. 2hrs Con A stimulated 
monocytes were incubated with GST-EC2CD63-Alexa (6~g.ml-l) in the presence or 
absence of unlabelled proteins (100~g.mrl): GST-EC2CD63, EC2CD63 (generated 
by thrombin cleavage of GST-EC2CD63), His6-EC2CD63, GST-EC2CD9 or GST at 
4°C. by FACS. The experiment was carried out as described in section. 2.2.10.6.2 by 
F ACS. The results are the mean values of 2 independent experiments carried out in 
triplicate, where Rl=Monocytes (CDI4+ve); R2=Monocytes (CDI4+ve); R3=MGCs 
(CD 14 +ve). Where UL denotes unlabelled. 
Binding of GST-EC2CD63-Alexa to the R3 sub population was specifically inhibited 
by unlabelled GST-EC2CD63, EC2CD63 (cleaved CD63) and His6-EC2CD63 
(inhibition of 69.09%, 61.90% and 70% respectively) but not by unlabelled GST-
EC2CD9 or GST. Binding of GST -EC2CD63 to Rl monocytes also appeared 
specific, since a similar inhibition pattern was observed. The specificity of binding to 
the R2 population is less clear, since unlabelled GST gave some inhibition. Overall, 
however, the results indicate that GST-EC2CD63 can bind to 
Con A stimulated monocytes specifically (Fig.S.2.16). 
5.2.2.4. Binding of fluorescent labelled GST -EC2 tetraspanins to THP-1 cells: 
FACS analysis 
The binding ofFITC labelled GST-EC2CD9, GST-EC2CD63 and GST was tested on 
unstimulated and Con A stimulated THP-l cells at 4°C by F ACS as described in 
section 2.2.10.6.2. The results are given in Fig.S .2.17. 
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Fig.5.2.17. Binding of FITC labelled GST-EC2CD63, GST-EC2CD9 and GST on 
THP-l cells cultured in the presence/absence of Con A (10flg.mr1 for 2hrs). Binding 
of recombinant proteins (6flg.mr1) was assessed at 4°C as described in section 
2.2.10.6.2 by F ACS. The results are the mean values of 1 experiment carried out in 
triplicate. 
No difference III binding between unstimulated and Con A stimulated cells was 
observed. It indicates that GST-EC2CD63 and GST-EC2CD9 may only bind to cells 
capable of fusing. 
Similarly the binding of AlexaFluor 647® labelled GST-EC2CD63 and GST was 
tested on unstimulated and Con A stimulated THP-l cells at 4°C by F ACS as 
described in section 2.2.10.6.2 (Fig.5.2.1S). 
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Fig.5 .2.1S. Binding of AlexaFluor 647® labelled GST-EC2CD63 and GST on THP-I 
cells cultured in the presence/absence of Con A (10flg.ml-1 for 2hrs). Binding of 
recombinant proteins (6flg.mr1) was assessed at 4°C as described in section 2.2.10.6.2 
by F ACS. The results are the mean values of 1 experiment carried out in triplicate. 
A slight increase in GST-EC2CD63-Alexa binding was observed on Con A 
stimulation. However, the mean fluorescence intensities observed with GST-
EC2CD63-Alexa on unstimulated and Con A stimulated THP-l cells were very low 
(~ 15 times less than the values observed with monocytes). 
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5.2.2.5. Binding studies with AlexaFluor 647® labelled GST-EC2CD63 on HIV-1 
infection of macrophages 
As described earlier (section 5.1) our collaborator Dr. Cecilia Cheng-Mayer (Aaron 
Diamond AIDS Research centre, New York) tested the binding of AlexaFluor 647 
labelled GST-EC2CD63 and GST in HIV-l infection of human macrophages. The 
binding was assessed by using Deltavision restoration microscopy with dual labelling 
experiments using Vpr-eGFP virus and AlexaFluor 647® labelled GST-
EC2CD63/GST. The results showed that GST-EC2CD63 Alexa is binding more 
strongly to the macrophages than GST-Alexa (Fig.5.2.19&Fig.5.2.20). 
Fig.5.2.19. Binding of GST -EC2CD63AlexaFluor 64 with HIV -1 infection of 
peripheral blood macrophages. The cells were pre incubated with O.IIIlM GST-
EC2CD63/GST labelled with AlexaFluor 647® (red) for Ihr before the addition of 
Vpr-eGFP virus (green). After fixation and permeabilization, cell membranes were 
stained with Con A-rhodamine (blue). Treatments: GST-EC2CD63 Alexa (A&B); 
GST-Alexa (C&D). The images were captured with Deltavision restoration 
Illicroscope. 
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Fig.5.2.20. Binding of GST-EC2CD63 AlexaFluor 647® with HIV-1 infected 
peripheral blood macrophages/monoyctes. The cells were pre incubated with 0.11 ~M 
GST-EC2CD63 labelled with AlexaFluor 647 (red) for 1hr before the addition ofVpr-
eGFP virus (green). After fixation and permeabilization, cell membranes were stained 
with Con A-rhodamine (blue). Three representative images from Deltavision 
restoration microscopy are shown, with co-localisation of virus and CD63EC2 
indicated by arrows. 
5.2.2.6. Binding of FllC-labelied GSl -EC2 tetraspanins with mouse oocytes 
The FITC, AlexaFluor 647® and rhodamine BITC labelled GST-EC2CD63 and GST-
EC2CD9 showed binding reactivity in our experiments on monocyte fusion and in 
studies by our collaborator Dr. Cecilia Cheng-Mayer on HIV -1 infection of 
macrophages. We further evaluated the binding of FITC labelled GST-EC2CD9 and 
GST-EC2CD151 on mouse oocytes at our collaborator Dr. Eileen McLaughlin's 
laboratory at University of Newcastle, Australia. The experiment was carried out as 
described in section. 2.2.l 0.7. 
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Fig.5.2.21.Binding of FITC labelled GST-EC2 tetraspanins to oocytes. The 
experiment was carried out as described in section 2.2.10.7 with FITC labelled GST-
EC2CD9/CD1511GST at 6Ilg.ml-1. The images were captured using Nikon Eclipse 
E400 immunofluorescence microscope. GST-EC2CD9-FITC (A&B); GST-
EC2CD151 -FITC (C&D); GST-FITC (E); Media control (F). The lmages were 
captured with Carl-Zeiss confocal microscope using 250x objective. 
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The results showed that the GST-EC2CD9-FITC and GST-EC2CD151-FITC are 
binding to mouse oocytes more strongly than GST-FITC or the media control. The 
binding is prominent at the microvilli region of the oocytes. This indicates that the 
binding of GST -EC2-FITC labelled proteins is specific, although it would be 
necessary to show inhibition of binding by unlabelled proteins to confirm this. 
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5.3. DISCUSSION 
The experiments described in chapter 4 indicated that the effects of CD63 and CD9 
EC2s on MGC formation were not directly related to inhibitory effects on cell 
adhesion, aggregation or cell numbers. To further investigate their possible 
mechanism of actions, attempts were made to determine whether they were binding, 
or being specifically taken up, by monocytes. It was not possible to unequivocally 
demonstrate binding of GST -EC2 tetraspanins using indirect techniques due to non-
specific binding of secondary reagents and also the binding was not very strong. 
Labelling of GST-EC2CD9 and GST-EC2CD63 with fluorescent dye 
(FITC/rhodamine BITCI AlexaFluor 647®) was therefore attempted. The conjugations 
were successful and yielded proteins that were still biologically active (i.e. inhibited 
MGC formation). Microscopic analysis with FITC labelled proteins showed some 
preferential binding of GST-EC2CD63 and GST-EC2CD9 to Con A stimulated cells, 
although GST alone was also binding to some extent. Interestingly, in some 
preparations it appeared that there was bright labelling of only certain Con A 
stimulated cells. As mentioned in chapter 1, studies using knockout mice have very 
recently shown that the seven-transmembrane spanning molecule DC-STAMP is 
crucial to the cell-cell fusion giving rise to osteoclasts and FBGCs (Yagi et ai, 2005). 
It was shown that osteoclast precursors from the DC-STAMP knockout mice could 
still undergo fusion with precursors from wild type mice. This suggests that 
expression of DC-STAMP only by a "founder" cell that initiates fusion is necessary. 
This is consistent with one macrophage taking the lead in "cellocytosing" another 
(Vignery, 2005a; Vignery, 2005b). Vignery suggests that once fusion of two cells has 
been initiated, that cell becomes the "leader" or "master" fuser and can fuse with 
other monocyte or multinucleated cells (Vignery, 2005b). Possibly labelled 
tetraspanin EC2s might be staining such "master" cells. However, other microscopy 
data was not consistent with this. Unfortunately, due to problems with Departmental 
Deltavision microscopy facility during these studies, it was difficult to obtain clear 
images of the cellular structures that the GST-EC2 proteins were labelling. Had time 
permitted these experiments would have been repeated and extended e.g. using 
subcellular markers. It would also have been interesting to look at different time 
points after Con A stimulation. 
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To try to verify if specific binding was occurring and to obtain more quantitative data. 
binding of the labelled GST-EC2 proteins was analysed by flow cytometry. FACS 
analysis showed increased binding of GST-EC2CD63 and GST-EC2CD9 on Con A 
stimulated monocytes relative to the GST control. FITC labelled GST -EC2CD63 and 
GST -EC2CD9 showed good binding at 4°C, which indicates specific binding, not just 
uptake. Increased staining was observed at 37°C, which presumably reflects some 
uptake, but the preferential staining of GST-EC2CD63 and GST-EC2CD9 relative to 
GST was still apparent, indicating specificity. GST-EC2CD63 labelled with 
AlexaFluor 647® also showed preferential binding to Con A stimulated monocytes, 
and this conjugate appeared more stable than FITC-Iabelled protein (FITC appeared 
to dissociate from the proteins on storage leading to reduced specific binding and 
higher backgrounds). Since GST also shows some binding to Con A stimulated 
monocytes the specificity of GST-EC2CD63 binding was assessed using excess 
unlabelled protein to try to block binding of labelled protein. Unlabelled GST-
EC2CD63, EC2CD63 (generated by thrombin cleavage from the GST fusion protein) 
and His6-EC2CD63 inhibited the binding of GST-EC2CD63-Alexa to Con A 
stimulated monocytes. However, no inhibition of binding to the RI and R3 
populations ofmonocytes was seen with unlabelled GST or GST-EC2CD9, indicating 
that the binding was CD63-EC2 specific. 
It is not yet clear how the binding of the tetraspanin EC2 regions to Con A stimulated 
monocytes relates to their inhibition of MGC formation. Both indicate a direct 
interaction of EC2CD63 with a monocyte membrane protein. It is possible that the 
proteins are binding to an as yet unidentified receptor and it will be of great interest to 
try to identify the molecule/s that these proteins are interacting with. The receptor 
could be a known tetraspanin-associated molecule, such as an integrins, or may be a 
newly emerging fusion receptor. If time had permitted, we might have carried out 
immuno-precipitation and cross-linking studies to identify the binding motif of 
EC2CD63 and associated molecular partners respectively. To date, no direct 
interaction of CD63 with other proteins has been reported, although many secondary 
or tertiary interactions, probably within TEMs, are known (Berditchevski, 2001; 
Hemler, 2003). Such interactions are assumed to be weak or indirect. However, it is 
possible that the recombinant EC2s, particularly if present as dimers or higher 
multimers (Kitadokoro et ai, 2001) could interact with TEM components with 
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sufficient affinity to gIve detectable binding. Hence EC2 might bind to TEM-
associated proteins such as integrins and disrupt interactions required for fusion. It is 
also conceivable that the EC2s might participate in homotypic or heterotypic 
interactions with tetraspanins expressed on the monocyte membranes. 
The binding of GST-EC2CD9-FITC with Con A stimulated monocyte does not 
appear to be as strong as EC2CD63. Also, since unlabelled GST-EC2CD9 does not 
inhibit GST-EC2CD63 binding to monocytes, it appears that the proteins may bind to 
distinct sites. Hence EC2CD9 effects on monocyte fusion might be different from 
GST-EC2CD63. Direct interactions of CD9 with transmembrane immunoglobulin 
gene superfamily members named EWI-F and EWI-2 (also called PGLR, CD9P-I, 
and FPRP) are known to occur (chapter I, 1.1.4.1; Hemler, 2003). Whether these 
proteins are involved in fusion is not yet known. As discussed above, it is also 
possible that CD9EC2 could be interacting with components of TEMs and modifying 
their activity. 
Little or no binding of labelled GST proteins to THP-l cells was observed, even on 
Con A stimulation. This is further evidence that binding of GST-EC2CD63 or CD9 is 
specific to stimulated monocytes. 
Although some tetraspanins have been shown to participate in primary interactions 
via their EC2 regions (reviewed in Martin et ai, 2005; Hemler, 2003) there have been 
few demonstrations of direct binding of tetraspanin EC2 proteins to cells. Wong and 
co-workers have demonstrated the specific binding of GST -EC2CD9 and GST-
EC2CD81 on hamster oocytes by indirect immunofluorescence assay (Wong et ai, 
2001). Since the surface expression of CD9 and CD81 are high on oocytes it is 
possible that GST-EC2CD9 and GST-EC2CD81 could form dimers or higher 
multimers with naturally expressed CD9 or CD81. Otherwise there may be direct 
binding to unidentified receptors or CD9 and CD81 associated proteins such as 
integrins, which may affect tetraspanin mediated cell signalling essential for the 
sperm-egg fusion. 
In addition we sent FITC, Alexa-Fluor 647® and rhodamine BITC conjugated GST-
EC2CD63 and GST to our collaborator Dr. Cecilia Cheng-Mayer, New York, u.S. to 
test the binding of GST-EC2CD63 on macrophages in their experimental system 
using HIV -1 virus. They found that GST -EC2CD63 is specifically binding/taken up 
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by macrophages and prevents the infection of HIV -1 virus with macrophages (Ho et 
ai, manuscript submitted). 
We tested the binding efficiency of FITC conjugated GST-EC2CD9 and GST-
EC2CD 151 on mouse oocytes at ARC Centre of Excellence in Biotechnology and 
Reproductive Science, University of Newcastle, Australia. The tetraspanin proteins 
showed stronger binding to the oocytes than GST control, indicating that the binding 
of GST-EC2 proteins are specific. Already it has been reported that CD9 is essential 
for the sperm egg-fusion (Miyado et ai, 2000; Le Naour et ai, 2000; Kaji et ai, 2000). 
At this stage the collaborators are unable to conclude the role of CD 151 on sperm-egg 
fusion based on the binding results. 
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CHAPTER 6 
PRELIMINARY CHARACTERISATION OF A 
HUMAN scFv WITH PUTATIVE SPECIFICITY 
FOR CD63 
6.1. INTRODUCTION 
This chapter describes attempts to define the specificity of a putative anti CD63 
human scFv antibody. The antibody was selected from a phage display library 
generated from peripheral B-Iymphocytes of patients with ocular melanoma. Library 
generation and selection of the antibody was carried out by a previous worker in the 
laboratory, Dr. Ann Marshall. 
Melanoma is a very serious form of skin cancer that begins in melanocytes and occurs 
more often in people with fair skin that burns or freckles easily 
(http://www.melanoma.com). The incidence of malignant melanoma has risen over 
the last 30 years and is now increasing at a faster rate than any other cancer in the US 
(Chung et ai, 2004; Smith et ai, 2001). Although early stage of the disease can be 
treated successfully with surgery, once melanoma has spread to regional lymph nodes 
or distant sites, the prognosis is much worse (e.g. survival is predicted to be less than 
12 months for patients with stage IV disease (Smith et ai, 2001)). Among the different 
types of melanoma, uveal melanoma is the most common intra ocular tumour in 
adults. Current treatment, such as radiation and enucleation can control primary 
tumour growth (Muller et ai, 2005), but neither is able to control metastatic tumour 
spread i.e. melanoma appears to be relatively resistant to conventional chemotherapy 
and radiotherapy, leading to a search for alternative treatments. Since there is 
evidence for an immune response to melanoma, there has been a great deal of interest 
in exploring immunotherapeutic approaches (Smith et ai, 2001; Komenaka et ai, 
2004). Whilst these have mostly been based on using melanoma antigens as T cell 
vaccines, there has also been interest in using antibody-based strategies (Lutzky et ai, 
2002: Altomonte and Maio, 2002). 
Traditionally, tumor-associated antigens have been identified by hybridomas derived 
from mice immunised with tumor cells. Several types of immunologic probes have 
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been used to characterize the antigenic profile of human melanoma cells. Among 
them, mouse mAbs have been the most effective in identifying a number of human 
melanoma associated Ags (MAAs) with distinct immunochemical and functional 
properties (Reisfeld et ai, 1987; Herlyn et ai, 1988; Graf et ai, 1989). Attempts have 
also been made to identify human melanoma associated antigens (MAAs) using both 
sera from patients with malignant melanoma and human mAb. Human mAb have 
been successful only to a limited extent primarily because of the methodological 
difficulties in constructing stable human mAb secreting hybridomas and cell lines 
(lrie et ai, 1982; Houghton et ai, 1983). More recently, antibody phage display has 
been used for the production of antibodies (Burton 1991; Winter et ai, 1994). The 
main advantage of this technique is that human antibodies can be produced much 
easier than is possible with human hybridomas. These can then be developed for 
therapeutic use without the need to humanize mouse mAb. Furthermore, by changing 
the selection conditions, the antigen binding properties of antibody phage can be 
influenced, e.g. by selection for high affinity antibodies or specificity for a pre-
determined epitope (Meulemans et ai, 1994; Hawkins et ai, 1992). The random 
pairing of V domains has the potential to generate artificial antibody specificities and 
could overcome the problem of the immune dominance of some antigens and epitopes 
in mice that limit the spectrum of specificities obtained with hybridomas. 
Antibody phage display techniques have been used both to characterise melanoma 
immunogens (Desai et ai, 1998; Li et ai, 2001) and to try to develop reagents for 
passive immunotherapy (Kupsch et ai, 1999; Wang et ai, 1999). Noronha et ai, 1998 
have isolated a human single chain fragment (scFv) by panning a synthetic phage 
antibody library with human melanoma cell lines such as S5 and SK-MEL28. The 
authors demonstrated that the scFv fragment reacts specifically with melanoma 
associated high molecular weight antigen 'HMW -MAA', which appears to be 
immunodominant in vitro and in vivo. Kupsch et ai, (1999) have constructed a human 
single chain scFv phage library using peripheral blood mononuclear cells of donor 
with increased auto- antibody titre to melanoma. The positive selection of library was 
carried out with human melanoma cells lines such as DX3 and HMB2 and the 
negative selection on human peripheral blood mononuclear cells. In this study the 
authors isolated two scFv clones that appeared largely specific to tumour cells 
although the antigen was not identified. 
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Originally CD63 was described as melanoma antigen, ME491, whose expression 
decreases as the disease progresses (Atkinson et aI, 1985; Hotta et aI, 1988; Kondoh 
et aI, 1993) but normal melanocytes express little CD63 (Sikora et aI, 1987; Hotta et 
aI, 1988). Antibodies to CD63 have been identified in the sera of melanoma patients 
(Smith et aI, 1997; Li et aI, 2003) and it has been suggested that decreased expression 
of CD63 in metastatic melanoma is consistent with immune escape (Smith et aI, 
1997) and enhanced invasiveness of human melanoma cells (lang et aI, 2003). In 
contrast to these, some reports state that CD63 is also expressed by metastatic 
melanoma (Barrio et aI, 1998). Evidence of an immune response to this protein has 
lead to the suggestion that CD63 might be a suitable vaccine candidate for malignant 
melanoma: When given in combination with interleukin 2, vaccination with 
recombinant hCD63 was found to inhibit tumour growth in hCD63 transgenic mice 
(Li et aI, 2003). 
In addition, CD63 has been suggested as a target for therapeutic antibodies in the 
treatment of cancers, since the molecule is rapidly internalised from the cell surface 
(e.g. macrophages, some tumours) and would therefore deliver drugs effectively 
(Barrio et aI, 1998; Audran et aI, 1995). Antibodies to CD63 could target drugs 
directly to cancer cells that express the protein on the cell surface (e.g. melanoma 
cells) (Barrio et aI, 1998). Alternatively, antibodies could target drugs (e.g. cytokines) 
to tumour-infiltrating macrophages that express CD63, causing their activation 
(Audran et aI, 1995). 
This chapter describes the preliminary characterisation of a putative human scFv anti 
CD63 antibody isolated from a phage display library generated from peripheral blood 
lymphocytes of patients with ocular melanoma. Such an antibody may have potential 
in the treatment of melanoma and other type of cancers. 
In this project we wished to compare the reactivity of human scFv generated against 
CD63 with existing whole molecule mouse anti CD63 antibodies. Initially, mouse 
mAb were tested with RBL2H3 cell line transfected with hCD63 gene (also known as 
RBL-hCD63); melanoma cell lines Mewo, Mel-17, VUP and DX3; myeloid cell lines 
THP-l, HL60 and K562; colorectal carcinoma cell line Lovo and ovarian carcinoma 
cell line IGR-OV. Except for RBL2H3-hCD63, these cells are naturally expressing 
different levels of CD63. RBL2H3hCD63 were used as a positive control since these 
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cell line has been widely used in the laboratory to study the structure/function of 
ectopically expressed human tetraspanin proteins (Smith et aI, 1995; Higginbottom et 
aI, 2000). The rat cell line RBL2H3 is not naturally expressing human CD63 but it 
expresses rat CD63 (Kitani et aI, 1991), which is 70% homologous to human CD63. 
Most mouse monoclonal antibodies that have been raised against human CD63 are 
specific to the human protein. 
As discussed previously, CD63 is predominantly intracellular in most cells and 
intemalises rapidly from the plasma membrane, due to the presence of a lysosomal 
targeting sequence (GYEM) at its C-terminus (Rous et aI, 2002). This has led to 
suggestions that CD63 could be used to target drugs. It was therefore of interest to 
compare surface:intracellular distribution and intemalisation of CD63 on the different 
cell lines. 
6.1.1. scFv phage library 
In previous work carried out in the laboratory by Dr. Ann Marshall, antibody phage 
display libraries were generated from the peripheral blood B-Iymphocytes of patients 
with ocular melanoma. Genes corresponding to VH (IgGl) and VL (K and A) were 
amplified from patient mRNA using specific primers (Sblattero and Bradbury, 1997) 
and cloned in to the pAKI00 vector (Krebber et aI, 1997) (Fig.6.1.1). To try to select 
for antibodies to CD63, libraries from 5 individual patients were pooled to give a 
library with approximately 107 members. The pooled library was subjected to 4 
rounds of panning against RBL2H3 cells transfected with human CD63 (RBL2H3-
hCD63), with 2 rounds of negative panning against untransfected RBL2H3 cells. 
Following the final round of panning, 50 randomly chosen clones were analysed by 
F ACS analysis. 9 clones appeared to show differential reactivity with RBL2H3-
hCD63 compared to untransfected cells. scFv-encoding DNA from 4 of the clones 
was sequenced and found to be identical (Fig.6.1.2). Analysis of the sequence using 
V-BASE shows that the heavy chain belongs to the VH4 subgroup (locus 4-34) and 
corresponds to the germline sequence. The light chain belongs to the VK2 subgroup 
(locus A3) and shows 2 amino acid mutations from germline (highlighted in red in 
Fig.6.1.2). 
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Fig. 6.1.1. Schematic representation of the strategy for cloning heavy and light chain 
genes to create a combinatorial library for scFv antibody. RNA from the lymphocytes 
(5xl07) of uveal melanoma patient was reverse transcribed to eDNA. 
Immunoglobulins heavy chain and light chain V regions were amplified by peR. The 
heavy and light chains were randomly combined and expressed on the surface of 
phage as scFv fragments. The clones with desired specificity were selected by binding 
to antigen. 
188 
r::In~i'iMf"Ingno\1n 
'\vt' IR<~~GION 
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81 CDR3 
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81 CDR3 121 
KLSSVTAADT AVYYCARGRG LIWKQQLVRT GMDVWGQGT 
Fig.6.1.2. Amino acid sequences (single-letter code) of the variable regions of the 
scFv light chain (VL) and heavy chain (VH). The CDRs are underlined and in bold. 
Residues that differ from germline sequence are shown in red. The numbering of the 
residues is according to Kabat (Kabat et ai, 1991). The Kabat antibody sequence 
database was accessed as described by Martin (Martin, 1996). Variable region genes 
were assigned using the MRC Centre for Protein Engineering VBASE 
(http://vbase.mrc-cpe.cam.ac.uk). 
Prior to studies on the scFv antibody, the expression of CD63 on a variety of human 
cell lines was examined using conventional mouse monoclonal antibodies. In these 
studies RBL2H3 cells transfected with the human CD63 gene were used as a positive 
control since this cell line has been widely used in the laboratory to study the 
structure/function of ectopically expressed human tetraspanin proteins (Smith et ai, 
1995; Higginbottom et ai, 2000). Although the RBL2H3 cells contain endogenous rat 
CD63 (Kitani et ai, 1991), most mouse monoclonal antibodies that have been raised 
against CD63 are specific to the human protein. 
Previous work by Dr. Ann Marshall had demonstrated very poor soluble expression of 
the scFv clones selected from the melanoma antibody phage display library. The 
studies on their specificity here were therefore carried out using scFv expressed on the 
surface of phage. Two of the identical scFv-expressing clones (4E and 5F) were 
studied, along with a control comprising vector with no insert. 
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6.2.RE8UL T8 
6.2.1. Comparison of total, cell surface and intracellular expression of 
CD63 on human cell lines 
The surface and intracellular expression of CD63 in different cell lines were assessed 
using fixed and permeabilised cell as described in section 2.2.6 by F ACS. There was 
considerable variation in the total amount of CD63 expressed by the cell lines. 
Generally, as expected, melanoma cell lines (Mewo, Mel-17, DX3 and VUP) 
expressed high levels. There was moderate expression by the myeloid cell lines 
(U937, THP-I and KS62) although expression by HL60 was low. CD63 was also 
expressed by colorectal carcinoma cell line LOVO and Ovarian carcinoma cell line 
IGR-OV. 
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Fig.6.2.1. Surface and intracellular expression levels of CD63 in different cell lines. 
The expression levels of CD63 was measured by F ACS as described in section 2.2.6 
using anti CD63 antibody HSC6-FITC at 14~g.mrl. The CD63 expression levels are 
expressed as MFI. The results are the mean values of2 experiments in triplicate. 
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Fig.6.2.2. Surface and intracellular expression levels of CD63 in different cell lines. 
The expression levels of CD63 was measured by F ACS as described in section 2.2.6 
using anti CD63 antibody HSC6-FITC at 14~g.mrl. The CD63 expression levels are 
expressed as %. The results are the mean values of 2 experiments in triplicate. 
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As expected, expression of CD63 was predominantly intracellular. Interestingly, the 
melanoma cell line Mewo expresses high levels of CD63 on the surface, almost as 
high as the hCD63 transfected RBL2H3 cell line (28.27% and 37.33% respectively). 
The monocytic leukaemic cell lines HL60 and K562 also express some amounts of 
CD63 on their surface i.e. 13.33% and 13.45% respectively. In contrast the surface 
expression of CD63 was very low (4%) with monocytic leukaemic cell line THP-l 
and melanoma cell lines, Mel-17, DX3 and VUP. The results are given in Fig.6.2.2. 
6.2.1.1. Immunofluorescent microscopy with cell lines expressing CD63 
The structural features of various CD63 expressing cell lines such as Mewo, Mel-17, 
U937, THP-l and RBL2H3-hCD63 were studied by immunofluorescence microscopy 
using cytospin slide preparation as described in section 2.2.4.1 with anti CD63 
antibody H5C6-FITC. 
D E 
Fig.6.2.3. Immunofluorescence staining of cell lines in cytospin slides. The slides 
were prepared as described in section 2.2.4.1 using FITC labelled anti CD63 
antibody-H5C6. Mewo (A); Mel-17 (B); U937(C); THP-l (D); RBL2H3-hCD63 (E). 
The images A, C, D and E were captured with Nikon Eclipse E400 
immunofluorescence microscope using 100x objective and the image (B) captured 
with Deltavision restoration microscope using 40x objective. 
Strong surface staining was observed with Mewo and RBL2H3-hCD63 cells since 
these cells are expressing more CD63 on their surface and a moderate staining with 
Mel-I7. Relatively less surface staining was observed with U937 and THP-l cells in 
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agreement with the F ACS data. All cell lines showed granular cytoplasmic staining 
(Fig.6.2.3). 
6.2.2. Comparison of antibody induced internalisation of CD63 on 
human cell lines 
Previous work from our laboratory has shown that human CD63 transfected into 
RBL2H3 cells is rapidly internalised in response to antibody ligation at 37°C (G.Mal, 
Ph.D thesis, University of Sheffield, 2005). In the present study we investigated the 
internalisation of CD63 in cells that naturally express this proteins. To induce 
internalisation, cells that had been pre-incubated with unlabelled anti CD63 antibody 
at 4°C were transferred to 37°C. Samples were removed at timed intervals and the 
amount of remaining cell surface bound anti CD63 antibody determined as described 
in section 2.2.7. 
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Fig.6.2.4. Antibody induced internalisation of hCD63 in different cell lines. The 
internalisation was measured by F ACS by labelling the cells with anti CD63 antibody 
-HSC6 at 15/lg.mr l at 4°C, then antibody internalisation was measured at 37°C as 
described in section 2.2.7. Internalisation was expressed as % relative to time zero 
(cells incubated throughout at 4°C). The results are the mean values of 2 experiments 
in triplicate. 
Rapid internalisation of cell surface CD63 was observed within lSmin. on all cell 
lines, with little further internalisation occurring after 45min. Thus, rapid 
internalisation appears to be general feature of this molecule. There were, however, 
some differences between cell lines in the extent of internalisation e.g. most of the cell 
surface CD63 was internalised after 45min on THP-l and K562 cells, whereas only 
~SO% was internalised on Mewo cells (Fig.6.2.4). 
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6.2.3. Reactivity of mouse anti CD63 antibodies in whole cell ELISA 
The binding reactivity of mouse monoclonal antibodies to CD63 such as HSC6 
(IgG 1), LP9 (IgM) and BEM-l (IgA) was tested against Mewo and Mel-17 cell lines 
by whole cell ELISA as described in section 2.2.12.3.3. 
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Fig.6.2.S. Titration of anti CD63 antibodies-HSC6 and LP9 against Mewo and Mel-17 
cell lines. The ELISA was carried out as described in section 2.2.12.3.3. 
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Fig.6.2.6. Titration of anti CD63 antibody-BEM-1 (supernatant) against Mewo and 
Mel-17 cell lines. The ELISA was carried out as described in section 2.2.l2.3.3. 
HSC6 and LP9 showed good and moderate binding reactivity respectively with Mewo 
cells in ELISA even at IS /-lg.mr I concentrations since the surface expression of CD63 
is higher in Mewo cells. In contrast, both HSC6 and LP9 showed little binding with 
Mel-17 cells (Fig.6.2.S). In addition the mouse hybridoma supernatant BEM-1 was 
also showed a moderately good binding reactivity with Mewo but not Mel-17 
(Fig.6.2.6). 
6.2.4. Preparation of scFv phage 
For the studies on the putative anti CD63 scFv antibody, phage were prepared from 2 
clones, 4E and SF , which had been shown by sequence analysis to contain identical 
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scFv genes. As a negative control colonies containing the pAK 100 vector with no 
inserted scFv encoding genes were used. All studies were carried out using scFv 
expressed on the surface of phage (scFv phage), since extensive previous attempts to 
express the scFv in soluble form were unsuccessful (Dr. Ann Marshall, unpublished 
observations). scFv phage preparations are frequently used in the preliminary 
characterisation of scFv antibodies (Steinberger et ai, 2001). 
6.2.4.1. Colony insert PCR 
Before proceeding with further studies on the putative anti CD63 scFv clones 4 E and 
5F, the bacterial colonies containing the phagemid vector were assessed for correct 
size and orientation of inserts encoding scFv fragment by colony direct PCR as 
described in section 2.2.12.1. 
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Fig.6.2. 7. Screening of individual scFv clones by direct amplification of bacterial 
colonies. Amplified products were run on 1 % agarose gel as described in section 
2.2.12.1. Hyper ladder I markers (Lanel); Vector pAKI00 without insert (Lane 2 and 
3); Vector pAKI00 with insert 4E (Lane 4 and 5); Vector pAKI00 with insert 5F 
(Lane 6 and 7); Positive control containing known scFv clone (Lane 8); Negative 
control with no bacterial DNA template (Lane 9), where bp-denote base pair. 
From the agarose gel it was observed that there were strong 800bp bands 
corresponding to the scFv insert in clones 4E, 5F and positive control clones. No band 
was developed with the colony from the no insert (vector only) control. The bands 
below 100bp might be due to unused primers in the reactions. Hence these results 
confirmed that the 4E and 5F bacterial colonies contained vector with correctly sized 
and correctly orientated scFv insert DNA (Fig.6.2.7). 
6.2.4.2. Preparation of scFv phage containing supernatents 
In the initial studies, crude phage-containing supernatants obtained after overnight 
infection of phagemid containing bacteria (3ml cultures) with helper phage, were 
used. However to improve phage numbers, supernates from larger volume (l50ml) 
cultures were used and subjected to PEG precipitation as described in section 2.2 .12.2 
(Sambrook et al 2001 ). This resulted in a higher yield of phage numbers in each 
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phage preparations. The phage-containing vector with no insert prepared under 
identical conditions was used as a negative control. 
6.2.4.3. Quantification of Phage 
6.2.4.3.1. Colony count method 
The initial studies were carried out with crude phage preparations, which are similar 
in principle to using crude hybridoma supemates or antisera. Hence to standardise the 
number of phage particles to be used in each experiment, such as ELISA and 
fluorescence microscopy, attempts made to quantify the phage particles present in 
each preparation either by colony count (section 2.2.12.3.1) or spectrophotometric 
method (section 2.2.12.3.2). The colony counting method estimates the number of 
infective phage particles present in the phage preparation. However, this method does 
not give an estimate of the number of phage that are able to bind, since the number of 
infective phage falls off rapidly with time, whereas antibody binding is stable for 
several weeks or even months (Steinberger et ai, 2001). The estimates of phage 
numbers are given in table 6.2.1. 
6.2.4.3.2. Spectrophotometric method 
Alternatively a spectrophotometric method (section 2.2.12.3.2) was used to measure 
the total phage content of an scFv phage preparation, although this method has the 
limitation that it will measure only the total number of phage particles as a function of 
protein content. This method will not give any indication about the antigen specific 
antibody fragment. From this study the number of phage particles per ml of phage 
preparations are given in table 6.2.1. 
Phage 
No insert 
4E 
5F 
Colony count method 
(Phage particles. mr') 
3.74 xl012 
2.25 xl0 13 
5.60 xl012 
Spectrophotometric method 
(Phage particles. mr') 
3.77 X 1013 
2.87x 10 14 
1.48 x 1014 
Table.6.2.1. Estimates of number of phage particles mrl of PEG concentrated phage 
preparation by colony count method and spectrophotometric method. The experiments 
were carried out as described in sections 2.2.12.3.1 & 2.2.12.3.2. The values are from 
a single experiment. 
Using these phage preparations vanous experiments such as whole cell ELISA 
titration against GST fusion proteins of hCD63EC2 region and inhibition ELISA etc. 
were carried out. 
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6.2.5. Assessment of scFv-phage specificity by whole cell ELISA 
6.2.5.1. Three stages ELISA 
In the initial stages of this work, a very limited range of anti-M13 phage reagents was 
commercially available. Hence the initial studies were therefore carried out using a 
"3-stage" whole cell ELISA, consisting of phage supernatants followed by anti-M13 
phage antibody labelled with biotin, followed by HRP-Iabelled Extravidin. Results 
obtained under standard conditions are shown for RBL2H3 cells (hCD63 transfected 
or untransfected) and melanoma cell lines Mewo and Mel-l 7. 
(A) 
0.75 
E 
.; 0.50 
10 
~ 
@ 
c 
o 0.25 
0.00 ..... -
(B) 
0.7 
E 
.; 0.5 
10 
~ 
@ 
C 
o 0.25 
- RBL 2H3-hCD63 
- RBL 2H3·Untransfected 
- Mewo 
_ Mel-17 
Fig.6.2.8. Binding in whole cell ELISA using scFv phage with RBL2H3/Mewo/Mel-
17 cells. ELISA was carried out as described in section 2.2.12.3.4 using anti M13-
biotin antibody at Illg.mr1 and Extravidin-HRP at O.5Ilg.ml-1. The cells in positive 
control were labelled with mouse anti CD63 antibody-H5C6 and followed by anti 
mouse IgG-HRP; the cells in negative control were labelled only with anti M13 HRP 
and Extravidin-HRP, where the binding studies with RBL2H3-hCD63 transfected and 
untransfected cells (A); Mewo and Mel-17 (B). 
Surprisingly, the 4E and 5F clones appeared to react with untransfected RBL2H3 
cells. However, although slightly higher binding values were observed with phage 4E 
and 5F the no insert phage control also gave high binding. The negative control (cells 
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were labelled only with anti M 13 HRP and Extravidin-HRP in the absence of phage) 
also showed a high backgrounds colour, indicating some non-specific binding of the 
secondary or tertiary reagent to these cells (Fig.6.2.8A). The binding of same phage 
preparations was tested with Mewo and Mel-17 cells. Almost no difference in binding 
was observed between the test phage (4E&SF) and controls (no insert and - ve 
control) (Fig.6.2.8B). 
Extensive attempts were made to optimise the assay (e.g. usmg different 
concentrations of secondary and tertiary reagents, using various different blocking 
agents). Although some improvements were made, backgrounds remained high (data 
not shown). 
6.2.5.2. Two stage ELISA 
At a later stage of the project, an anti M13 antibody directly labelled with HRP 
became available. Two layer whole cell ELISA was carried out as described in section 
2.2.12.3.S using PEG concentrated phage. 
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Fig.6.2.9. Binding of scFv phage in whole cell ELISA with RBL2H3-hCD63 and 
untransfected cells. ELISA was carried out as described in section 2.2.12.3.S using 
anti MI3-HRP. The results are the mean OD@4S0nm of 1 experiment in triplicate. 
In the two layers ELISA very low levels of background colour was measured (Fig. 
6.2.9). In addition the phage 4E and SF showed a significant higher binding value 
with RBL2H3-hCD63 and untransfected cells than no insert control. The binding of 
phage to untransfected cells was unexpected. Based on this interesting result the same 
phage preparation was titrated against Mewo and Mel-17 cell lines under identical 
experimental conditions as described in section 2.2.12.3.S. 
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Fig.6.2.10. Titration of scFv phage in whole cell ELISA with Mewo cells. ELISA was 
carried out as described in section 2.2.12.3.5 using anti MI3-HRP antibody. The 
results are the mean OD@4S0nm of 1 experiment in triplicate. 
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Fig.6.2.11. Titration of scFv phage in whole cell ELISA with Mel-17 cells. ELISA 
was carried out as described in section 2.2.12.3.5 using anti MI3-HRP antibody. The 
results are the mean OD@4S0nm of 1 experiment in triplicate. 
The results showed that the binding of phage 4E and SF with Mewo and Mel-17 was 
~ two folds higher than no insert control (Fig.6.2.1 O&Fig.6.2.11). 
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Fig.6.2.12.Titration of scFv phage in whole cell ELISA with RBL2H3-hCD63 . 
ELISA was carried out as described in section 2.2.12 .3.S using anti M13-HRP 
antibody. The results are the mean OD@4S0nm of 1 experiment in triplicate. 
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Fig.6.2.l3. Titration of scFv phage in whole cell ELISA with RBL2H3-untransfected 
cells. ELISA was carried out as described in section 2.2.12.3.S using anti M13-HRP 
antibody. The results are the mean OD@4S0nm of 1 experiment in triplicate. 
The binding reactivity of phage no insert, 4E and SF were also tested with RBL2H3-
hCD63 and RBL2H3 untransfected cells. The 4E and SF showed higher binding 
values than no insert control with RBL2H3-hCD63 and RBL-untransfected cells (Fig. 
6.2.l2&Fig.6.2.13). The results indicate that at least in the whole cell ELISA assay, 
the scFv phage are recognising an antigen that is expressed at high levels on 
transfected and untransfected RBL2H3 cells. 
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Fig.6.2.14. Titration of scFv phage 4E in whole cell ELISA with RBL2H3-hCD63 , 
RBL2H3-untransfected cells, Mewo and Mel-I? ELISA was carried out as described 
in section 2.2.12.3.5 using anti MI3-HRP antibody. The results are the mean 
OD@450nm of I experiment in triplicate. 
An additional fresh batch of phage 4E was prepared and its binding was tested against 
Mewo, Mel-I?, RBL2H3-hCD63 and RBL untransfected cells at the same time under 
identical experimental conditions as described in section 2.2.12.3.5. The results are in 
agreement with the previous results (Figs.6.2.10-6.2.I3) i.e. higher binding values 
observed with RBL2H3-hCD63 and RBL2H3 untransfected cells than Mewo and 
Mel-I? (Fig.6.2.I4). This indicates that scFv are reacting with an antigen that is 
highly expressed by the RBL2H3 cells. 
6.2.6. Binding of scFv phage to tetraspanins EC2 proteins 
6.2.6.1. Titration of GST and EC2CD63 
The binding reactivity of the phage with GST-EC2CD63 prepared as described in 
section 2.2.8.1 was also tested. The preliminary experiments with GST -EC2CD63 
were carried out to optimise the concentration of GST-EC2CD63 to be coated on the 
ELISA plate. Different concentrations of immobilised GST-EC2CD63 were titrated 
against anti CD63 antibody-H5C6 and anti GST antibody as described in section 
2.2.5.5. 
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Fig.6.2.1S. Titration of EC2CD63 and GST in GST-EC2CD63. The ELISA was 
carried out as described in section 2.2.S.S. EC2CD63 was estimated by coating the 
plate with anti CD63 antibody HSC6 (1Sllg.mrl) and followed by Goat anti mouse 
IgG-HRP (1: 1 000). The concentration of GST was estimated by coating the plate with 
anti goat GST antibody (SJlg_mrl) and followed by mouse anti Goat-Sheep HRP 
(Sllg.mr1). The results are the mean OD@4S0nm of2 experiments in duplicate. 
From the result it was observed that the GST-EC2CD63 at IOllg.mrL was an optimum 
concentration for coating the ELISA plate for the binding studies (Fig.6.2.1S). 
6.2.6.2. Binding reactivity of scFv phage with GST -EC2CD63 
The binding reactivity of phage no insert, 4E and SF were tested against immobilised 
GST-EC2CD63 as described in section 2.2.12.3.6. 
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Fig.6.2.16. Titration of scFv phage: No insert, 4E and SF with GST-EC2CD63. The 
ELISA was carried out as described in section 2.2.12.3.6. The results are the mean 
OD@4S0nm of 2 experiments in duplicate. 
The phage 4E and SF showed higher binding with GST-EC2CD63 than no insert 
phage i.e. OD values of 4E and SF were ~four folds higher than no insert control (Fig. 
6.2.16). 
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6.2.6.3. Specificity of scFv phage binding with GST -EC2CD63 
The specificity of the 4E and 5F phage against different GST-EC2 tetraspanins such 
as CD63, CD9, CD81 and CD9 mutant C153A was tested. In this study GST was 
also included as an additional control. 
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Fig.6.2.17. Titration of phage 'no insert' with different GST-EC2 tetraspanins and 
GST proteins. The ELISA was carried out as described in section 2.2.12.3.6. The 
results are the mean OD@450nm of 2 experiments with same phage preparation. 
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Fig.6.2.18. Titration of scFv phage '4E' with different GST -EC2 tetraspanins and 
OST proteins. The ELISA was carried out as described in section 2.2.12.3.6. The 
results are the mean OD@450nm of2 experiments with same phage preparation. 
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Fig.6.2.19. Titration of scFv phage '5F' with different GST -EC2 tetraspanins and 
OST proteins. The ELISA was carried out as described in section 2.2.12.3.6. The 
results are the mean OD@450nm of2 experiments with same phage preparation. 
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The no insert phage showed little difference in binding between the GST-EC2CD63 
and other EC2 tetraspanins or GST control (Fig.6.2.17). In contrast 4E and 5F showed 
higher binding values with GST-EC2CD63 than the other GST-EC2 tetraspanins or 
GST. However, some binding to the other recombinant proteins was observed. 
The specificity of the scFv phage 4 E against CD63 was tested by inhibition ELISA as 
described in section 2.2.12.3.7. 
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Fig.6.2.20. Inhibition of binding of scFv phage 4E against GST-EC2CD63. The 
ELISA was carried out as described in section 2.2.12.3.7 with phage 4E, in the 
presence of increasing concentration of soluble protein. The results are the mean 
OD@450nm of 1 experiment. 
At highest concentrations (lOOllg.mr l ) of free GST-EC2CD63 and EC2CD63 
(generated by thrombin cleavage from GST-EC2CD63) some inhibition of the 
binding of scFv phage 4E with immobilised GST -EC2CD63 was observed. However, 
this experiment would have to be repeated to see if the result is significant. 
6.2.6.4.1mmunofluorescence microscopy with scFv phage 
The binding reactivity of phage No insert, 4E and 5F was tested against RBL2H3 
untransfected and RBL2H3-hCD63 cells by immunofluorescence microscopy as 
described in section 2.2.3.2. 
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Fig.6.2.21. Immunofluorescence images of scFv phage binding with RBL2H3-hCD63 
and RBL2H3 untransfected cells in Lab-Tek® chamber slide. The assay was 
performed as described in section 2.2.3.2 using anti M13-FITC monoclonal antibody. 
Where RBL2H3 untransfected cells (A&B); RBL2H3-hCD63 cells (C&D). The 
phage used: No insert (A&C); 4E (B&D). The images were captured with Nikon 
Eclipse E400 immunofluorescence microscope using 20x objective. 
The results of fluorescence microscopy are in agreement with the results from whole 
cell ELISA i.e. the phage 4E showed strong binding with RBL untransfected and RBL 
2H3-hCD63 cells and almost no binding was observed with no insert phage (Fig. 
6.2.21 ). 
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6.3.DISCUSSION 
The combinatorial library technology is a novel innovation for generating 
recombinant proteins. This technique has been exploited to produce human antibodies 
to tumour antigens. This chapter describes attempts to further characterise a human 
scFv phage antibody cloned from a patient with ocular melanoma with putative 
specificity for human CD63. This chapter also compares the reactivity of human scFv 
antibody and mouse (whole molecule) anti CD63 antibodies. 
Initially, the expression levels of total, cell surface and intracellular expression of 
CD63 were compared in different human tumour cell lines by F ACS analysis using 
the mouse monoclonal antibody, H5C6. There was variation in total amount of CD63 
expressed, with melanoma cell lines usually showing highest levels. All cell lines 
showed a higher intracellular expression compared with surface expression. This was 
expected since CD63 has a lysosomallintemalisation motif (GYEVM) at its C-
terminus (Rous et ai, 2002). However, some cell lines showed higher levels of cell 
surface CD63. As expected, the "control" RBL2H3-hCD63 cell line (transfected with 
the human CD63 gene and selected by F ACS sorting for high surface expression) 
showed ~37% of CD63 on the plasma membrane. Notably, the melanoma cell line 
Mewo expressed ~28% of CD63 on the surface, whereas the other melanoma cell 
lines had :S 6% as surface CD63. Immunofluorescence microscopic examination of 
CD63 staining was performed for some of the tumour cell lines. These were 
consistent with results obtained from F ACS analysis. 
The intemalisation of surface CD63 at 37°C in response to antibody cross-linking was 
compared for the different tumour cell lines. Rapid intemalisation of cell surface 
CD63 has previously been observed for macrophages (Audran et ai, 1995), breast 
cancer cell lines (Barrio et aI, 1998), dendritic cells (Mantegazza et ai, 2004) and 
hCD63 transfected RBL2H3 cells (G. Mal, PhD thesis, University of Sheffield, 2005). 
This property may make CD63 useful as an antigen for drug targeting (Audran et ai, 
1995; Barrio et ai, 1998). All cell lines showed rapid intemalisation of CD63, with a 
high amount of CD63 intemalising within 15min. However, whilst some cell lines 
showed intemalisation of most cell surface CD63 by 45min (e.g. ~ 80% for THP-1 
and K562 cells) others showed less (e.g. less than 500/0 for Mewo cells). Whilst 
further work is needed to reveal the significance of this, it suggests that whilst some 
cell surface CD63 is free to rapidly intemalise on these cells, a proportion is not. 
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On the basis of F ACS results, the Mewo and Mel-17 melanoma cell lines, expressing 
high and low amounts of surface CD63 respectively, were selected for initial testing 
of scFv-phage, along with hCD63 transfected and untransfected RBL2H3 cells. 
Although the scFv phage had been initially selected by F ACS analysis, subsequently 
problems using phage in F ACS were encountered, such as high non-specific binding. 
Since whole cell ELISA assays had been used successfully by other workers in the 
group to analyse scFv phage to cell surface antigens, this assay was employed. 
Mouse antibodies to CD63 were titrated against Mewo and Mel-17 initially. All 
antibodies (H5C6, IgG; LP9, IgM; BEM-l, IgA hybridoma supernate) gave reactivity 
with Mewo cells but not Mel-l 7. This may reflect the level of CD63 on the surface of 
the two cell lines. Lack of reactivity with Mel-17 may indicate that this assay is less 
sensitive than FACS, or that epitope(s) recognised by the mouse anti-CD63 are 
sensitive to fixation. 
Two clones, expressing identical scFv genes, were used to generate scFv phage, along 
with negative (no scFv insert) control. After optimization these were tested in whole 
cell ELISA. Both clones showed good reactivity with RBL2H3-hCD63, but 
surprisingly also with untransfected RBL2H3 cells. They also reacted with human 
Mewo and Mel-17, showing similar reactivity but less than with the rat cell line. The 
clones were then tested against recombinant tetraspanins EC2s in conventional 
ELISA. Although some higher reactivity with GST-EC2CD63 was seen, there was 
also reactivity with the other recombinant proteins. An attempt was made to inhibit 
binding of the scFv-phage to plate-bound GST-EC2CD63 with free GST-EC2CD63. 
Some inhibition was seen, but only at high concentrations of free protein, and this 
should be repeated. 
From these results it seems clear that the scFv phage is not specific for human CD63 
and the original observations may have been mistaken. It is possible that there is 
reactivity with rat CD63, and some cross-reactivity with human CD63, which shows 
70% identity (Kitani et aI, 1991). If there had been time, the scFv phage would have 
been tested against other cell lines from other animal species transfected with human 
CD63 (e.g.Chinese Hamster Ovary cells). The scFv phage could also have been tested 
in Western blotting with celllysates to determine the molecular weight of the antigen. 
It is possible that the scFv is not very specific and low affinity. The sequence is very 
similar to germline antibody sequence, as found in low affinity IgM antibodies. 
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CHAPTER 7 
GENERAL DISCUSSION 
Tetraspanins appear to play roles in a number of crucial cellular functions including 
activation, motility and fusion. Recent reports state that these proteins are also 
involved in various pathological conditions such as cancer and viral infections. 
Recently Takeda and co-workers reported the involvement of tetraspanins in 
multinucleated giant cell formation from monocytes (Takeda et ai, 2003). Hence in 
the work described in chapters 3-5 of this thesis we further investigated the roles of 
tetraspanins in mononuclear phagocyte fusion using a panel of different recombinant 
EC2 tetraspanins. 
Previously Takeda and co workers reported that anti CD9 and CDS I antibodies 
enhanced the fusion of Con A stimulated peripheral blood monocytes, whereas no 
effect was observed with anti CD63 antibodies (Takeda et ai, 2003). In contrast GST-
EC2CD9 inhibited MGCs formation. As described in chapter 3, we successfully 
established a Con A-induced fusion system using fresh human peripheral blood 
monocytes. In agreement with the studies described above, we found that anti CD9 
antibodies enhanced MGC formation. However, a panel of different anti CD63 
antibodies, including IgG, IgA and IgM isotypes and Fab fragments inhibited MGC 
formation. GST-EC2CD9 and GST-EC2CD63 inhibited MGC formation whereas 
GST alone, and GST-EC2CDS1, GST-EC2CDS2 and GST-EC2CD15I had no effect. 
CD63-EC2 alone (without the GST fusion protein) also inhibited MGC formation. 
GST-EC2CD63 and GST-EC2CD9 inhibited the fusion within 24hrs and produced 
very small MGCs, whereas in their absence the size and number of nuclei in MGCs 
were increased as the incubation period increased (section 3.2.10). 
From the dose/response studies, overall it appeared that GST-EC2CD63 and 
EC2CD63 inhibited MGC formation with ICso values in the nanomolar range (section 
3.2.5. and 3.2.S). Interestingly, nanomolar concentrations of GST-EC2CD63 
completely inhibited CCR5-tropic HIV infection of macrophages (Ho et ai, 
manuscript submitted). In these cases, however, GST-EC2CD9, GST-EC2CDS1 and 
GST -CD 151 were also inhibitory and GST alone had effects at micromolar 
concentrations. 
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As discussed in chapter 3, there were some variations in the activities of different 
preparations of the GST-EC2 tetraspanins. Although all preparations of EC2CD63 
and EC2CD9 inhibited MGC formation at high concentrations, these varied in 
potency. These proteins were expressed in a bacterial system, and although correct 
folding was checked using conformation-specific antibodies, the level of correctly 
folded protein could vary. Also, in the case of GST-EC2 proteins, there was variable 
contamination with GST. Although GST had no effect on MGC formation, it might be 
preferable to use pure EC2 proteins. Alternatively, improved purification techniques, 
such as reverse-phase HPLC, allowing isolation of correct conformers could be used. 
The yields of GST-EC2CD63 were also generally lower than of GST-EC2CD9. This 
may be due to the larger size of CD63EC2 and that it has two more cysteine residues 
that are thought to give an extra disulphide bond (Seigneuret et al, 2001, see Fig 
1.1.1.B). CD63 is also heavily glycosylated in vivo. More recently, the better yields of 
GST-EC2 tetraspanins have been obtained by expressing constructs in E.coli strains 
such as Origami, that facilitate disulphide bond formation (Francine Martin, 
University of Sheffield, personal communication). Attempts have been made to 
express tetraspanin EC2s in mammalian cells, but the yields were very poor (Dr L. 
Partridge, personal communication). 
A problem with the fusion assay with human monocytes was variability between 
donors. The fusion index observed on Con A stimulation was typically 75-95% but 
poorer rates were observed with some individuals, which could not be used for 
experiments. Variability in fusion index may be due to blood donor variability since 
the expression of certain cytokines varies between individuals (Yaqoob et al, 1999). 
Some individuals may also be more sensitive to inhibition by EC2 tetraspanins than 
others. Attempts to induce fusion in cell lines were not successful here, but it might be 
possible to induce fusion in cell lines using different cytokines. Another source of 
variability in the fusion index between the different experiments may be due to Con 
A. Since Con A requires optimum pH of 7 (Becker et al, 1975) for its activity, if the 
media used for the experiments is slightly acidic/alkali it may affect the function of 
ConA. 
It was important to confirm whether the inhibitory effect CD63 and CD9 EC2s on 
MGC formation is due to altering molecular mechanisms involved in the fusion 
process or these proteins are affecting the functions which are related to monocyte 
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fusion such as adhesion and aggregation. It was also possible that the recombinant 
proteins might be having cytotoxic or anti-proliferative effects; however, as described 
in chapter 4, the tetraspanin EC2s did not affect cell numbers. Whilst Takeda et aI., 
and colleagues found that anti-f31 and anti-f32 integrins inhibited monocytes adhesion 
and aggregation, respectively, their anti CD9 and anti CD81 antibodies had no 
significant effects. This indicated that the inhibition of MGC formation by the anti-
tetraspanin antibodies was not related to involvement in these integrin-mediated 
functions. The EC2CD9 and EC2CD63 proteins did not inhibit aggregation or initial 
adhesion of monocytes in our system. However, incubation with CD63 EC2 (with 
GST removed by cleavage) resulted in reduced numbers of adherent cells, which had 
been stimulated with Con A. As discussed in chapter 4, this may be because the EC2 
inhibits formation of MGCs, which we had observed to be strongly adherent relative 
to cultured monocytes/macrophages. However, it is possible that EC2CD63 might 
interfere with adhesion strengthening or spreading, which may be associated with 
MGC formation (McNally and Anderson, 2002). 
Chapter 5 describes attempts to investigate the binding/uptake of GST-EC2 proteins 
by monocytes. Although further microscopy studies are needed, F ACS analysis 
indicate that GST-EC2CD9 and GST-EC2CD63 are able to bind specifically to Con A 
stimulated monocytes. As mentioned in chapter 5, it would be of great interest to 
carry out chemical cross-linking and "pull down" experiments to try to determine 
what proteins the tetraspanin EC2s are interacting with. 
Overall, our results indicate roles for tetraspanins CD9 and CD63 in MGC formation. 
Since inhibitory effects were observed with recombinant EC2 regions, and these 
proteins showed some binding to monocytes, we can conclude that these regions of 
the CD9 and CD63 molecules are involved. The effects are tetraspanin-specific, since 
no inhibition was observed with recombinant EC2s of CD81, CD82 or CD 151. In 
addition no inhibition was observed with murine CD9 EC2, which shows 77% 
sequence identity in this region. 
Our results for CD9, with anti CD9 antibodies enhancing MGC formation whereas 
CD9 EC2 inhibits, confirm the observations made by Takeda and co-workers (Takeda 
et ai, 2003). Whilst they also found enhancement of MGC formation with anti CD81 
antibodies, the lack of an effect with CD81 EC2s suggests a less direct role for this 
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tetraspanin, perhaps in modulating the activity of CD9. The authors also reported that 
the expression levels of CD9 and CD81 were upregulated during the normal culture 
condition for ~ 2days but under the fusogenic conditions Con A down regulated the 
expression of CD9 and CD81, whereas the expression of CD63 was up regulated. In 
addition to this, alveolar and bone-marrow derived macrophages from CD9-1- and 
CD81-1- mice showed enhanced MGC formation compared to macrophages from 
control mice both in vitro and in vivo (in response to a Propioibacterium acnes-
induced lung inflammation). Finally they showed that mononuclear phagocytes from 
CD9/CD81 double knock out mice showed enhanced fusion and spontaneous MGCs 
formation in the lung and enhanced osteoclastogenesis in the bone. This led them to 
suggest that CD9 and CD81 normally act to negatively regulate MGC formation and 
our findings are consistent with this hypothesis, at least for CD9. Hence when CD9 is 
"masked" by antibody or its expression down-regulated, a suppressive effect is 
removed and MGC formation occurs. When exogenous CD9 EC2 is added, it blocks a 
component/s required to generate MGCs and the process is inhibited. The effects of 
CD9 EC2 suggest a direct interaction of this protein in cis or in trans with molecules 
on the monocyte surface and binding of CD9 EC2 to Con A stimulated monocytes is 
consistent with this. 
CD9 might associate with other molecules that have been implicated in monocyte 
fusion, such as CD44 and CD47 (chapter 1, 1.2. reviewed in Vignery, 2000 and 
Vignery, 2005a), CD98 (Tabata et ai, 1994) or ADAMS (Namba et ai, 2001). 
Although no direct interactions between these proteins have been reported, there is 
evidence that they may occur in trans within the context of TEMs. Hence there are 
reports that CD9 associates with CD44 (Jones et ai, 1996; Toyo-oka et ai, 1999; 
Yashiro-Ohtari et ai, 1998) and with CD47 (Longhurst et ai, 1999). An association 
between CD9 and ADAMS proteins was reported in sperm:egg fusion (Zhu and 
Evans, 2002). There is evidence that CD9 on the egg cell surface interacts in trans 
with ADAMS on sperm cells (Takahashi et ai, 2001). CD98 also associates with 
integrins and has been implicated in sperm:egg fusion. It has been suggested that 
CD98 may be a component of an egg surface "tetraspanin web" that includes 
tetraspanins CD9 and CD81, integrins and integrin-associated proteins that is 
necessary for fusion (Takahashi et ai, 2001). A ''tetraspanin web", including CD9. 
CD81, CD98, integrins and ADAMS proteins has been suggested to be involved in 
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testicular development (Tres and Kierszenbaum, 2005). The interaction of 
tetraspanins with other molecules recently implicated in monocyte fusion, such as the 
purinergic receptor (Falzoni et ai, 1995; Chiozzi et ai, 1997; Falzoni et ai, 2000) or 
DC-STAMP (Yagi et ai, 2005), has not to our knowledge been investigated. It is also 
possible that the interaction of CD9 with the EWI proteins is in some way involved in 
MGC formation. It would be interesting to examine the expression of some of these 
molecules under fusogenic conditions (i.e. on induction of monocytes with Con A). 
Very recently, CD9 has also been shown to function as a receptor for the cytokine IL-
16 on mast cells (Qi et ai, 2005). IL16 also acts as a chemokine and activator of 
monocytes (Cruikshank et ai, 1987). Although no role for IL-16 has been ascribed to 
IL-16 in MGC formation, it is conceivable that this T-cell derived cytokine might be 
involved in regulating the process. 
The suppressive role of CD9 in monocyte/macrophage fusion is in contrast to studies 
suggesting a positive involvement of this tetraspanin in other fusion processes. Hence, 
as described in chapter 1, anti CD9 antibodies (Chen et ai, 1999; Miyado et ai, 2000; 
Takahashi et ai, 2001) and recombinant CD9 EC2s (Zhu et ai, 2002; Higginbottom et 
ai, 2003) inhibit sperm:egg fusion, whilst CD9 null mice show loss of fertility due to 
a defect in oocyte fusion (Miyado et ai, 2000; Le Naour et ai, 2000; Kaji et ai, 2000). 
Anti CD9 antibodies are also reported to inhibit virus-induced fusion (Loffler et ai, 
1997) and inhibit or delay muscle cell fusion (Tachibana and Hemler, 1999). This 
suggests that these fusion processes differ from MGC formation, or that CD9 has 
different functions depending on the cells where it is expressed. 
It is worth noting that the negative regulatory role proposed for CD9 in MGC 
formation is partly based on the observation that anti CD9 antibodies enhance MGC 
formation. There are possibilities that these antibodies might cause cell activation, 
interact with Fcy receptors, or cross-link proteins associated with CD9 in the 
tetraspanin web. It would be interesting to examine the effects of Fab fragments of 
anti CD9 antibodies on monocyte fusion. 
Previously Takeda et ai (2003) reported that substantially higher numbers of MGCs 
were observed in the air space of CD9 and CD81 null mice challenged with 
Propionibacterium acnes than wild type mice, suggesting that CD9 and CD81 co-
ordinately prevent the fusion of mononuclear phagocytes (Takeda et ai, 2003). In 
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contrast the same research group very recently (Yamane et aI, 2005) reported that 
CD9 may be needed to promote the formation of certain types of granuloma (Yamane 
et aI, 2005). In an in vivo model of hepatic granuloma formation using injected 
Propionibacterium acnes, compared to normal litter mates CD9-knockout mice 
showed dissemination of bacteria and an 80% reduction in number and size of 
granulomas. Production of granuloma-inducing cytokines, TNF-alpha and IFN-
gamma, was delayed and chemotactic activity for macrophages was suppressed in the 
liver of mutant mice. In wild type mice CD9 expression was upregulated on 
hepatocytes when challenged with P. acnes, although the monocytes/macrophages 
recruited into granulomas were reported to stain weakly for CD9 (Yamane et aI, 
2005). 
The inhibitory effects of several anti CD63 antibodies and CD63 EC2s strongly 
suggests a positive role for this tetraspanin in MGC formation. Takeda and co-
workers noted that CD63 expression was increased under fusogenic conditions, but 
saw no inhibition with an anti CD63 antibody (Takeda et aI, 2003). This lack of an 
effect may be due to differences in the antibodies, or slight differences in assay 
systems used. Unlike CD9, to date, there are no reports of a role for CD63 in cell:cell 
fusion, although the translocation of CD63 from granules to the plasma membrane in 
neutrophils and eosinophils has lead to speculation that it could be involved in 
intracellular membrane fusion (Mahmudi-Azer et aI, 2002). The molecule has well-
reported roles in membrane trafficking (Ryu et aI, 2000; Kobayashi et aI, 2000; Rous 
et aI, 2002). CD63 has a lysosomal targeting/internalisation motif (GYXX$, where $ 
is a hydrophobic residue (Robinson and Bonifacino, 2001)) at its C-terminus. This 
part of the molecules has been shown to be important in the CD63-mediated co-
internalisation of ~-subunit of the gastric H, K-ATPase ion pump (Duffield et aI, 
2003) and a membrane-type 1 matrix metalloproteinase (Takino et aI, 2003). Hence, 
one of its functions appears to be as an "adaptor" protein, inducing rapid 
internalisation (and thus moderating the functions) of molecules that it associates 
with. Cell surface CD63 is rapidly internalised on antibody cross-linking (Audran et 
aI, 1995; Barrio et aI, 1998), and even when monovalent Fab fragments are used 
(Mantegazza et aI, 2004; our unpublished observations). Inhibition ofMGC formation 
by anti CD63 antibodies might therefore be due to internalisation of a required cell 
surface component, either CD63 or a molecule that it interacts with. The effects of 
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CD63 EC2s suggest a direct interaction with a molecule involved in MGC formation. 
The binding of CD63 EC2 to Con A stimulated monocytes also suggests a direct 
interaction with a monocytes membrane protein. The identity of such a protein is a 
matter of speculation; it could be a molecule already implicated in monocyte fusion, 
or an unknown protein. To date, no direct interactions of CD63 with other cell surface 
proteins have been reported, although many secondary and tertiary interactions have 
been demonstrated by co-immunoprecipitation in mild detergents (Hemler, 2003). 
Such interactions occur in cis, probably within the context ofTEMs, and are assumed 
to be weak or indirect. However, as mentioned in chapter 5.3, it is possible that the 
recombinant EC2s, which might be present as multimers (Kitadokoro et aI, 2001), 
could bind to components of the TEMS. 
As discussed in chapter 1 (1.1.5.) tetraspanins are known to interact with integrins and 
to regulate integrin-dependent functions (Berditchevski, 2001; Hemler, 2003). There 
are reports that CD9 and CD63 associate with (31 integrins in various cell types 
(reviewed in Berditchevsky, 2001) and with (31 integrins and (32 integrins in 
monocytes (Takeda et aI, 2003). These interactions have been demonstrated by co-
immunoprecipitation in mild detergents, indicating that they probably occur within 
TEMs (Hemler, 2003). Antibodies to (31 and (32 integrins have been shown to inhibit 
MGC formation (Tabata et aI, 1994; Most et aI, 1990; Gasser and Most, 1999; Takeda 
et aI, 2003), although these antibodies may inhibit monocyte adhesion (McNally and 
Anderson, 2002) and/or aggregation (Tabata et aI, 1994; Takeda et aI, 2003) rather 
than fusion itself. Complex formation between CD9 and integrins is reported down-
regulated under fusogenic conditions (Takeda et aI, 2003). The implications of this 
for monocyte fusion are unclear, but may relate to the known role of tetraspanins in 
adhesion dependent signalling mediated by integrins (Berditchevski, 2001). 
Interestingly, antibody-induced intemalisation of CD63 has been shown to lead to 
reduced cell surface expression of CD29 ((31 integrin subunit), CD 11 b (aM integrin 
subunit), CD18 ((32 integrin subunit) and as intregrin in dendritic cells with 
concomitant increased migration (Mantegazza et aI, 2004). CD63 is also implicated in 
integrin-mediated adhesion-dependent signalling and associations with 
phosphatidylinositol4-kinase (PI 4-kinase) (Hemler, 1998; Yauch and Hemler, 2000) 
and the Src tyrosine kinases Lyn and Hck (Skubitz et aI, 1996) have been observed. 
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As suggested above, there is a possibility that CD63 might be involved integrin-
mediated adhesion strengthening or spreading of MGCs. A recent report showed that 
anti CD63 antibodies inhibited FCERI-dependent degranulation of adherent, but not 
nonadherent, mast cells (Kraft et aI, 2005). The anti CD63 antibodies also inhibited 
mast cell adhesion to fibronectin and vitronectin. Anti CD63 antibodies were shown 
to impair signalling via the Gab2-PI3 kinase pathway, which is known to be essential 
for both pI-dependent adhesion and degranulation. Hence, antibodies to CD63 or 
EC2CD63 might affect adhesion-dependent signalling in monocytes undergoing 
MGC formation. 
As discussed in chapter 1 (1.2.5.4.), it has been suggested that MGC formation occurs 
through a process akin to phagocytosis. Several groups have observed that 
phagocytosis of whole cells appears to occur during MGC formation (Gasser and 
Most, 1999 and references therein; Vignery, 2005a) leading to a model termed 
"cellocytosis" (Vignery, 2005a). According to this model, after the binding of one 
macrophage to another, one cell takes the lead and phagocytoses the other. McNally 
and Anderson also very recently demonstrated that fusion to form multinucleated 
giant cells (FBGCs) exhibits features of ER-mediated phagocytosis (McNally and 
Anderson, 2005). CD63 has also been implicated in phagocytosis. For example, it has 
been shown that CD63 is selectively internalised from the plasma membrane during 
phagocytosis of yeast particles by immature dendritic cells (Mantegazza et aI, 2004). 
It is possible that CD63 might also be involved in "cellocytosis" giving rise to multi-
nucleated giant cells. It would be interesting to investigate the effects of the 
tetraspanin EC2s on phagocytosis. 
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